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Abstract
The yeast Saccharomyces cerevisiae utilizes nutrient sensor activity at the
plasma membrane to regulate growth. Amino acids are sensed by the membrane
protein Ssy1p, and a signal is transduced to the novel intracellular regulatory
protein Ptr3p. This leads to an upregulation of the expression of amino acid
permease genes and PTR2, the gene encoding the di/tri-peptide transporter
Ptr2p. Using a reporter gene assay, this study found that various amino acids
induced PTR2 expression to different levels. Peptide and amino acid induction
required Ptr3p, while Ssy1p was required for amino acid induction, but not
peptide induction. Ptr3p-mediated, amino acid/dipeptide-induced expression of
PTR2 did not involve transcriptional regulation of CUP9, a gene encoding a
repressor of PTR2 expression. A functional chimeric protein formed by the fusion
of GFP to the N-terminus of Ptr3p was found to be associated with the plasma
membrane in a punctate pattern. A two-hybrid and co-immunoprecipitation
analysis showed that Ptr3p interacted with the cytoplasmic, N-terminal 282
amino acid domain of Ssy1p further supporting the suggestion that Ssy1p/Ptr3p
interaction was involved in generating a signal after amino acid sensing.
We also showed that STP1 and STP2, genes previously hypothesized to
encode pre-tRNA splicing proteins and bind to the BAP2 promoter as
transcription factors, were required for regulation of the di/tri-peptide transport
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system. The data provide the first evidence about the involvement of STP1 and
STP2 in the di/tri-peptide transport system suggesting their function as
transcription factors of PTR2. In contrast to the PTR2 expression pattern, in
medium containing a rich nitrogen source STP1 and STP2 are expressed at
higher levels in comparison to their expression in medium with a poor nitrogen
source. STP2 likely acts downstream of PTR3 as shown by epistasis studies, and
PTR3 does not regulate the expression of STP1 or STP2.
To provide insights into the function of Ptr3p, we performed a two-hybrid
analysis to identify proteins that may interact with Ptr3p. We identified proteins
involved in transport, transcription processes, and unknown functions
suggesting that Ptr3p plays role in numerous pathways. We used two different
computational algorithms to predict that Ptr3p contains two putative nuclear
localization signals (NLS), and alanine substitution of one of these NLS
decreased its function as a regulator of PTR2. PROSPECT, a 3-dimensional
protein structure algorithm, also calculated that Ptr3p has a RING finger and a
seven-bladded β-propeller motif. Alanine site-directed mutagenesis of some
conserved residues in the ring finger motif reduced the function of Ptr3p.
Mutations within the predicted β-propeller motif indicated that this motif may
act as an autoinhibitory domain, because their substitution resulted in a more
functional mutant than the wild type Ptr3p. Finally, we identified functional
ix

domains of Ptr3p. The expression of Ptr3p residues 1-250 or 1-500 partially
complemented a ptr3∆ phenotype, and residues 250-678 appeared to be as
functional as full length Ptr3p. These results add further to an understanding of
the role of Ptr3p in the amino acid induced signal transduction pathway.
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PART I
GENERAL INTRODUCTION

1

CHAPTER I
A REVIEW OF THE PEPTIDE TRANSPORT LITERATURE

The ability of organisms to engage in carrier-mediated transport of small
peptides (two to five amino acids) is ubiquitous. Peptide transporters with
obvious structural similarities have been documented in bacteria, fungi, plants
and animals. Peptide transport is important in terms of sources for amino acids,
carbon, and nitrogen, whether these nutrients being scavenged from the
environment by free-living microorganisms or absorbed from body fluids by
metazoans. Additionally, in mammalian systems, these transporters have also
been documented as a means for absorption of peptidomimetic drugs, including
β-lactam antibiotics, angiotensin converting enzyme (ACE), and renin inhibitors
(Leibach and Ganapathy 1996; Yang et al. 1999).
The common baker's yeast Saccharomyces cerevisiae provides a suitable
model eukaryote for the study of peptide transport. The sequence of its genome
is complete, making it amenable to genetic analysis. Furthermore, the organism
can be easily maintained and manipulated for use in physiological assays. This
introduction will summarize the function and regulation of the peptide transport
systems of S. cerevisiae and will integrate this information into the rapidly
2

emerging field of peptide transport in other organisms. Reviews on the subject
of proton-coupled peptide transport in higher eukaryotes have been published
recently (Daniel and Herget 1997; Fei et al. 1998; Meredith and Boyd 2000).

Function of the peptide transport systems of S. cerevisiae.

Distinction between dipeptide and oligopeptide transport and multiplicity of
peptide transport families.
S. cerevisiae has two genetically and physiologically distinct proton-coupled
peptide transport systems. The PTR (Peptide TRansport) system is specific for
di/tri-peptides and consists of at least three inter-dependent genes. PTR2
encodes an integral membrane protein (Ptr2p) involved in the physical
translocation of peptides across the plasma membrane. PTR1 regulates the
transcription of PTR2 and is essential for peptide transport. PTR3 is another
regulatory element, and while not absolutely essential, enhances the expression
of PTR2.
Tetra- and pentapeptides are transported by members of the OPT
(OligoPeptide Transport) family, first described in the human pathogen Candida
albicans (Lubkowitz et al. 1997). At least 3 different members of the OPT family
exist in S. cerevisiae. The best studied of these members is Opt1p which transports
3

both the opioid pentapeptide enkephalin and glutathione. No regulatory
elements for the OPT system with homology to PTR1 or PTR3 of the PTR system
have been identified. The OPT family is much smaller than the PTR family, and
to date, members have been limited to fungi and plants. The OPT family is
distinct from the PTR family with no homology between the two families at both
the DNA and protein sequence levels. Despite the clear differences in substrate
specificity between these two families, there are features common to both
groups. Transport is dependent upon the proton-motive force and is enhanced
by growth on a poor nitrogen source and by the presence of micromolar
quantities of amino acids in the growth medium.
With the rapid discovery of di/tri-peptide and oligopeptide transporters
in many diverse organisms, some confusion has arisen with the nomenclature for
the various groups. The family of di/tri-peptide transporters has been called the
PTR family (Steiner et al. 1995) and the POT (Proton-dependent Oligopeptide
Transport) family (Paulsen and Skurray 1994; Saier 2000). The POT term was
proposed before the identification of proteins in eukaryotes that transport
authentic oligopeptides, namely those consisting of four or more amino acids.
Furthermore, within this family, individual members have been named "OPT" as
well, such as the Drosophila “OPT 1,” (Roman et al. 1998) and the C. elegans
“OPT1,” “OPT2” and “OPT3” (Fei et al. 2000), providing further confusion as to
the nature of the substrate that is being transported. For the purposes of the
4

present discussion, the term "PTR family" refers to transporters demonstrated to
translocate only di/tri-peptides. The name "OPT family" is reserved for those
transporters that have been demonstrated to translocate peptides of four or more
amino acids.
Historically, the first reported peptide transporters were described in
prokaryotes as ABC transporters (ATP-Binding Cassette), also referred to as
traffic ATPases. The common term used is ABC transporters. The bacterial
transport systems include Dpp and Opp from E. coli and Salmonella typhimurium
(reviewed by Payne and Smith 1994) that are relatively specific for dipeptides
and peptides from two to six amino acids, respectively. Eukaryotic members of
this superfamily include the pharmacologically important multi-drug resistance
protein (P-glycoprotein) and cystic fibrosis transmembrane conductance
regulator (CFTR). Much later, bacteria were found to also possess PTR family
transporters, including the DtpT transporters of Lactococcus lactis and Bacillus
subtilis (Hagting et al. 1994: Saier et al. 1999). Several as yet uncharacterised E. coli
transporters, including YhiP, DtpT, f493 and YjdL have also been identified
(Saier 1999). The proton-coupled permeases are not traffic ATPases and are
encoded by a single gene, rather than the operon organization of Dpp and Opp.
In addition, the tripeptide permease Tpp of S. typhimurium may represent a third
class of transporter that is energized by the proton-motive force, but is neither a
traffic ATPase or a PTR family member (Smith et al. 1999). Recently, two
5

additional families of proton-motive force driven peptide transporters have also
been described (Saier 2000). The PAT (Peptide-Acetyl-CoA Transporter) family
members are found in bacteria and eukaryotes. While largely uncharacterised,
members of this family are thought to transport acetyl coA in the endoplasmic
reticulum and golgi of humans and small peptides into E. coli. The PUP
(Peptide-Uptake Permease) family is restricted thus far to E. coli and Rhizobium
meliloti and is involved in the uptake of thiazole ring-containing peptide
antibiotics.

The PTR System.
The ability of S. cerevisiae to transport intact di/tri-peptides was investigated in
the 1970's (Naider et al. 1974; Becker and Naider 1977, Becker and Naider 1980 for
review). Multiple transport systems were not detected, but evidence for
regulation was described. The uptake of peptides was substantially greater in
cells grown on a poor nitrogen source, such as proline, when compared to cells
grown on a rich nitrogen source, such as ammonium sulfate (Becker and Naider
1977; Nisbet and Payne 1979). Subsequent work added another level of
regulation by showing that peptide transport activity could be further induced
by micromolar concentrations of amino acids in the nitrogen-poor growth
medium (Island et al. 1987). Genetic complementation analysis coupled with Nmethyl-N-nitro-N-nitrosoguanidine mutagenesis documented that peptide
6

transport involved at least three components, identified as PTR1, PTR2 and PTR3
(Island et al. 1991). The transcription of PTR2 is regulated by PTR1, and PTR1 is
essential for peptide transport. PTR2 expression is also regulated by PTR3.
However unlike PTR1, PTR3 is not absolutely essential, but is required for the
optimal expression of PTR2. The isolation and characterization of PTR1 and
PTR3 have been completed and are detailed in a later section of this introduction
(Regulation of the peptide transport systems, p. 25). PTR2 isolation and
characterization are detailed below.

PTR2.

Ptr2p, the protein encoded by PTR2, is necessary and sufficient to translocate
di/tri-peptides into the yeast cell. First described by Perry (Perry et al. 1994), it
encodes an integral membrane protein of 601 amino acids containing predicted
12 membrane-spanning domains. The transporter is specific for di/tri-peptides,
with a preference for peptides containing hydrophobic amino acids.
Energetically, transport is coupled to the proton-motive force with a transport
optimum at pH 5.5.
Using the sequence for Ptr2p as the query in a BLAST search (Altschul et
al. 1997), over 100 high quality hits on the sequence query in a plethora of
organisms including bacteria, other fungi, plants, mammals, Drosophila and
Caenorhabditis elegans were found. A phylogenetic tree of approximately thirty
7

non-redundant hits was constructed to determine the degrees of relatedness
among the family members (Fig. 1). Interestingly, most of the family members
were segregated into groups based on the type of organism (i.e. mammal,
invertebrate, plant or fungus). Within the mammalian members, further
segregation occurred based on tissue of origin (intestine, kidney or brain). It is
also of interest to note the redundancy of peptide transporters in various species
with PTR family members. Arabidopsis thaliana and C. elegans have several
distinct PTR2 homologues. In humans, the characterized PTR family homologs
are limited to hPEPT1 and hPEPT2, found primarily in small intestine and
kidney, respectively. Additional uncharacterised human orthologues to the rat
brain transporter have been identified by bioinformatic analysis of the human
EST database (Botka et al. 2000). Northern blot analysis of the putative PTR
family members hPHT1 and hPHT2 revealed broad tissue distribution. However,
no expression was detected in the brain. Detailed analysis of the sequence
alignment of these PTR family members reveals a number of highly conserved
regions across this family of proteins occurring primarily within the membrane
spanning domains (Fig. 2). The most highly conserved is the “FYING” motif,
named for the conserved F247, Y248, I251, N252 and G254 residues in the fifth
transmembrane domain (TMD). In a few members of the PTR family, the Y248
residue is not conserved (data not shown) and so this consensus sequence has
also been called the “FING” region (Steiner et al. 1995). Other conserved
8

Fig. 1. PTR family tree (Hauser et al., 2001). Approximately thirty non-redundant
hits from a BLASTP search were used to construct the tree using the CLUSTAL
method (Lasergene 99, DNASTAR Inc., Madison, WI). Family members that
have been physiologically characterized are indicated in bold, while italics
indicates theoretical translations. The NCBI GI number is listed next to each
member.
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A. thaliana 440678
A. thaliana 2160144
A. thaliana 1076331
A. thaliana PTR2-B 1172704
Tomato 4102839
Almond 6635838
Rice 6409176
A. thaliana 6822060
A. thaliana 6759441
Barley 489404
A. thaliana 6587832
Tobacco 9581819
Rat Brain 2208839
Mouse Macrophage 4580995
Rat Intestine 1730492
Mouse Intestine 8925899
Human Intestine 1172435
Rabbit Intestine 548474
Human Kidney 2833272
Rabbit Kidney 1172436
Rat Kidney 2499990
Mouse Kidney 7228472
Drosophila 7290444
Drosophila OPT1 4115343
C. elegans OPT-3 7672730
C. elegans OPT-2 2811011
C. elegans 7411560
Drosophila 7299229
S. pombe 9453830
S. cerevisiae PTR2 486583
C. albicans CaPTR2 1172741
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sequences include the WQIPQY in TMD 10 and EXCERFXYYG in TMD 1. Based
on sequence conservation described above, site directed mutagenesis of highly
conserved regions has been used to pinpoint residues important for transporter
function in PTR family members. Ala-scanning mutagenesis of F247, I251, N252
and G254 of the “FYING” motif in S. cerevisiae results in decreased ability of
strains carrying these mutations to grow on dipeptides, decreased sensitivity to
toxic dipeptides, and virtually eliminated transport of radiolabeled dileucine
(Wiles and Becker, unpublished observation). Mutagenesis of the low-affinity
human intestinal homologue, hPept1, and its renal high-affinity counterpart,
hPept2, has also been undertaken. The residue Y167 in the intestinal transporter
is homologous to Y248 in the “FING” motif region of the S. cerevisiae Ptr2p.
Mutagenesis of this residue (Y167A, Y167 F, Y167S, Y167H) rendered the protein
unable to transport peptide (Yeung et al. 1998), suggesting an essential role for
this residue in peptide transport. Mutagenesis of two other highly conserved
residues in hPepT1 (W294 and E595; W362 and E480 in the S. cerevisiae protein,
respectively) also rendered the protein inactive (Bolger et al. 1998). A residue
that is vital for transporter function of hPept1, but has no counterpart in yeast, is
H57. Mutagenesis of this residue (H57A, H57N, H57Q) eliminated peptide
transport by hPEPT1 expressed heterologously in Xenopus oocytes (Meredith and
Boyd 1996; Terada et al. 1996; Fei et al. 1997).

11

Fig. 2. Highly conserved regions in nine representative members of the PTR
family (Hauser et al., 2001). The consensus sequence determined using the
CLUSTAL method (Lasergene 99, DNASTAR Inc., Madison, WI) is indicated
above each alignment. Residues that match the consensus are boxed. The bars
above the consensus indicate the relative location of the consensus sequences in
relation to the putative transmembrane domains. The number in the left-hand
column corresponds to the first residue of the consensus sequence of each
protein. The NCBI GI number is listed next to each member.
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88
34
54
54
54
23
22
52
42

243
195
200
200
200
153
162
183
172

466
450
473
472
472
575
581
608
593

NE.CERF.YYG.

Consensus

VELSERFSYYGL
AELLERAAFYGV
NECCERLAYYGI
NECCERLAYYGI
TECCERLAFYGI
NEFCERFSFYGM
NEFCERFSYYGM
NEFCERFSYYGM
NEFCERFNYYGM

S. cerevisiae PTR2 486583
Rat Brain 2208839
A. thaliana 1076331
A. thaliana PTR2-B 1172704
Almond 6635838
C. elegans OPT-3 7672730
Human Intestine 1172435
Rabbit Kidney 2833272
Drosophila OPT1 4115343

FF..FYF.IN.GSL.

Consensus

VFMFFYFMINVGSLS
FFNWFYWSINLGAIL
FFNWFYFSINIGALV
FFNWFYFSINIGALV
FFNWFYFSINIGALV
FFSFFYFAINGGSLF
FFSIFYLAINAGSLL
YFSGFYLAINAGSLI
FFSLFYFAINAGSLI

S. cerevisiae PTR2 486583
Rat Brain 2208839
A. thaliana 1076331
A. thaliana PTR2-B 1172704
Almond 6635838
C. elegans OPT-3 7672730
Human Intestine 1172435
Rabbit Kidney 2833272
Drosophila OPT1 4115343

..WQIPQY.

Consensus

VCWQIPAYV
IWWQIPQYV
VLWQIPQYF
VLWQIPQYF
IFWQIPQYF
ILWSLPQYI
MALQIPQYF
IAWQLPQYA
ILWQLPQIV

S. cerevisiae PTR2 486583
Rat Brain 2208839
A. thaliana 1076331
A. thaliana PTR2-B 1172704
Almond 6635838
C. elegans OPT-3 7672730
Human Intestine 1172435
Rabbit Kidney 2833272
Drosophila OPT1 4115343
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The OPT System.

A second peptide transport activity, genetically and physiologically distinct from
the PTR system, exists in fungi. First described in the yeasts C. albicans and
Schizosaccharomyces pombe (Lubkowitz et al. 1997; Lubkowitz, et al. 1998), OPT
family members translocate tetra- and pentapeptides across the plasma
membrane.

Like the PTR system, oligopeptide transport is coupled to the

proton-motive force (Hauser et al., 2000), and activity of the C. albicans
transporter has been found to be sensitive to nitrogen source and low
concentrations of amino acids in the growth medium (Lubkowitz et al. 1997). By
sequence homology to CaOpt1p additional members of the OPT family have
been identified, including three homologues in S. cerevisiae.

Unlike the

ubiquitous PTR2 family, the OPT family thus far appears limited to fungi and
plants (Fig. 3), with the fungal members more closely allied to each other than to
the plant members. Recently, nine oligopeptide transporter (OPT) orthologs
(AtOPT1 to AtOPT9) in Arabidopsis were identified (Koh et al., 2002). Based on
hydropathy analysis, the family members are predicted to have 12 – 14
transmembrane domains. Sequence comparisons showed that the AtOPTs form
a distinct subfamily when compared to the fungal OPTs (Figure 3). Hauser et al.
(2001) found three regions of high conservation (SPYXEVRXXV, NPG-PFXXKEH,
and GLNXXTEXIXGY) upon comparing the sequences of seven OPT family
members. However, only the second of these motifs is highly conserved, with an
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Fig. 3. OPT family tree (Stacey and Becker, personal communication). Twenty
protein sequences from plants and fungi were aligned using ClustalX (1.81;
Thompson et al., 1997). Phylogenetic trees were generated using the neighborjoining algorithm in Phylip3.57c (Felsenstein, 1993). Numbers on the branches
indicate bootstrap values out of 100. Sequences are annotated with NCBI GI
numbers.
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invariant glutamine residue, when all current members of the OPT family are
compared (Figure 4).

In addition, this comparison revealed an additional

conserved region, the KP motif, K[L/F][G/A][H/M/T]YMK[I/V/L][P/D/S]PR.
The final invariant amino acid, glycine, found in all OPT members is found in the
sequence FFIIGA. These various motifs are found in regions predicted to be
hydrophilic suggesting that they are probably critical to function.
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Multiplicity of OPT genes in S. cerevisiae.
Of the three homologs identified in S. cerevisiae, the best characterized is encoded
by the gene OPT1, while the second is encoded by the ORF YPR194c. The third
homologue (ORF YGL114w) has been identified only by sequence homology.
The OPT family homologs characterized in Saccharomyces (Opt1p and Ypr194cp)
are different from those in C. albicans and S. pombe in that the S. cerevisiae
members are not expressed during vegetative growth conditions. No mRNA or
phenotypic expression of either OPT1 or YPR194c was initially discovered.
Functional genomic analysis such as serial analysis of gene expression (SAGE)
(Velculescu et al. 1997) and DNA microarray analysis (Chu et al. 1998) suggests
that these genes are expressed during sporulation. To see expression of OPT1
and the product of YPR194c in log phase cells, it was necessary to place the genes
under the control of the constitutive ADH promoter (Lubkowitz et al. 1998).
Under these conditions it was determined that the protein encoded by YPR194c
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Fig. 4. OPT conserved domains (Stacey and Becker, personal communication).
ClustalX (1.81; Thompson et al., 1997) alignment of twelve OPT sequences from
plants and eight OPT sequences from fungi indicated the presence of four
conserved amino acid residues. Numbers at the top indicate the positions of the
three domains with respect to the consensus sequence. Sequences are annotated
with NCBI GI numbers.
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conferred roughly the same phenotypic characteristics as the C. albicans and S.
pombe OPT transporters: growth on tetra- and pentapeptides, sensitivity to toxic
peptides and ability to transport radiolabeled KLGL peptide.

Enkephalin transport by Opt1p.
Reports in the literature suggested that endogenous opioids are translocated
across the vascular endothelium via a saturable transport system (Banks and
Kastin 1997), but no specific protein carrier had been identified. Recently, we
have discovered that Opt1p (Hauser et al. 2000) transports the opioids leucine
enkephalin (YGGFL, leu-enkephalin) and methionine enkephalin (YGGFM, metenkephalin) into S. cerevisiae. A strain expressing Opt1p under the constitutive
ADH promoter grew on leu-enkephalin or met-enkephalin as a sole source of
leucine or methionine, respectively, to satisfy auxotrophic requirements. These
same cells also accumulated intact radiolabeled leu-enkephalin with an apparent
Km of 310 µM. It was verified that extracellular hydrolysis of the peptide did not
occur, although it was rapidly hydrolysed inside the cell. Like the PTR system,
leu-enkephalin transport is driven by the proton-motive force, with a pH
optimum of 5.5. Additionally, transport is sensitive to temperature and to
uncouplers of cellular energetics as well as the sulfhydryl reagent pCMBS.
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Inhibition of leu-enkephalin transport.
Opt1p does not transport free tyrosine, or di- and tripeptides such as leucylleucine and GGF as determined by competition with radiolabeled leu-enkephalin
for uptake. The tetrapeptides GGFL, KLGL, and the pentapeptide metenkephalin competitively decrease leu-enkephalin transport, suggesting that the
amino terminal tyrosine is not required for substrate recognition. Only weak
inhibition of transport was seen in the presence of amidated leu-enkephalin or
the amidated tetrapeptide Tyr-MIF-1, a known substrate for the opioid transport
activity of the mammalian central nervous system (Barrera et al. 1989),
suggesting that the carboxyl terminus is required for substrate recognition by
Opt1p.
Peptide opioid receptor antagonists, such as DADLE (Tyr-D-Ala-Gly-Phe-DLeu enkephalin) and DPDPE (Tyr-D-Penicillamine-Gly-Phe-D-Penicillamine
enkephalin) also antagonize transport of leu-enkephalin. Interestingly, naloxone
and naltrexone, which are non-peptide opioid receptor antagonists, also inhibit
uptake of leu-enkephalin in yeast, suggesting that the receptor and the Opt1
transporter recognize similar molecular features. We have also determined that
naloxone is transported by Opt1p with a very low affinity, further confirming its
interaction with the transporter (Hauser and Becker, unpublished observation).
Naloxone and naltrexone do not inhibit the function of Ptr2p, suggesting that the
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inhibitors are interacting directly with Opt1p and not simply disrupting
membrane integrity.

Glutathione transport.
Recently, Opt1p has also been found to be a high-affinity glutathione transporter
(Bourbouloux et al. 2000), the first described for any eukaryote. Glutathione is
the most abundant non-protein thiol compound present in almost all prokaryotic
and eukaryotic cells. It plays numerous roles including control of redox potential,
protection against oxidative stress, detoxification of endogenous and
exogenously derived toxins, protein folding, storage, and transport of organic
sulfur (Meister and Anderson, 1983; May et al, 1998). The uptake of GSH (γ-GluCys-Gly) was measured in several yeast strains with selected transporter gene
disruptions (ptr2 , ypr194c , opt1 ,) individually and in combination. Only
strains containing a functional copy of OPT1 were able to transport GSH. Kinetic
analysis yielded an apparent Km of 52 µM for GSH by Opt1p. Both oxidized
glutathione and the glutathione conjugate GS-NEM competed for GSH uptake.
As expected, di- and tripeptides did not compete (Bourbouloux et al. 2000).
Recent work in our laboratory has shown that leu-enkephalin also competes with
GSH uptake, and visa versa (Donhardt and Becker, unpublished observation),
although our results suggest a slightly higher Km for GSH as compared to that
reported by Bourbouloux and coworkers. Taken together, these data suggest that
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Opt1p is a multifunctional protein that participates in glutathione transport and
oligopeptide transport.

Regulation of the peptide transport systems.

Regulation of peptide transport in prokaryotes.
In prokaryotes, little is known about regulation of peptide transport systems. The
dpp operon, for example, is negatively regulated by phosphate limitation in E.
coli, but not regulated by nitrogen source, amino acids, or peptides (Smith and
Payne, 1992). The explanation for why phosphate limitation regulates dpp
expression remains unclear. The expression of opp genes, on the other hand, was
repressed by the amino acid leucine (Austin et al., 1989). Lrp, which is a leucineresponsive regulatory protein, modulated this negative leucine regulation on opp
transcription. Interestingly, the expression of the high-affinity transport of
branched-chain amino acids operons, livJ and livKHMGF, were repressed by Lrp,
but leucine relieves the Lrp negative regulation (Calvo and Matthews, 1994). The
mechanism of Lrp regulation was proposed to be the result of intracellular
leucine sensing. Intracellular leucine binds to Lrp, and the Leu-bound Lrp goes
through a conformational change that alters its ability to interact with DNA or
other proteins (Calvo and Matthews, 1994). Another regulation involves a
repression by GcvB, which encodes a small-untranslated RNA, of opp and dpp
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(Urbanowski et al., 2000). The mechanism is unknown, but opp regulation occurs
likely at the translational level, while dpp regulation seems to be at the mRNA
level.
Another type of peptide transport regulation is observed in the expression
of the Tpp operon in S. typhimurium. The Tpp transcription is not regulated by
nitrogen or carbon source, but is induced by anaerobic growth conditions and
amino acids like leucine (Gibson et al., 1987). However, unlike the Opp
regulation, which occurs as a response to intracellular amino acid, the
modulation of Tpp expression is a result of extracellular amino acid sensing. A
two-component sensor, coded by the ompB genes, is required for this type of
regulation to occur (Gibson et al., 1987; Stock et al., 1989). The extracellular
leucine was sensed by this sensor and regulatory signals were transduced
leading to induction of Tpp. The detailed signal transduction mechanism of this
pathway is not known.

Regulation of peptide transport in eukaryotes.
Peptide transport systems identified in eukaryotes belong either to the OPT
family, transporters that translocate peptides of four or more amino acids or the
PTR family, transporters that translocate di/tri-peptides. The OPT transporters
identified in fungal genera Candida albicans (Lubkowitz et al., 1997), Saccharomyces
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cerevisiae (Lubkowitz et al., 1998) and Schizosaccharomyces pombe (Lubkowitz et al.,
1998) are regulated by poor nitrogen source. The C. albicans transporter activity
was sensitive to nitrogen source and low concentrations of amino acids in the
growth medium. In 1991, Payne et al. reported that the addition of peptide
mixtures to the culture medium increased the transport of oligopeptides and
di/tri-peptides. In the mammals, another peptide transport system was observed
in the bi-directional tranport of peptides across the blood-brain barrier. Whether
this transport system belongs to the OPT family and under a similar regulation is
under investigation. However, it is suggested that alcohol regulates the tranport
of the pentapeptide methionine enkephalin since peptide transport system 1
(PTS-1) modulates the uptake of an opiate methionine enkephalin (Plotkin et al.,
1997). Other types of regulation are not known.
Di/tri-peptide transport in plants was initially observed in the scutellum,
an absorptive tissue surrounding the endosperm, of barley and wheat seeds
(Sopanen et al., 1977; Higgins and Payne, 1980; Salmenkallio and Sopanen, 1989).
Photoaffinity cross linking with a dipeptide analog identified two candidate
proteins (66 and 41 kd) involved in this transport system (Hardy and Payne,
1991). The 66-kd protein is identical to the recently identified di/tri-peptide
transport HvPTR1 protein expressed in the scutella of germinating barley grain
(Waterworth et al., 2000). Sequence analysis of the full-length HvPTR1 cDNA
(2260 bp) revealed an open reading frame with 58% identity to the Arabidopsis
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thaliana peptide transporter AtPTR2-B (West et al., 1998). Peptide transport in
plants should provide a significant source of nutrients for plant development.
For example, HvPTR1 expression was detectable only during early germination,
while inhibition of AtPTR2-B expression by its antisense message caused a late
flowering and arrested seed development (Song et al., 1997).
In humans, the PTR family homologs that have been characterized are
limited to hPEPT1 and hPEPT2, found primarily in the small intestine and
kidney, respectively. Regulation of di/tri-peptide transport in mammals has
been less studied at the molecular level than in yeast. The expression of PEPT1
seems to be under developmental regulation in a tissue- and cell-type specific
manner. For example, besides the small intestines, hPEPT1 was also observed in
the liver, showing that it may function to clear the products of peptide hormone
degradation (Nussberger et al., 1997). The intestinal expression of PEPT1 was
induced postpartum, possibly by suckling, and again at the time of weaning
(Shen et al., 2001). Its expression was also observed in the colon only during the
first week of life.
Expression studies with rat and rabbit homologs of hPEPT1 confirm their
function in mediating small peptide uptake. The rat homolog of hPEPT1 was
specifically expressed in the brush border epithelial cells of the intestine (Wenzel
et al., 1996). The rat PEPT1 was the predominant carrier of β-lactam antibiotics in
the rat small intestine, showing that peptide absorption by the intestine is an
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important phenomenon for oral drug delivery (Fricker and Drewe, 1996; Walter
et al., 1996). The rabbit PEPT1 expression was abundant in the small intestine,
supporting its role as a small peptide transporter in the small intestine (Fei et al.,
1994). PEPT1 expression was increased after a brief fasting or malnourishing
conditions (Lee et al., 1999; Ihara et al., 2000). Furthermore, the up-regulation of
rat PEPT1 was affected by selective amino acids (Phe, Arg, and Lys) and
dipeptides (Gly-Sar, Gly-Phe, Lys-Phe, and Asp-Lys) through transcriptional
activation of the PEPT1 gene (Shiraga et al., 1999). Thus, functional expression of
PEPT1 is affected by dietary intake.
In the human intestinal cell line Caco-2, hPEPT1 mRNA half-life,
transcription, and protein levels are also induced after growth in peptide
containing medium (Walker et al., 1998). A direct response of Caco-2 cells to
peptides indicates that peptide induction of hPEPT1 is independent of regulation
by neurons or hormones (Walker et al., 1998). However, hormonal regulation of
hPEPT1 exists. Insulin, for example, did not change the hPEPT1 mRNA, but the
amount of hPET1 protein was increased at the apical membrane. The mechanism
appears to be increased translocation of the transporter from a preformed
cytoplasmic pool (Thamotharan et al., 1999). EGF treatment, on the other hand,
negatively regulates peptide uptake in Caco-2 cells by decreasing the number of
hPEPT1 protein in the apical membrane (Nielsen et al., 2001).
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In another study, protein kinase C (PKC) activity resulted in a decrease in
the peptide uptake rate in Caco-2 cells (Brandsch et al., 1994). Protein synthesis
was not required in the PKC-dependent negative regulation of peptide transport.
Furthermore, flavonoids that inhibit epidermal growth factor-receptor tyrosine
kinase activity stimulate PEPT-1-mediated uptake of the beta-lactam antibiotic
cefixime in Caco-2 cells (Wenzel et al., 2001). Thus, protein kinase activity may
directly regulate the intestinal peptide transport.
LLC-PK1, an hPept2 homologue, was described in porcine kidney cells
(Wenzel et al. 1998) and demonstrated to be regulated by PKC- and protein
kinase A (PKA) -dependent signalling pathways via a change in substrate
affinity (Wenzel et al. 1999). Although PKC and PKA sites are present in the loop
between the eighth and ninth TMDs, it is unclear whether the kinases act directly
on the transporter or exert their effects indirectly. Interestingly, the Ptr2p
transporter of Saccharomyces lacks this loop region. The regulation of expression
of PTR2 has an absolute requirement for PTR1 (Alagramam et al. 1995) and can
also be enhanced by PTR3 (Barnes et al. 1998). Regulation of di/tri-peptide
transport system will be discussed in further details in a section below.
In rat choroids plexus, PEPT-2 was shown to mediate the uptake of
neuropeptides (Teuscher et al., 2001). This transporter was recently found to be
expressed in the peripheral nervous system (Groneberg et al., 2001a) and lung
(Groneberg et al., 2001b), where PEPT-2 may serve as uptake system for products
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of protein degradation, for removal of biologically active short-chain peptides
and non-peptides such as peptidomimetics. In the kidney cells, a calmodulin
antagonists affected the peptide transport activity, indicating that calmodulin
modulated the peptide uptake in the kidney (Brandsch et al., 1995).
Regulatory elements of peptide transport in S. cerevisiae.
The S. cerevisiae di/tri-peptide transport is regulated by at least 2 genes, PTR1
and PTR3. PTR1 regulates the transcription of PTR2 and is essential for peptide
transport. PTR3 is another regulatory element, and while not absolutely
essential, enhances the expression of PTR2. Regulatory elements including those
with homology to PTR1 or PTR3 of the PTR system have not been identified in
the OPT system making it difficult to initiate study of peptide regulation in this
system. Therefore, instead of the newly discovered OPT family, the PTR system
was used as a model system to study the regulation of peptide transport in S.
cerevisiae. In this dissertation, I focused on regulation of di/tri-peptide transport,
which is discussed in detail below.

Regulation of di/tri-peptide transport system.
The yeast PTR system is regulated in response to signals, which include nitrogen
source and the presence of small amounts of amino acids (Barnes et al., 1998;
Island et al., 1987). Transport was found to be up-regulated when cells were
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grown in a poor nitrogen source such as allantoin or proline, and downregulated in cells grown on a rich nitrogen source such as ammonium sulfate
(Becker and Naider, 1977; Nisbet and Payne, 1979). Peptide transport is also
subject to a high level of induction by micromolar amounts of various amino
acids irregardless of the nitrogen source (Island et al., 1987). Previous northern
analysis of PTR2 expression indicated that amino acid regulation of peptide
transport occurred at the level of gene expression (Perry et al., 1994). Finally,
di/tri-peptide uptake was accelerated by extracelullar dipeptides (Turner et al.,
2000). Regulation of di/tri-peptide tranport is mediated by at least two genes:
PTR1 and PTR3.
These genes were discovered along with PTR2 by a genetic
complementation analysis coupled with N-methyl-N-nitro-N-nitrosoguanidine
mutagenesis (Island et al. 1991). The transcription of PTR2 is regulated by both
PTR1 and PTR3. However, while PTR1 is essential for peptide transport, PTR3 is
not absolutely essential but is required for the optimal expression of PTR2. The
isolation and characterization of PTR1 and PTR3 have been completed and are
detailed below.

PTR1.

The ptr1 allele mutant is characterized by its total inability to utilize small
peptides to satisfy auxotrophic requirements, resistance to the growth inhibiting
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effects of toxic peptides and inability to accumulate radiolabeled dipeptides at
wild type levels (Island et al. 1991). In addition, ptr1 strains display subtle defects
in sporulation and slightly decreased growth rates (Alagramam, unpublished
observation; Bartel et al. 1990). Cloning of the PTR1 gene by functional
complementation of a S. cerevisiae ptr1 strain deficient in peptide transport
reveals that PTR1 encodes a soluble protein of 1950 amino acids, which is
identical to Ubr1p (Alagramam et al. 1995). The protein Ubr1p encoded by UBR1
was previously termed N-recognin (or E3), and was shown to be an essential
component of the N-end rule pathway, a ubiquitin-dependent protein
degradation system (Bartel et al. 1990). This system targets proteins carrying a
degradation signal called the N-degron (Bachmair et al. 1986), which comprises a
destabilizing N-terminal residue and a lysine residue (Bachmair and Varshavsky
1989, Varshavsky 1996). Further, Dohmen (Dohmen et al. 1991) found that
Ubr1p/Ptr1p acts in concert with a specific ubiquitin-conjugating enzyme
encoded by the gene UBC2/RAD6 in the degradation of N-end rule substrates.
Ubiquitin-dependent proteolysis is an important regulatory mechanism that
controls many cellular processes. In this pathway, ubiquitin (Ub) is activated for
transfer to substrate protein by ATP-dependent attachment to a ubiquitinactivating enzyme (E1). Ub is then transferred to a Ub-conjugating enzyme (E2),
which then transfers Ub to substrate proteins through an interaction with a Ubprotein ligase (E3), ultimately conjugated in an isopeptide linkage via a lysine
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residue of a substrate protein. Within the PTR system, the substrate for
ubiquitin-dependent protein degradation system mediated by Ubr1p/Ptr1p is
Cup9p, a protein previously shown to be involved in detoxification of copper in
S. cerevisiae (Varshavsky 1996). This protein was identified in a genetic screen
since mutations in CUP9 bypassed a requirement of PTR1 for peptide import and
PTR2 expression. Cup9p is a homeodomain-containing protein that binds to the
PTR2 promoter and, in the presence of Ubr1p/Ptr1p, is released from the
promoter relieving the repression of PTR2 expression (Byrd et al. 1998).
Several domains have been identified in Ubr1p/Ptr1p. A basic residuerich domain located between amino acids 1081-1220 is involved in binding to
Ubc2p/Rad6p (Xie and Varshavsky 1999). Furthermore, the RING-H2 domain
located between amino acids 1176-1367 is absolutely required for ubiquitylation
of N-end rule substrates, but not for binding of Ubr1p to Ubc2p/Rad6p or to
substrates. Premature truncation of the last 15 amino acids containing an acidic
tail of Ptr1p abolishes both peptide transport and ubiquitin-mediated
degradation of an engineered N-end rule substrate (Anderson and Becker,
unpublished observation). This suggests that this domain may be necessary for
protein-protein interaction between Ubr1p/Ptr1p and Cup9p or the ubiquitin
conjugating protein Ubc4p. Ubr1p/Ptr1p has two substrate binding sites, one for
N-terminal type 1 with basic residues and the other for N-terminal type 2 with
bulky hydrophobic residues (Kwon et al. 1999). In vitro studies showed that
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binding of dipeptides with destabilizing N-terminal residues at these sites
allosterically activated the degradation of Cup9p (Turner et al. 2000). The data
suggest that imported peptides bind to Ubr1p/Ptr1p and accelerate the
Ubr1p/Ptr1p-dependent degradation of Cup9p, thus relieving the Cup9p
repression on the PTR2 expression. However, since dipeptides are thought to
degrade quickly as they are transported into the cell, the question whether intact
dipeptide really binds to Ptr1p in vivo is critical to determine whether this
positive feedback mechanism occurs in the cytoplasm. Finally, UBR1/PTR1 is not
required for the expression of PTR3, another regulatory protein in di/tri-peptide
transport system (Barnes et al. 1998). Whether PTR1 and PTR3 regulate the di/tripeptide uptake within the same or different pathway (s) is unknown.

PTR3.
In contrast to ptr1 and ptr2 strains, which exhibited a total inability to utilize
small peptides to satisfy amino acid auxotrophic requirements, the ptr3 strain
was characterized by its partial ability to transport di/tri-peptides and by a
decreased sensitivity to the toxic amino acid analogs ethionine and mfluorophenylalanine (Island et al. 1991). Cloning of the PTR3 gene by functional
complementation of a peptide transport deficient S. cerevisiae ptr3 strain revealed
that PTR3 encoded a soluble 678 amino acid protein with no similarity to any
previously identified coding sequences (Barnes et al. 1998). Furthermore, Ptr3p
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did not contain any signature sequences indicative of previously characterized
functional motifs. Since mutations in PTR3 did not interfere with nitrogen
regulation of peptide transport, PTR3 is specifically required for amino acid
induction of peptide transport activity (Barnes et al. 1998). This gene is also
required for amino acid-induced expression of some amino acid permeases such
as BAP2, the gene encoding the branched amino acid permease. Moreover, PTR3
does not function strictly as an activator since it is also necessary for repression
of GAP1 (General Amino Acid Permease). Genetic analysis showed that PTR3
functions with CUP9 and PTR1 in regulating PTR2 expression (Barnes et al. 1998).
This finding indicates that the ubiquitin-mediated degradation of a
transcriptional repressor is linked with the amino acid sensing mechanism.
A gene required for amino acid sensing involved in regulating amino acid
permeases has been identified. This gene, SSY1, encodes Ssy1p, which is a
homologue of an amino acid permease (Didion et al. 1998, Iraqui et al. 1999).
Cells containing the ssy1∆ allele are resistant to toxic peptides and amino acid
analogues (Didion et al. 1998). Ssy1p does not transport amino acids, but
functions as a receptor for amino acids. An amino-terminal, cytoplasmic
extension found in Ssy1p, but not amino acid permeases, appears to be involved
in transducing a signal to intracellular target(s) subsequent to binding of amino
acid to an extracellular domain of Ssy1p. Characterization of single null mutant
ssy1∆ or ptr3∆ and the corresponding double mutant shows identical phenotypes
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indicating that Ptr3p interacts with Ssy1p for regulating expression of both
peptide transporters and amino acid permeases (Didion et al. 1998, Barnes et al.
1998, Klasson et al. 1999). Genetic interactions among SSY1, PTR3, and SSY5
further suggested that the products of these genes form an amino acid sensor
machinery named SPS, which stands for Ssy1p-Ptr3p-Ssy5p (Forsberg and
Ljungdahl, 2001).
We recently tested whether, in addition to amino acids, extracellular
dipeptides regulate the expression of PTR2. We showed that both the amino
acids and dipeptides induced PTR2 expression (Hauser et al., 2001). SSY1 was
critical for amino acid induction, but not as crucial for dipeptide induction. PTR3
is required for both amino acid and peptide induction, although it appears to
play a greater role in the latter case. The discovery of a dual role for PTR3 in
induction by either amino acids or dipeptides, suggests another layer of
regulation of peptide transport. It is uncertain whether dipeptides must be
transported into the cell or if they are detected by a dipeptide sensor similar to
Ssy1p. PTR2 is required for induction by dipeptides, but is not necessary for
amino acid induction. Recently, in vitro binding assays showed that dipeptides
accelerate peptide transport by binding to Ptr1p/Ubr1p (Turner et al. 2000). This
result may support the requirement for PTR2 in dipeptide induction since the
peptides must be transported by Ptr2p in order to enter the cells and interact
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with Ubr1p/Ptr1p. However, biochemical evidence indicates that dipeptides are
hydrolysed as soon as they are internalized (Payne and Smith, 1994).
The biochemical function of Ptr3p remains a mystery, although there are
some hints to its cellular role. There are no characterized homologs of Ptr3p in
the entire protein database, although an uncharacterised Ptr3p homologue has
been identified through the C. albicans genome sequencing project (Narita and
Becker, unpublished observation). A small region (amino acids 511-575) of Ptr3p
shows protein sequence homology to several amino acid permeases as well as to
the transcription factor Gcn4p (Klasson et al. 1999). The function of this portion of
Ptr3p is not known, although the region may serve as a regulatory amino acid
binding site. Use of the PEST-Find algorithm (Rechsteiner and Rogers 1996)
revealed that Ptr3p contains a sequence that closely matches the consensus for a
PEST motif (Barnes and Becker, unpublished observation) indicating its role as a
signal for ubiquitin-mediated protein degradation, similar to Cup9p. Obviously,
further study is required to unravel the function of Ptr3p and the protein
interactions involved in regulating peptide transport. This dissertation will
mainly focus on studying the di/tri-peptide transport through dissecting the
function of Ptr3p. Studies on the amino acid sensing system in S. cerevisiae
provide some hints on the function of this novel protein.
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Conclusion.
The recent expansion in the identification of new peptide transporters in both the
PTR and OPT families has served to underscore how little is known about these
important proteins. While we have knowledge of the gross characteristics of
these families of transporters, such as tissue expression, energetic coupling, and
substrate affinity and specificity, little is known about more subtle aspects of
their function, such as control of expression. In many cases, most notably within
A. thaliana, C. elegans and humans, multiple PTR family orthologues have been
identified within the same organism. Why is this redundancy of transporters
needed? Obvious possibilities are different kinetic properties (i.e. high vs. low
affinity transporters) and differential tissue expression, but the regulation of their
tissue-specific or developmental expression has not been investigated. In this
respect, work in S. cerevisiae will be useful since many genes involved in the
regulation of expression of PTR2 have been identified and their roles are being
elucidated. Perhaps some of what this system yields can be generalized to other
organisms.
The restriction of OPT family members to fungi, plants and bacteria raises
an interesting question. Do animals lack the ability to transport oligopeptides, or
are the DNA sequences of potential metazoan transporters so different from
those of the current OPT family members that they can not be identified by
sequence homology? If no OPT family orthologues or other oligopeptide
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transporters can be identified in animals, specifically in mammals, then the
fungal OPT family members provide a good target for peptidomimetic drug
delivery with a minimum of host side-effects. Clearly, a more extensive search
for mammalian homologs is warranted, as well as further investigation into the
regulation of OPT family member expression.
The lack of any sort of sequence homology between the PTR and OPT
families is also quite surprising. From an evolutionary standpoint, these proteins
did not evolve from a common ancestor, but still converged on a common
solution to complete similar tasks. It would be of interest to determine the
strategies employed by each of these transporters to selectively recognize either
di/tri-peptides or oligopeptides. The multiplicity of peptide transporters and
the regulation of their expression and activity present a fascinating and
challenging biological system for further study.
As discussed above, little is known about the detailed mechanism of
peptide transport regulation. Previously, a novel regulatory component of the
PTR system in S. cerevisiae, PTR3, was cloned and analyzed, providing a starting
point to unravel regulatory pathways of peptide transport (Barnes et al., 1998).
Although it was proposed that Ptr3p is involved in amino acid induction of
peptide transport as a component of an amino acid sensor machinery together
with Ssy1p and Ssy5p (Klasson et al., 1999), the biochemical function of Ptr3p is
unknown. In this study several studies were proposed, and the data obtained
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should give useful information to define Ptr3p function (Fig. 5). First, the
involvement of Ptr3p in both amino acid and dipeptide induction of peptide
transport should be analyzed. Evidence of physical interaction between Ptr3p
and the amino acid sensor Ssy1p, as well as the cellular localization of Ptr3p,
would form a foundation to determine the function of Ptr3p. Further insights
into the function of Ptr3p should be gained by establishing a connection between
PTR3 and other genes known to modulate peptide transport. These data would
constitute a rough draft of the regulatory network within peptide transport
regulation pathways. Finally, a computational algorithm together with site
directed mutagenesis studies could be utilized to identify any motif or functional
domain in Ptr3p. Such information would provide hints on how Ptr3p regulates
the peptide transport process. In this dissertation, I report the molecular, genetic,
and functional analysis of Ptr3p, a novel regulatory protein of peptide transport
in S. cerevisiae.
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Fig. 5. Proposed studies on Ptr3p. To gain information on the function of Ptr3p in
induction of peptide transport system, we analyze: 1) The involvement of Ptr3p
in both amino acid and dipeptide induction of peptide transport, 2) Physical
interaction between Ptr3p and the amino acid sensor Ssy1p, 3) Cellular
localization of Ptr3p, 4) Interaction between PTR3 and other genes or proteins,
and 5) Functional analyses on Ptr3p, which include computational algorithms
together with site directed mutagenesis studies to identify any motif or
functional domain in Ptr3p.
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regulation pathways. Finally, a computational algorithm together with site
directed mutagenesis studies could be utilized to identify any motif or functional
domain in Ptr3p. Such information would provide hints on how Ptr3p regulates
the peptide transport process. In this dissertation, I report the molecular, genetic,
and functional analysis of Ptr3p, a novel regulatory protein of peptide transport
in S. cerevisiae.
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PART II
ROLE OF PTR3P IN AMINO ACID AND DIPEPTIDE INDUCED
REGULATION OF DI/TRI-PEPTIDE TRANSPORT IN S. CEREVISIAE
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CHAPTER I
INTRODUCTION

The yeast S. cerevisiae is known to utilize nutrient sensors acting at the
plasma membrane to initiate proper growth responses. Some members of the
sugar and amino acid transport gene families act as nutritional sensors. For
example, Snf3p and Rgt2p, whose structures are similar to hexose transporters,
have been suggested to transduce nutritional signals regarding extracellular
glucose availability (Ozcan et al., 1998). Another sensory protein, Ssy1p, acts as a
receptor in an amino acid-inducible signal transduction pathway. Ssy1p is
required for amino acid induction of the di/tri-peptide transporter (Didion et al.,
1998) and amino acid permeases such as the branched amino acid permease
BAP2 (Grauslund et al., 1995; Didion et al., 1996) and the general amino acid
permease GAP1 (Jauniaux and Grenson, 1990).
Ssy1p is a transmembrane protein that both hydropathy analysis and
subcellular fractionation studies show to be localized at the plasma membrane
(Didion et al., 1998; Iraqui et al., 1999a; Klasson et al., 1999). It was hypothesized
that Ptr3p transduced an amino acid-responsive signal from Ssy1p to
downstream effectors including Ptr1p/Ubr1p and Cup9p, that resulted in a
change in PTR2 expression (Iraqui et al., 1999b; Klasson et al., 1999). Ptr3p was
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physically associated with the cell membrane according to subcellular
fractionation by gradient centrifugation (Klasson et al., 1999), and genetic
interactions suggested that Ptr3p was a component of the proposed amino acid
sensor Ssy1p-Ptr3p-Ssy5p complex named SPS (Klasson et al., 1999; Forsberg and
Ljungdahl, 2001a).
Specific systems mediating transport of intact peptides across the plasma
membrane in an energy-dependent manner have been observed in most cells
examined (Ganapathy and Leibach, 1991; Payne and Smith, 1994; Becker and
Naider, 1995). Once internalized, these peptides are rapidly hydrolyzed by
intracellular peptidases and may then serve as a source of nitrogen or amino
acids for growth. In S. cerevisiae, the transport of peptides containing two or three
residues

(dipeptide/tri-peptide

transport)

has

been

well

characterized

physiologically and genetically (Becker and Naider, 1995). The products of at
least three genes, PTR1, PTR2, and PTR3 were shown by mutagenesis and
complementation analysis to mediate and regulate the di/tri-peptide transport
process (Island et al., 1991).
PTR2 encodes a transporter protein consisting of 601 amino acids
predicted to contain 12 membrane-spanning domains on the basis of hydropathy
analysis (Perry et al., 1994). PTR1 (or UBR1) encodes a 1951 amino acid protein
that functions as a regulator of PTR2 expression (Alagramam et al., 1995) through
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its involvement in the proteolytic destruction of a PTR2 repressor Cup9p via the
N-end rule ubiquitin pathway (Byrd et al., 1998). PTR3 encodes a protein of 678
amino acids, which functions to regulate the peptide transport system in a
complex manner. Unlike ptr2 and ptr1 strains that exhibited negligible levels of
peptide transport activity, ptr3 mutants (Island et al., 1991) and ptr3∆ strains
(Barnes et al., 1998) are leaky. ptr3 strains maintained the ability to use peptides
as a source of amino acids for growth but gained resistance to toxic dipeptides in
the presence of ammonium. Although Klasson et al. (1999) showed that a Ptr3p
region consisting of amino acid 511-575 shares some homology to several amino
acid permeases, there are no other regions of homology to any protein in the
current database reported to date.
The yeast PTR system is regulated in response to signals that include
nitrogen source and the presence of small amounts of amino acids (Barnes et al.,
1998; Island et al., 1987). Transport was found to be up-regulated when cells
were grown in a poor nitrogen source such as allantoin or proline, and downregulated in cells grown on a rich nitrogen source such as ammonium sulfate
(Becker and Naider, 1977; Nisbet and Payne, 1979). Peptide transport is also
subject to a high level of induction by micromolar amounts of various amino
acids irregardless of the nitrogen source (Island et al., 1987). There is no obvious
relationship between the physical-chemical properties of amino acids and their
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ability to act as inducers for di/tri-peptide transport. Previous northern analysis
of PTR2 expression indicated that amino acid regulation of peptide transport
occurred at the level of gene expression (Perry et al., 1994). Finally, di/tri-peptide
uptake was accelerated by extracelullar dipeptides, which once taken up by the
cells were suggested to gain access to allosteric binding sites in Ptr1p/Ubr1p
thereby activating ubiquitin-mediated degradation of the PTR2 repressor Cup9p
(Turner et al., 2000). The Cup9p degradation then leads to up-regulation of PTR2
expression as reported by a lac-Z reporter gene assay (Hauser et al., 2001).
We were interested in studying further the involvement of Ptr3p in the
amino acid and dipeptide regulation of peptide transport. In this paper, we
report on the effect of amino acid supplementation on di/tri-peptide transport
by gene reporter assays, we analyze whether extracellular amino acids and
dipeptides regulate the expression of PTR2 through the same or different
mechanisms, and we study Ptr3p localization and its physical interaction with
Ssy1p.
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CHAPTER II
MATERIALS AND METHODS

Strains and media.
Yeast strains used are listed in Table 1. The strains used in this study were
grown routinely on YEPD medium (1% yeast extract, 2% peptone, 2% glucose,
2% agar). Strains transformed with a plasmid were cultured on minimal medium
lacking uracil or leucine (0.67% Difco yeast nitrogen base with ammonium
sulfate, without amino acids, 2% glucose, 0.2% casamino acids). For peptide
toxicity assays, cells were inoculated into medium lacking ammonium sulfate
(0.67% Difco yeast nitrogen base without amino acids and ammonium sulfate, 2%
glucose) supplemented with 0.1% proline as a nitrogen source, and leucine
(228 µM) as inducer (proline medium). For two-hybrid analysis, cells were grown
in minimal dropout media containing 2% glucose (Glu) or 2% galactose plus 1%
raffinose (Gal) and are designated by the component that is left out (e.g. SC
(Glu)–ura –leu –his –ade medium has 2% glucose and lacks uracil, leucine,
histidine, and adenine). 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-Gal)
minimal dropout plates contained 40 mg/ml X-Gal and phosphate buffer at pH
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Table 1. S. cerevisiae strains used.
Strain
FY2
BWS-201
ssy1∆
PB1X-2A∆
BBY-47

Reference
Winston et al. (1995)
Barnes et al. (1998)
This work
Perry et al. (1994)
Bartel et al (1990)

BLS-201

Genotype
MATa ura3-52
MATa ura3-52 ptr3::Loxp
MATa ura3-52 ssy1::Loxp
MATa ura3-52 leu2-3 lys1-1 his4-32 ptr2::LEU2
MATa ura3-52 leu2-3,112 lys2-801 trp1-1 his3∆200 gal ubr1-∆1::LEU2
MATa ura3-52 cup9::Loxp

BLS-206

MATa ura3-52 ptr3::Loxp cup9::Loxp

Barnes et al. (1998)

PJ69-4A

MATa trp1-901 leu2-3,112 ura3-52 his3-200
gal4∆ gal80∆ GAL2-ADE2 LYS2::GAL1-HIS3
met2::GAL7-lacZ

James et al. (1996)
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Barnes et al. (1998)

7.0. DNA was introduced into yeast by LiAc-mediated transformation as
described (Gietz et al., 1995). Construction of ssy1∆ strain in the FY2 background
was accomplished by the method of Guldener et al. (1996), which results in the
replacement of a target ORF with the dominant selectable kanr marker. Briefly,
bipartite oligonucleotide primers (SSY1kan-F and SSY1kan-R; Table 2) were used
to PCR-amplify the kanr marker from the pUG6 plasmid resulting in 40 bp
extension of the SSY1 ORF flanking a functional kanr cassette. PCR amplification
using these primers yielded a 1.7 kb fragment that contained the kanr cassette
flanked by the 40 nucleotides of SSY1. Transformants were identified on the
basis of resistance to G418 (300 µg/mL) and were verified by PCR and Southern
analysis (data not shown).
Plasmids.
All plasmids were created by in vivo ligation between the insert gene and the
empty vector. Plasmids and nucleotides used in this study are shown in Table 2
and 3. The plasmid pUTR-PTR3 was created by polymerase chain reaction (PCR)
amplification of PTR3 gene including its 5’ and 3’ UTR using primers pRS316-3-F
and pRS316-3-R, and the resultant product was ligated into pRS316. A unique
BglII site was introduced by a site directed mutagenesis right before PTR3 start
codon using primer SDM3-(START) creating plasmid pUTR3(1-678). The
plasmid pGFP-PTR3 was created by polymerase chain reaction (PCR)
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amplification of the GFP cassette using primers sGFP3-F and SGFP3-R, and the
resultant product was ligated into the pUTR3(1-678) such that a fusion protein
was created with GFP at the N-terminus and under the PTR3 endogenous native
promoter. The plasmid pLACZ-2 was created by PCR amplification of the PTR2
promoter and PTR2 and the resultant product was ligated into the lacZ/URA3/2µ-based vector pYLZ6 (Hermann et al., 1992) such that the reporter lacZ genes were under the control of native PTR2 promoter. The plasmids pGBDUC1 and pGAD-C1 used for two-hybrid analysis were obtained from James et al.
(1995). pGBD-PTR3 was created by PCR amplification of the ORF (YFR209W)
using primers pGBD-PTR3-F and pGBD-PTR3-R, and the resultant products was
ligated into the URA3/2µ-based vector pGBDU-C1 such that the gene was fused
with the Gal Binding Domain (GBD) gene and under the control of an ADH
promoter. pGAD-NSSY1 (YDR160w) was created by PCR amplification of the a
cassette encoding only the first 282 amino acids of Ssy1p using primers pGADNSSY1-F and pGAD-NSSY1-R. The resultant products were cloned into the
LEU2/2µ-based vector pGAD-C1 such that the genes were fused to the Gal
Activating Domain (GAD) gene and were under the control of an ADH
promoter. pHis6-PTR3 was created by PCR amplification of the ORF (YFR209W)
using primers His6-PTR3-F and His6-PTR3-R, and the resultant products was
ligated into pDB20 such that the gene was under the control of an ADH
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Table 2. Plasmids used.
Plasmids
pLACZ-2
pGFP-PTR3
pGFP-N-FUS
pAJ226
pVT-RGS4-GFP
pAJ232
pGBDU-C1
pGBD-PTR3
pGAD-C1
pGAD-NSSY1
pHis6-PTR3
pGAD-FLAGNSSY1

Description
PTR2 promoter lac-Z fusion in pYLZ6
GFP and PTR3 fusion in pUTR3(1-678)
the GFP fusion vector in p416MET25

Reference
This work
This work
Niedenthal et al.
(1996)
RAT1 fused with GFP in pTD150
Johnson, A. (1997)
RGS4 fused with GFP in pRSETB-GFP
Srinivasa et al.
(1998)
Johnson, A. (1997)
RAT1 (NLS∆) fused with GFP in pTD150
two-hybrid expression vector containing James et al. (1995)
GBD
GBD-PTR3 in pGBDU-C1
This work
two-hybrid expression vector containing James et al. (1995)
GAD
GAD-NSSY1 in pGAD-C1
This work
His6-PTR3 in pDB20 under an ADH This work
promoter
FLAG-NSSY1 in pGAD-C1
This work
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Table 3. Nucleotides used.
Oligonucleotides
PTR2-F
PTR2-R
ACT-F
ACT-R
SSY1kan-F
SSY1kan-R
pRS316-3-F
pRS316-3-R
SDM3-(START)
sGFP3-F
sGFP3-R
pGBD-PTR3-F
pGBD-PTR3-R
pGADNSSY1-F
pGADNSSY1-R
His6Ptr3p-F
His6Ptr3p-R
FLAGNSSY1

Sequence
5’-TTCCGCACCATTCCAAAACTACAT-3’
5’-GCAGCACAGAAAACTCCCGTCAAC-3’
5’-GCCGGTTTTGCCGGTGACGAC-3’
5’-GGAAGATGGAGCCAAAGCGTG-3’
5’-AAACTGCTTAAAAATAGGGAAGTTCCTTGAGGAATCA
GCTGAAGCTTCGTACGC-3’
5’-ATAATAATACTAATAATAGTACATATAACCCTAAGCAT
AGGCCACTAGTGGATCTG-3’
5’-GATCCCCCGGGCTGCAGGAATTCGATATCAAGCTTAA
CGCCCGATCTCAAGATTT-3’
5’-AGCTGGGTACCGGGCCCCCCCTCGAGGTCGACGGTTG
CACCCCATCTAAACGAAA-3’
5’-GGTACGAAATACAGATCTGAT AGGCGTTCATGC-3’
5’- CACATACATAGGTACGAAATACAGATCTGATAGGCGT
TCATGGCTAGCAAAGGAGAAGAA-3’
5’- GGCAAAAAAGTACTCCTTTTCTTCGTCCAGATCATGG
CAGCCGGATCCTTTGTATAG–3’
5’-GAGTAGTAACAAAGGTCAAAGACAGTTGACTGTATCG
CCGCACGCACACTCACACATACAT-3’
5’-TGAAGTGAACTTGCGGGGTTTTTCAGTATCTACGATTC
ATACCAGAACCTTAAACATACG-3’
5’-CGATGATGAAGATACCCCACCAAACCCAAAAAAAGAG
ATCAAGAGGCCAAAAGTTAT-3’
5’-ACGATTCATAGATCTCTGCAGGTCGACATCGATGGATC
CCCCAGTTGCCCTGGACCTATTG-3’
5’-CCAAGCTTCGAGCGGCCGCCAGTGTGATGGATATCC-3’
5’-AGTCCAAAGCTTCGACGGCCGCCAGTGTGATGGAA
C-3’
5’-TTCAATAGGTCCAGGGCAACTGGGGGATCCATCGACT
ACAAGGACGACGATGACAAGGGTACCGTCGACCTGCAG
AGATCTATGAATCGTAGATACTGA-3’
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promoter. pGAD-FLAG-NSSY1 was created by in vivo ligation using the
FLAGNSSY1 oligonucleotide. Plasmids were transformed into yeast by the LiAcmediated transformation as described (Agatep et al., 1998), and transformants
were selected by growth on minimal medium lacking uracil or leucine.
Northern analysis.
Yeast total RNA was isolated by phenol-chloroform extraction as previously
described with the following modifications (Schmitt et al., 1990; Perry et al., 1994).
All phenol-chloroform extractions were performed with 15 ml spin phase-lock
gel tubes (5 Prime-3 Prime, Inc., Boulder, CO). Total RNA was quantified by
monitoring absorbance at 260 nm, and 25 µg per lane was loaded into a
formaldehyde-reducing gel as described (Perry et al., 1994). Gels were run for 3 h
at 75 V in running buffer containing 10% MOPS and 10% formaldehyde and then
vacuum-transferred to a nylon hybridization membrane (Bio Trans, ICN
Pharmaceuticals, Costa Mesa, CA) in 10xSSC (1x SSC is 0.15 M NaCl plus 0.015
M sodium citrate). The RNA was UV cross-linked with the Stratalinker UV
source as specified by the manufacturer (Stratagene, La Jolla, CA). Blots were
rinsed with 4x SSC and prehybridized for 4 h at 420C in Northern MaxTM
prehybridization/hybridization buffer (Ambion, Austin, TX). Radioactive probes
were prepared as follows. The following DNA fragments were obtained by PCR
(the oligonucleotides used to prime the reactions are indicated in parentheses; 1
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µg of genomic DNA isolated from yeast strain FY2 served as the template): a 1.7
kb fragment of PTR2 (PTR2-F and PTR2-R), a 1.0 kb fragment of CUP9 (CUP9-F
and CUP9-R), a 1.8 kb fragment of BAP2 (BAP2-F and BAP2-R), a 2.8 kb fragment
of UGA35 (UGA35-F and UGA35-R), and a 0.92 kb fragment of ACT1 (ACT1-F
and ACT1-R). PCR products were analyzed by restriction analysis to ensure their
identity and gel purified. DNA fragments were labeled with [α-32P]dATP (3000
Ci/mmol; ICN Pharmaceuticals, Costa Mesa, CA), using a megaprime DNA
labeling

system

Hybridizations

(Amersham
were

Pharmacia

carried

Biotech,

out

in

Inc.,

Piscataway,

Northern

NJ).

MaxTM

prehybridization/hybridization buffer (Ambion, Austin, TX) containing 10%
dextran sulfate sodium salt at 420C overnight (106 cpm/ml). Blots were rinsed
once in 1x SSC plus 0.1% SDS at 650C for 20 min, twice in 0.1xSSC plus 0.1% SDS
at 650C for 20 min. Data analysis was performed by electronic, filmless
autoradiography (Instant-Imager, Packard BioScience Company, Meriden, CT),
and quantification of signal by InstantImager analysis software (Packard
BioScience Company, Meriden, CT).

After a background correction, signal

strengths were normalized to the levels of actin mRNA present in RNA
preparations.
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Reporter assay.
All cells were grown overnight in minimal medium lacking uracil and
ammonium sulfate (0.67% Difco yeast nitrogen base without amino acids and
ammonium sulfate, 2% glucose) supplemented with 0.1% proline as a nitrogen
source, and appropriate concentration of amino acid or dipeptide supplement to
induce the di/tri-peptide transport. Under these growth conditions proline used
as a nitrogen source does not serve as an amino acid inducer. The following day,
amino acid or dipeptide supplement was added, and the cells were grown for
another 2 hours. Then, standard liquid β-galactosidase assay for yeast cells was
performed (Kippert, 1995). To test the amino acid inducing potential (Fig. 1), the
mean Miller Unit values for each data set were normalized to the miller unit
values of β-galactosidase assay of wild-type (FY2) cells under leucine induction.
For other analyses, data points and error bars reflect the mean and standard
deviation of a minimum of four independent measurements.
Toxicity assay.
Functionality of any Ptr3p fusions and fragments were measured by their ability
to complement the ptr3∆ phenotype using peptide toxicity assays. This assay has
been shown many times to mirror the results of peptide uptake experiments and
expression of PTR2 (Island et al., 1987; Barnes et al., 1998). When toxic dipeptides
do not inhibit growth, uptake of radiolabeled dipeptide and PTR2 are greatly
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lowered. Cells were grown overnight in medium lacking uracil and ammonium
sulfate (0.67% Difco yeast nitrogen base without amino acids and ammonium
sulfate, 2% glucose) supplemented with 0.1% proline as a nitrogen source, and
leucine (228 µM) as inducer (proline medium) and suspended in sterile water at
5.0 X 106 cells per ml. Fractions (1 ml) were added to 0.8% Noble agar and plated
on MM containing Leu and Trp supplements to induce peptide transport. A total
of 0.38 mmol of L-ethionine (Eth) or L-alanyl-L-ethionine (Ala-Eth) was added to
a disk made of Whatman 3MM filter paper. L-ethionine was obtained from
SIGMA (St. Louis, MO), and Ala-Eth was synthesized as previously described
(Naider et al., 1974). Disks containing each compound were placed on the surface
of the plates. After 48 h of incubation, zones of inhibition were measured for all
plates. Figures shown are representation of three independent measurements.
Fluorescent Microscopy.
Cells containing pSGFP-PTR3 grown in minimal medium with or without
leucine/tryptophan amino acid inducer, or Arg-Leu dipeptide inducer, were
used for fluorescence microscopy studies. Controls for cellular localization of
GFP fusion proteins (see Table 2) include nuclear localized Rat1p-GFP and
cytoplasmic localized Rat1p(NLS∆)-GFP, which are encoded by gene fusion in
plasmids pAJ226 and pAJ232, respectively (gifts from Dr. Arlen W. Johnson at
University of Texas at Austin) and plasma membrane localized Rgs4p-GFP,
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which is encoded by gene fusion in plasmid pVT-RGS4-GFP (a gift from Dr.
Maurine E. Linder at Washington University School of Medicine at St. Louis).
Intact cells were observed and photographed with an Olympus microscope.
Images were captured to Adobe Photoshop (Adobe Systems, Inc., San Jose, CA)
with a Hamamatsu C5810 color chilled camera.
Yeast two-hybrid.
The yeast two-hybrid analysis was conducted by utilizing His, Ade, and lac-Z
assays as described (James et al., 1995). Strain PJ69-4A containing pGBD-PTR3,
pGBD3(1-250), pGBD3(1-500), or pGBD3(500-678) was transformed with pGADNSSY1. The selection for interacting clones was performed in media containing
glucose and lacking histidine (plus 2 mM 3-aminotriazole) or lacking adenine.
Then, the colonies were further tested for lac-Z expression by plating them on
minimal dropout media containing galactose/raffinose and X-Gal. Strong (89T
and 89L plasmids) and zero (pGBT9.C and pGAD424.C plasmids) interaction
controls (Bartel et al., 1996) were a kind gift from the Stanley Fields laboratory
(Daniel Lockshon, University of Washington, Seattle, WA).
Co-immunoprecipitation.
Whole cell lysates of His6Ptr3p or FLAG-Nssy1p were prepared in 20 mM TrisHCl, pH 6.5, 150 mM NaCl, 5 mM MgCl2, 2% Triton X-100 by glass bead lysis.
Immunoprecipitations were conducted as described in protocol Seize™ Primary
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Immunoprecipitation

Kits

(Pierce,

Rockford,

IL).

For

His6Ptr3p

immunoprecipitations, 1 ml of cell extracts were precleaned with protein A/G
plus agarose by rotating at 40C for 1 hour. The supernatant was transferred to a
fresh tube. His6 antibody (SIGMA, St. Louis, MO) was added in the presence of
20 µl fresh protein A/G plus-agarose and incubated at 40C for 4 hours. The
extract was then washed with washing buffer (Pierce, Rockford, IL). Proteins
were separated on SDS-PAGE gel under the reduced condition, transferred to
Hybond-ECL (Amersham Pharmacia Biotech, Inc., Piscataway, NJ), blocked with
5% milk, incubated with HRP-conjugated India-His reagent (SIGMA, St. Louis,
MO) at a 1:1000 dilution (16 h, 4 °C), and then detected using ECL detection kit
(Amersham

Pharmacia

Biotech,

Inc.,

Piscataway,

NJ).

For

co-

immunoprecipitation, protein A/G sepharose coupled with His6 was incubated
with cell extracts containing pHis6PTR3 or empty vector (pDB20-His6). After
washing the agarose beads were incubated with cell lysates expressing FLAGNssy1p (overnight, 4 °C), washed, and proteins were separated on SDS-PAGE
gel under the reduced condition. Blots were incubated with a monoclonal FLAG
antibody (1:1000 diluted), HRP-conjugated anti-mouse IgG (1:2000 diluted), and
then detected using ECL detection kit (Amersham Pharmacia Biotech, Inc.,
Piscataway, NJ).
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CHAPTER III
RESULTS

Various amino acids induce PTR2 to different levels.
The effect of amino acid supplementation on expression of PTR2 as measured by
liquid β-galactosidase assay was compared to the response to toxic dipeptides as
an assay for peptide transport (Island et al., 1987; Fig. 1). Responses measured by
the toxic peptide assay or the reporter gene assay to most amino acids were
similar. However, the dipeptide toxicity assay showed a higher inducing effect
for K, T, and I as compared to induction measured by the liquid β-galactosidase
assay. On the other hand, while the dipeptide toxicity assay was not sensitive
enough to show detectable levels of induction for the amino acids E, M, G, Q, D,
P, and R, the liquid β-galactosidase assay could detect quantitatively low levels
of induction of PTR2 expression. Although most non-polar amino acids were
good inducers, we could not deduce a correlation between the physical/chemical
properties of an amino acid and its induction potential. Both assays confirmed
that L and W were the best amino acid inducers. These amino acids were used in
all subsequent amino acid induction treatments.
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Fig. 1. Comparison of effects of different amino acids on induction of peptide
toxicity and reporter gene expression. FY2 (wild-type) strain containing the
pLACZ-2 reporter plasmid was grown in minimal medium with and without
amino acids (as indicated by their one-letter abbreviation) as inducers of the
peptide transport system and then assayed by dipeptide toxicity or liquid βgalactosidase assays (see Materials and Methods). One-hundred percent was
normalized to the expression of PTR2 induced by leucine as measured by either
gene induction or response to toxic dipeptide.
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Amino acid induction of PTR2 expression requires Ssy1p.
Extracellular amino acids are sensed by an amino acid sensor protein Ssy1p,
which transduces the signal to Ptr3p and other downstream effectors such as
Ssy5p, Ubr1p/Ptr1p, and Cup9p leading to an increase in PTR2 expression
(Iraqui et al., 1999a; Klasson et al., 1999; Forsberg and Ljungdahl, 2001a). To
determine the extent to which induction required Ssy1p and to measure this
effect quantitatively, we used a lac-Z reporter gene under control of the native
PTR2 promoter. Measurement of the expression patterns by both a liquid βgalactosidase assay and northern analysis were comparable as expression levels
were low in FY2 and ssy1∆ strains, and an increase in expression was readily
apparent in the wild-type FY2 strain upon the addition of amino acids as
determined by either assay (Fig. 2). Most notably, amino acid induction was
highly dependent on the presence of Ssy1p as indicated in both assay systems.
Dipeptide sequence is important for induction of PTR2 expression.
We have shown previously that the dipeptide W-A induced PTR2 expression
(Hauser et al., 2001). To study physical/chemical properties of dipeptide
inducers, assays were performed with various dipeptides and the lac-Z reporter
gene, and the results are presented in Fig. 3. First, we showed that the dipeptide
R-E induced PTR2 expression to a greater extent than did the amino acids L and
W (Fig. 3A, compare L/W to R- E lanes). The components of R-E, represented by
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Fig. 2. PTR2 expression patterns determined by PTR2 northern analysis (A and B)
and liquid β-galactosidase assay on the lac-Z reporter gene under the native
PTR2 promoter (C). For each analysis, FY2 (wild-type) and ssy1∆ null mutant
strains were grown in minimal medium without and with amino acids (indicated
by +L/W, leucine and tryptophan) as inducers of the peptide transport system.
For northern analysis, the data are represented as well by signal strengths (cpm)
relative to the levels of actin mRNA (ACT1) levels (B).
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Fig. 3. Effects of dipeptides and amino acids on PTR2 expression. Each strain
containing the pLACZ-2 reporter plasmid was grown in minimal medium
without or with amino acids or dipeptide and then assayed for reporter gene
expression. Amino acids and dipeptides added to the media are indicated in the
abscissas with dipeptide shown with a “dash” (for example R-E is arginylglutamic acid) and amino acids by a “slash” ( for example L/W is leucine and
tryptophan). (A) Wild-type FY2, (B) Comparison between FY2 and ssy1∆, (C)
Comparison between FY2 and ptr3∆, and (D) Comparison between FY2 and
ptr2∆.

82

A.

B.
1250

FY2
ssy1∆

1250

FY2
1000
1000

750
750

500
500

250

250

0

0

none

none L/W R-E R/E L/W W-A A-W R-A A-R
+
R-E

C.

L/W

R-E

W-A

R-A

R-E

W-A

R-A

D.
1250

1250

FY2
ptr2∆

FY2
ptr3∆
1000

1000

750

750

500

500

250

250

0

0
none

L/W

R-E

W-A

R-A

none

83

L/W

R and E, did not induce di/tri-peptide transport to the same extent as that
induced by the dipeptide R-E (compare R/E to R-E). A mixture of dipeptide and
amino acids showed that the induction by amino acids and dipeptide was not
additive. In fact, it was about 30% lower than amino acids or dipeptide induction
alone (lane L/W+R-E compared to L/W or R-E). To determine whether the
sequence of the amino acid components in a peptide affected its ability to induce,
we chose the four peptides Trp-Ala (W-A), Ala-Trp (A-W), Arg-Ala (R-A), and
Ala-Arg (A-R). The dipeptide W-A induced PTR2 expression about 3-fold higher
than that induced by amino acids L and W (Fig. 3A, compare W-A to L/W), but
dipeptide A-W only induced PTR2 to about 60% of that induced by amino acids
L and W (compare A-W to L/W). Dipeptide R-A induced PTR2 expression about
2-fold higher than that induced by amino acids L and W (compare R-A to L/W),
but dipeptide A-R only induced to about 40% of that induced by amino acids L
and W (compare FY2+A-R to FY2+L/W).
Dipeptide induction of PTR2 expression is not totally dependent on Ssy1p.
To examine whether dipeptides may also act as inducers of PTR2 expression via
the amino acid induction pathway, specifically through the amino acid sensor
Ssy1p, gene reporter assays were performed in wild-type and ssy1∆ strains. In
the absence of Ssy1p, the induction by amino acids L and W was decreased to the
level of PTR2 expression without any inducer (Fig. 3B). In contrast, the dipeptide
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R-E induced PTR2 expression about the same in the absence or presence of
Ssy1p. W-A induced PTR2 to the same level as that induced by R-E in ssy1∆ cells,
although R-A mediated induction was lower. However, Ssy1p was required for
maximal induction of PTR2 by W-A and R-A as shown by 2-fold higher level of
β-galactosidase in FY2 cells compared to ssy1∆ cells induced by either W-A or RA. These data indicate that Ssy1p is not required for, but may modulate,
induction by some dipeptides.
Ptr3p is required for optimal dipeptide induction of PTR2 expression.
To analyze whether PTR3 is involved in dipeptide induction, gene reporter
assays were performed in the wild-type and ptr3∆ strains. PTR3 deletion reduced
induction both by amino acids and dipeptides. In ptr3∆ cells the level of amino
acid induction was decreased to that of the wild-type cells without any inducer
(Fig. 3C). Induction by the dipeptide R-E in ptr3∆ cells was at the same level as
that induced by R-A in ptr3∆ cells, although W-A-induced PTR2 expression was
somewhat higher. Optimal induction required PTR3 as shown by a 3-4 fold
higher level of lac-Z in FY2 cells compared to ptr3∆ cells induced by either R-E,
W-A, or R-A. The results suggest that Ptr3p is necessary for optimal dipeptidemediated induction of PTR2 expression.
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Dipeptide induction of PTR2 expression requires Ptr2p.
Previously, extracellular dipeptides containing a basic or hydrophobic Nterminal residue were proposed to provide a positive feedback loop for di/tripeptide uptake by being transported and subsequently binding to allosteric sites
on intracellular Ptr1p/Ubr1p, thereby activating ubiquitin-mediated degradation
of the PTR2 repressor Cup9p (Turner et al., 2000). To test whether Ptr2p was
required for dipeptide induction of PTR2 expression, ptr2∆ cells were tested for
their PTR2 expression using a lac-Z reporter gene under the native PTR2
promoter (Fig. 3D). In contrast to amino acid induction, which was similar in
wild-type FY2 and ptr2∆ cells (Fig. 3D, L/W, closed and hatched bar), dipeptide
induction was abolished in a ptr2∆ background. The activities in the ptr2∆
background with no addition (none) and dipeptide addition (R-E, W-A, or R-A)
were less than 10 Miller units making them undetectable (R-E) or barely
detectable (W-A and R-A) as shown in Fig. 3D.
PTR3 is not required for CUP9 expression.
Cup9p is known to be a transcriptional repressor of PTR2 (Byrd et al., 1998). Since
ptr3∆ was shown to be epistatic to cup9∆ by genetic analysis (Barnes et al., 1998)
and both amino acid and dipeptide induction of PTR2 expression involve Cup9p
degradation, we carried out an experiment to determine whether PTR3 was
involved in regulation of CUP9 expression. All cells (wild-type FY2 and ptr3∆
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strains) were grown in medium lacking ammonium sulfate (0.67% Difco yeast
nitrogen base without amino acids and ammonium sulfate supplemented with
2% glucose and 2 µg/mL of uracil with 0.1% proline as a nitrogen source).
Leucine (228 µM) and tryptophan (98 µM) were added to induce peptide
transport. CUP9 expression was not affected by amino acid induction in the
presence of Ptr3p (Fig. 4, lanes 1 and 3). In the absence of Ptr3p, amino acids
increased CUP9 expression by only 30% (lanes 2 and 4). A similar increase of 30%
in CUP9 expression occurred when the wild-type is compared to the ptr3∆ in the
absence of amino acid induction (lanes 1 and 2). These data indicate that PTR3
does not greatly affect CUP9 expression in the presence or absence of inducing
amino acids. The same expression patterns were observed for the dipeptide
induction treatment (data not shown). However, we note that deletion of PTR3
leads to a small increase of CUP9 expression with amino acid induction as
measured by northern analysis (lanes 3 and 4).
GFP-Ptr3p is functional.
Previous sucrose gradient centrifugation showed that Ptr3p was localized at the
plasma membrane as a peripheral protein in the presence or absence of Ssy1p
(Klasson et al., 1999). However, because Ptr3p was easily removed from the
plasma membrane by a mild detergent, it was hypothesized that Ptr3p
dissociates from the plasma membrane after amino acid-induced signaling.
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Fig. 4. The effect of PTR3 on CUP9 expression patterns determined by northern
analysis. FY2 (wild-type) and ptr3 null mutant strains were grown in minimal
medium with (indicated by +L/W) or without amino acids as inducers of the
peptide transport system. CUP9 expression was determined by northern analysis
(A). These data are represented in (B) as signal strengths (cpm) relative to the
levels of actin mRNA (ACT1) normalized to the expression observed in each
condition.
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Therefore, Ptr3p localization in vivo under various physiological conditions was
tested as described below. A fusion of GFP to the N-terminus of Ptr3p was
engineered and expressed in yeast cells from a high-copy-number plasmid. The
GFP-Ptr3p fusion protein retained its Ptr3p function as shown by a toxic peptide
assay (Fig. 5). The zone of inhibition by the toxic dipeptide Ala-Eth (A-E) in ptr3∆
cells containing pGFP-PTR3 (Fig. 5B) was similar to that of ptr3∆ cells containing
pUTR-PTR3, which expressed PTR3 under its native promoter (Fig. 5C), or to
that of wild-type PTR3 cells (data not shown). ptr3∆ cells containing pGFP alone
were not able to transport the toxic dipeptide A-E (Fig. 5A) as indicated by the
absence of the zone of inhibition surrounding the disk containing A-E. ptr3∆ cells
with the pGFP plasmid were not sensitive to the toxic amino acid Eth (Fig. 5A).
This pleiotropic effect of the ptr3∆ allele was previously reported (Island et al.,
1987). However, toxicity to Eth was fully restored in cells expressing PTR3 or
GFP-PTR3 (Fig. 5B and C). These data indicate that the fusion GFP-Ptr3p
complemented the ptr3∆ phenotype.
GFP-Ptr3p is localized in a punctate pattern associated with the plasma
membrane.
GFP-Ptr3p in both ptr3∆ and ssy1∆ cells was associated with the plasma
membrane in a punctate manner (Fig. 6E and F). Confocal microscopy also
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Fig. 5. Toxic peptide sensitivity as a measure of GFP-Ptr3p function. GFP-Ptr3p
in ptr3∆ cells was tested for the ability to complement the ptr3∆ phenotype by
measuring the zone of inhibition in a lawn of cells due to transport of the toxic
amino acid ethionine (E) and the toxic dipeptide alanyl-ethionine (A-E). The disk
on the left contained E, whereas the disk on the right contained A-E. The toxic
components were spotted on the disks (white circles) on the petri plates. (A)
ptr3∆ cells containing pGFP alone. (B) ptr3∆ cells containing pGFP-PTR3. (C)
ptr3∆ cells containing pUTR3(1-678), which expressed PTR3 under its native
promoter.
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Fig. 6. In vivo localization of GFP-Ptr3p. On the left half of each panel (A-F) are
Differential Interference Contrast (DIC) images, and on the right half of each
panel (A-F) are images of GFP fluorescence. Arrows (panels E and F) indicate
discrete areas of localization. (A) FY2 cells containing nuclear localized Rat1pGFP control. (B) FY2 cells containing plasma membrane localized Rgs4p-GFP
control. (C) FY2 cells containing cytoplasmic localized Rat1p(NLS∆)-GFP control.
(D) ptr3∆ cells containing GFP alone. (E) ptr3∆ cells containing GFP-Ptr3p. (F)
ssy1∆ cells containing GFP-Ptr3p.
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showed punctate localization at the plasma membrane (data not shown). The
punctate localization was due to the Ptr3p moiety since it was not observed
when GFP was expressed alone (Fig. 6D), nor was it observed when GFP was
fused to control proteins known to be localized to the nucleus, plasma
membrane, and cytoplasm (Fig. 6A, B, and C). For example, the control plasma
membrane localized protein GFP-Rgs4p (Fig. 6B) showed a distinct ring pattern
of fluorescence, consistent with the plasma membrane localization, and GFP
expressed alone showed a cytoplasmic localization with exclusion from vacuoles
readily apparent (Fig. 6D). Addition of leucine and tryptophan or Arg-Glu to
induce di/tri-peptide transport did not affect GFP-Ptr3p localization (data not
shown). The deletion of SSY1 gene did not affect the punctate localization of
GFP-Ptr3p (Fig. 6F).
Ptr3p interacts strongly with the N-terminal domain of Ssy1p.
Because Ssy1p is localized to the plasma membrane, and Ptr3p is peripherally
associated with the cytosolic face of the plasma membrane as shown by
subcellular fractionation studies, it has been suggested that they interact (Klasson
et al., 1999). We focused on testing the 282 amino acid N-terminus of Ssy1p as a
Ptr3p interaction domain because of its predicted cytoplasmic location and its
lack of similarity to other yeast amino acid permeases. To test whether the N95

terminal domain of Ssy1p interacts with Ptr3p, we performed a protein-protein
interaction analysis by the two-hybrid assay (James et al., 1996). As the bait, full
length Ptr3p was fused to the Gal Binding Domain (GBD) protein. The fusion
GBD-Ptr3p retained its Ptr3p function (about 50% of the wild-type Ptr3p) shown
by a toxic peptide assay (data not shown). Yeast expressing GBD-Ptr3p and
pGAD-NSsy1p tested positive for His and Ade prototrophy indicating a physical
interaction between Ptr3p and Ssy1p (N-terminal, 282 residues). Neither GBDPtr3p nor GAD-NSsy1p alone autoactivated the His or Ade systems or induced
lac-Z (Fig. 7B). The interaction of Ptr3p and NSsy1p was strong as shown by the
level of activation of lac-Z by both the X-Gal plate and liquid β-galactosidase
assays (Fig. 7A and B). Similar to a strong interaction control (Fig. 7A), the blue
color showed up after PJ69-4A cells containing pGBD-PTR3 and pGAD-NSSY1
were incubated for two hours on the X-Gal plate (Fig. 7, panel A, sector c). Liquid
β-galactosidase assays showed that the GBD-Ptr3p interacted two-times stronger
than the strong interaction control (Fig. 7B).
Ptr3p interacts with the N-terminal domain of Ssy1p in vitro.
To study the interaction between Ptr3p and the N-terminal tail of Ssy1p in vitro, coimmunoprecipitation was performed. Cell extracts transformed with pHis6PTR3 or empty
vector (pDB20-His6) were incubated with protein A/G
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Fig. 7. Two hybrid assay and co-immunoprecipitation of Ptr3p and Ssy1p
(residues 1-282). (Panel A) An X-gal plate assay showing the strength of
interaction between Ptr3p and the N-terminal domain of Ssy1p (c) compared
with strong (a) and zero (b) interaction controls. (Panel B) A liquid βgalactosidase assay of cells expressing GBD-Ptr3p, GAD-NSsy1p, a strong
interaction control (89T and 89L plasmids), a zero interaction control (pGBT9.C
and pGAD424.C plasmids), and both GBD-Ptr3p and GAD-NSsy1p. (Panel C)
Co-immunoprecipitation between His6-Ptr3p and GAD-FLAG-NSsy1p. Cell
extracts expressing FLAG-NSsy1p were incubated with proteinA/G agaroseHis6-antibody previously loaded with cell extracts containing pHis6PTR3 (lane 1
and 2) or empty vector pDB20-His6 (lane 4 and 5). After washing and elution,
bound proteins were run on SDS-PAGE, immunoblotted with FLAG antibody,
and detected as described in Materials and Methods.
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agarose coupled with His6 antibody. Cell extracts containing pGAD-FLAGNSSY1 were added to the agarose and incubated at 4 °C overnight. After
extensive washing, bound proteins were eluted by boiling in SDS sample buffer,
separated on 10% SDS-PAGE, and analyzed by Western blotting using a FLAG
antibody. As shown in Fig. 7C, lanes 1 and 2 showed bands with molecular
weight corresponding to the expected molecular weight of GAD-FLAG-NSsy1p
(72 kDa). No band corresponding to the approximate molecular weight of GADFLAG-NSsy1p was observed in lanes 4 and 5. The data show that Nssy1p is
captured by Ptr3p bound to the agarose column confirming two-hybrid results
indicating that Ptr3p interacts with the N-terminal domain of Ssy1p.
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CHAPTER IV
DISCUSSION

We report here the involvement of the Ptr3 protein in both amino acid and
peptide induction of the di/tri-peptide transport system in S. cerevisiae. Ptr3p,
previously known to regulate the amino acid induction of PTR2 expression, was
now found to be involved in dipeptide induced PTR2 expression. PTR3 deletion
reduced induction by dipeptides (Fig. 3C), suggesting that Ptr3p is important for
optimal dipeptide induction. Therefore, Ptr3p may function as a shared
regulatory protein between the amino acid and dipeptide induction pathways.
To analyze the difference between amino acid and dipeptide induction, their
effects were observed in the presence or absence of the amino acid sensor Ssy1p,
the novel regulatory protein Ptr3p, and the di/tri-peptide transporter Ptr2p. In
contrast to amino acid induction, dipeptide induction of PTR2 expression did not
require Ssy1p. In the absence of Ssy1p, the induction by amino acids L and W
was reduced to the level of PTR2 expression without any inducer, but the
dipeptide induction in the absence of Ssy1p (Fig. 3B) was decreased (W-A or RA) or not changed (R-E).
While Ptr2p deletion had little effect on amino acid induction of PTR2
expression, the absence of Ptr2p abolished the dipeptide induction effect on the
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expression of PTR2. Turner et al. (2000) suggested that extracellular dipeptides
may be taken up by Ptr2p, and then play regulatory roles by binding to di/tripeptide regulatory proteins such as Ptr3p or Ptr1p/Ubr1p. An in vitro binding
assay indicated that dipeptides accelerated the di/tri-peptide uptake by binding
to Ptr1p/Ubr1p thereby activating ubiquitin-mediated degradation of the PTR2
repressor Cup9p. However, the question of how fast dipeptides are degraded in
the cells remains to be solved to prove that intact dipeptide actually binds to
Ptr1p/Ubr1p in vivo. Since the cells are able to sense extracellular nutrients such
as amino acids and sugars, the above data might indicate that Ptr2p functions not
only as a di/tri-peptide transporter, but also as a dipeptide sensor. Such a dual
function has been shown for GLUT2, a human homolog of Snf3p, the major
facilitative glucose transporter isoform expressed in hepatocytes, pancreatic βcells, and absorptive epithelial cells (Thorens et al., 1988). GLUT2 protein has
been suggested recently to transduce signals from the plasma membrane to the
nucleus and to propagate glucose-regulated gene expression in humans
(Guillemain et al., 2000). The large cytoplasmic oriented hydrophilic loop
between transmembrane VI and VII of GLUT2 is responsible for the glucoseinduced gene expression after glucose sensing (Guillemain et al., 2000). The loop
is unique among glucose tranporters for GLUT2, and overexpression of the loop
resulted in a dominant negative effect on the glucose-mediated gene expression
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in wild-type cells. In addition, the loop rapidly moves from the cytoplasm to
nucleus in response to extracellular high glucose concentration, and moves in the
opposite direction when the cells are grown in low levels of glucose. Further
investigation is needed to determine whether dipeptide induction is triggered by
internal or external intact dipeptides, and whether Ptr2p can act as both a
transporter and a dipeptide sensor protein.
We observed that the components of these dipeptides did not induce
PTR2 expression to the same extent as did the dipeptides, suggesting that the
induction was dependent on intact peptide. The dipeptide sequence appeared to
be important for induction of PTR2 expression. The data indicated a requirement
for a bulky or hydrophobic N-terminal residue of a dipeptide to bind to
Ubr1p/Ptr1p, (Turner et al, 2000). The expression of PTR2 induced by both R-E
and amino acid addition was not additive. Instead, it was lower than amino acid
or R-E induction alone (Fig. 3A) suggesting antagonism that might involve
competition for components of amino acid and dipeptide sensing pathways.
To analyze further the involvement of Ptr3p in amino acid and dipeptide
induction of di/tri-peptide transport, subcellular localization of GFP-Ptr3p was
performed in several different conditions. A functional GFP fusion to the Nterminus of Ptr3p localized in a punctate association with the plasma membrane.
The localization pattern was not affected by the addition of amino acid and
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dipeptide inducers or in the absence of Ssy1p. However, these experiments do
not exclude the possibility that regulatory events following Ssy1p/Ptr3p
interaction require that Ptr3p disengage from the membrane and localize in some
other compartment(s) (Klasson et al., 1999). In this case, Ptr3p may act similarly
to Std1p, which interacts with the C-terminal domain of the glucose sensors,
Snf3p and Rgt2p, to transduce signals from the plasma membrane to the nucleus
(Schmidt et al., 1999). The punctate association may indicate the presence of
unrecognized compartmentalization of a sensory complex at the cell membrane.
In fact, a punctate localization of Std1p has been reported (Schmidt et al., 1999). A
similar punctate pattern localization in the ssy1∆ strain indicated that additional
interactions were responsible for Ptr3p localization. Preliminary results of a twohybrid library screen indicated that Ptr3p interacted with portions of membrane
transporters Vap1p, Thi7p, and Ygr125wp (Narita and Becker, unpublished
observation). Further experiments will be required to verify these associations
and the localization of a sensory complex.
Previous genetic analysis strongly suggested that Ptr3p interacted with
the N-terminal 280 amino acid cytoplasmic portion of Ssy1p (Klasson et al., 2000).
Support for Ssy1p-Ptr3p interaction was shown in a comprehensive study on
yeast protein-protein interaction by the Yeast PathCallingTM screen (Uetz et al.,
2000; GeneScape Portal Web Site, http://portal.curagen.com/). The function of
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N-terminal residues of Ss1p may be comparable to that of the carboxy-terminal
extensions of glucose transporter homologs Snf3p and Rgt2p, which interact with
Std1p or Mth1p (Schmidt et al., 1999) and generate a signal for induction of
proper transcription of several hexose transporter genes after sensing either low
or high extracellular glucose concentration (Ozcan et al., 1998). By two hybrid
and co-immunoprecipitation experiments, we provide the first evidence that
Ptr3p and the N-terminal domain of Ssy1p interact in vivo and in vitro. The
results suggest that upon amino acid sensing, the N-terminal domain of Ssy1p
may signal amino acid availability through interaction with Ptr3p. Consequently
Ptr3p propagates a signal cascade to downstream targets such as Ssy5p, which
was shown to interact with Ptr3p by two hybrid analysis (Bernard and Andre,
2001a), leading to the expression of PTR2 and amino acid permeases such as
BAP2. The signaling is likely to cause changes in conformations and covalent
modifications of Ssy1p, Ptr3p, and Ssy5p since the presence of the other two
components and extracellular amino acids altered electrophoretic mobility of
these proteins (Forsberg and Ljungdahl, 2001a).
Recent

discoveries

of

additional

proteins

involved

in

inducing

transcription of amino acid and peptide permeases indicate that amino acid
sensing is connected to several different pathways. One pathway may involve
components of the SCFGRR1 ubiquitin-ligase complex involved in cyclin
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degradation. The SCFGRR1 ubiquitin-ligase complex is essential for transcription
of genes under Ssy1p control, which upon amino acid addition leads to a
signaling pathway in which Grr1p, an F-box protein, and Uga35p, a transcription
factor of Cys6-Zn2 family, regulate expression of amino acid permeases (Iraqui et
al., 1999a; Bernard and Andre, 2001b). Another mechanism may involve an
indirect Ssy1p control of the functional expression of amino acid permeases
(Forsberg et al., 2001b). Two independent ubiquitin-mediated processes
negatively modulate amino acid uptake: a novel membrane-bound ubiquitin
ligase system (Asi1p, Asi2p, Asi3p) that affects the transcription of amino acid
permease genes and a ubiquitin ligase system (Rsp5p, Bul1p, Bro1p) that affects
traffic of amino acid permeases in the late endosomal vacuolar protein sorting
pathways. Finally, other genes that control BAP2 expression such as Leu3p,
Tup1p, Stp1p, and Stp2p transcription factors may also provide additional
pathways (Nielsen et al., 2001). The elucidation of the above signal transduction
pathways presents a challenging problem, and the regulation among these
pathways portrays a fascinating system by which cells respond to their
nutritional environment.
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PART III
STP1 AND STP2 REGULATE THE EXPRESSION OF PTR2, A DI/TRIPEPTIDE TRANSPORT GENE, IN S. CEREVISIAE
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CHAPTER I
INTRODUCTION

The yeast Saccharomyces cerevisiae takes up peptides containing two to
three amino acids from the extracellular environment to serve either as nitrogen
sources or amino acids for protein biosynthesis once inside the cell. Transport
across the plasma membrane is active, driven by the proton gradient, via a single
di/tri-peptide transporter that is encoded by PTR2 (Perry et al., 1994). Ptr2p is an
integral membrane protein of 601 amino acids containing 12 membrane-spanning
domains that is necessary and sufficient to translocate di- and tri-peptides into
the yeast cell (Perry et al., 1994). The transporter is specific for di- and tripeptides, with a preference for peptides containing hydrophobic amino acids.
It was noted that the uptake of di/tri-peptides was substantially greater in
cells grown on a poor nitrogen source, such as proline, when compared to cells
grown on a rich nitrogen source, such as ammonium sulfate (Becker and Naider,
1977; Nisbet and Payne, 1979). Subsequent work added another level of
regulation by showing that peptide transport activity could be further increased
by micromolar concentrations of amino acids in a nitrogen-poor or nitrogen-rich
growth medium (Island et al., 1987). Two genes, PTR1/UBR1 and PTR3, have
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been identified as encoding regulatory proteins of the di/tri-peptide transport
system (Island et al., 1987; Alagramam et al., 1995; Barnes et al., 1998).
Amino acid induction of peptide transport appears to be regulated by a
sensory pathway mediated in part by the Ssy1p-Ptr3p-Ssy5p (SPS) complex
(Didion et al., 1998; Klasson et al., 1999; Forsberg and Ljungdahl, 2001). Upon
binding of extracellular amino acids to Ssy1p, a membrane protein, a signal is
transduced through Ptr3p and Ssy5p to downstream effectors including
Ptr1p/Ubr1p, activating ubiquitin-mediated degradation of the PTR2 repressor
Cup9p and resulting in induced expression of PTR2 (Alagramam et al., 1995;
Byrd et al., 1998). Extracellular dipeptides also accelerate di/tri-peptide uptake.
Once taken up by the cells, dipeptides appear to gain access to allosteric binding
sites of Ptr1p/Ubr1p thereby activating ubiquitin-mediated degradation of the
Cup9p (Turner et al., 2000) and up-regulation of PTR2 expression (Hauser et al.,
2001).
Recently, STP1 and STP2, genes previously hypothesized to encode pretRNA splicing proteins (Wang and Hopper, 1998), were identified as
transcription factors for BAP2, a branched amino acid permease whose
expression is also induced by extracellular amino acids through the SPS complex
(Grauslund et al., 1995; Didion et al., 1996; Nielsen et al., 2001). In this
communication, using response to toxic amino acids and peptides, direct
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radiolabeled dipeptide uptake, and a reporter gene assay, we provide evidence
that STP1 and STP2 are involved in regulating the di/tri-peptide transport
system through PTR2 expression. Single and double deletions of STP2 and PTR3
showed an epistatic relationship indicating that STP2 may act downstream of
PTR3. The data presented strongly suggest that STP1 and STP2 are additional
regulatory proteins of the di/tri-peptide transport system that mediate the amino
acid or dipeptide induction of PTR2 expression as PTR2 transcription factors.
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CHAPTER II
MATERIALS AND METHODS

Strains and media.
Yeast strains used are listed in Table 1. The strains used in this study were
grown routinely on YEPD medium (1% yeast extract, 2% peptone, 2% glucose,
2% agar). Strains transformed with a plasmid were cultured on minimal medium
lacking uracil (0.67% Difco yeast nitrogen base with ammonium sulfate, without
amino acids, 2% glucose, 0.2% casamino acids). For peptide toxicity assays, cells
were inoculated into medium lacking ammonium sulfate (0.67% Difco yeast
nitrogen base without amino acids and ammonium sulfate, 2% glucose, with
auxotrophic marker amino acids) supplemented with 0.1% proline as a nitrogen
source, and leucine (228 µM) and tryptophan (98 µM) or Arg-Glu (1 µM) as
inducer (proline medium). Plasmids were introduced into yeast by LiAcmediated transformation as described previously (Gietz et al., 1995; Agatep et al.,
1998). RG-stp2∆ and RG-stp1∆ strains were obtained from Research Genetics
(Birmingham, AL). These deletion mutant strains were maintained on the basis
of resistance to G418 (300 µg/mL) and were verified by PCR (data not shown).
Construction of stp2∆ and ptr3∆stp2∆ strains in the FY2 background was
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Table 1. S. cerevisiae strains used.
Strain
FY2
ptr3∆ or
BWS-201
stp2∆
ptr3∆stp2∆
RG-stp1∆

Genotype

MATα ura3-52
MATα ura3-52 ptr3::Loxp

MATα ura3-52 stp2::Loxp
MATα ura3-52 ptr3∆15 stp2::Loxp
MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 stp1::Loxp

RG-stp2∆

MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 stp2::Loxp

ptr2∆ or
PB1X-2A∆

MATa ura3-52 leu2-3 lys1-1 his4-32 ptr2::LEU2
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Reference
Winston et al. (1995)
Barnes et al. (1998)
This work
This work
Research
Genetics
(strain #14297)
Research
Genetics
(strain #16603)
Perry et al. (1994)

accomplished by the method of Guldener et al. (1996), which results in the
replacement of a target ORF with the dominant selectable kanr marker. Briefly,
bipartite oligonucleotide primers (STP2kan-F and STP2kan-R; Table 2) were used
to PCR-amplify the kanr marker from the pUG6 plasmid resulting in 40 bp
extension of the STP2 ORF flanking a functional kanr cassette. PCR amplification
using these primers yielded a 1.7 kb fragment that contained the kanr cassette
flanked by the 40 nucleotides of STP2. Transformants were identified on the
basis of resistance to G418 (300 µg/mL) and were verified by PCR (data not
shown).
Toxicity assay.
Functionality of any deletion strain was measured by its ability to uptake the
toxic amino acid ethionine (Eth) or the toxic dipeptide Ala-Eth. Cells were grown
overnight in proline medium and suspended in sterile water at 5.0 X 106 cells per
ml. Portions (1 ml) were added to 0.8% Noble agar and plated on proline
medium containing Leu and Trp or Arg-Glu supplements to induce peptide
transport. A total of 0.38 mmol of L-ethionine (Eth) or L-alanyl-L-ethionine (AlaEth) was added to a disk of Whatman 3MM filter paper. L-ethionine was
obtained from SIGMA (St. Louis, MO), and Ala-Eth was synthesized as
previously described (Naider et al., 1974). Disks containing each compound were
placed on the surface of the plates. After 48 h of incubation, zones of inhibition
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Table 2
Plasmid and nucleotides used.
Plasmid or
Description or sequences
oligonucleotides
PLACZ-2
PTR2 promoter lac-Z fusion in pYLZ6
PMSI
PTR2 in pYCP50 under native PTR2 promoter
STP2KAN-F
5’- CAAGAGAGCAAAAAGTTGGGCAGCT
GAAGCTTCGTACGC-3’
STP2KAN-R
5’-CGTAAAATACCTGAAACCGCCGCATA
GGCCACTAGTGGATCTG-3’
PTR3-F
5’-CATACATAGGTACGAAATAC-3’
PTR3-R
5’-CCACTTTTGTCTATGAGAGTG-3’
STP1-F
5’-CGTTCAAAAATGCCCTCTACC-3’
STP1-R
5’-TTTTCGATGGCGTGCTTCTT-3’
STP2
Forward and reverse primers were obtained
from Research Genetics.
ACT1
Forward and reverse primers were obtained
from Research Genetics.
PTR2
Forward and reverse primers were obtained
from Research Genetics.
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Reference
This work
Perry et al. (1994)
This work
This work
This work
This work
This work
This work
-

were measured for all plates. Pictures shown are representation of three
independent measurements.
Uptake assays.
Transformed cells were grown overnight to mid-exponential phase in proline
medium. The uptake assay was initiated by combining equal volumes of prewarmed (30 °C) cells and 2X uptake assay mixture (2% glucose, 20 mM sodium
citrate/potassium phosphate, pH 5.5, 500 µM Leu-Leu (SIGMA, St. Louis, MO),
320 µM L-leucyl-L-[3H]leucine (16 mM, 10 mCi/mmol). L-Leucyl-L-[3H]leucine
was synthesized by standard solution-phase techniques. All compounds were
dissolved in either water or sodium citrate/potassium phosphate buffer (pH 5.5).
After 10 minutes, aliquots (90 µl) were removed and washed four times by
vacuum filtration with 1 ml ice-cold water onto a membrane filter (HAWP,
Millipore, Bedford, MA). The membranes were counted by liquid scintillation
spectrometry, and results were reported as nmol/mg dry weight. Data points
and error bars reflect the mean and standard deviation of a minimum of four
independent measurements.
Reporter assay.
All cells were grown overnight in proline medium supplemented with leucine
(228 µM) and tryptophan (98 µM) or dipeptide Arg-Glu (1 µM) to induce di/tripeptide transport. The following day, amino acid or dipeptide supplement was
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added, and the cells were grown for another 2 hours. Then, standard liquid βgalactosidase assay for yeast cells was performed (Kippert, 1995). Data points
and error bars reflect the mean and standard deviation of a minimum of four
independent measurements.
RNA isolation and northern blot analysis.
Total RNA from approximately 2-3x108 cells was extracted using the PureScript
RNA isolation kit from Gentra Systems. 15µg of total RNA was denatured with
glyoxal (Ambion, Austin, TX), and run on a 1% agarose gel. The RNA was
transferred to a Magnacharge positively-charged nylon membrane (MSI,
Westboro,

MA)

using

a

downward

alkaline

transfer

(modified

from

Chomczynski, P., 1992). Probe templates were amplified from wild-type genomic
DNA, using gene-specific primers as described in Table 1 and Taq polymerase
(SIGMA, St. Louis, MO). These PCR products were purified with Edge
BioSystems’ Quick Step PCR purification kit. Purified PCR products were labeled
with

32P

using Ambion’s Strip-EZ DNA kit. Blots were prehybridized overnight

at 42°C in Ambion’s NorthernMax prehybridization/hybridization buffer,
supplemented with 100µg/ml sheared salmon sperm DNA. Probe hybridization
was

carried

out

overnight

at

42°C

in

Ambion’s

NorthernMax

prehybridization/hybridization buffer, supplemented with 10% Dextran Sulfate,
and approximately 2-3 x 106 CPM/ml of probe. After hybridization, the blots
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were washed for 30 minutes at 50°C in the following buffers: 3X SSC, 0.05%
sodium pyrophosphate, 0.5% SDS; 1X SSC, 0.05% sodium pyrophosphate, 0.5%
SDS; 0.2X SSC, 0.05% sodium pyrophosphate, 0.5% SDS. The hybridized filters
were then placed on damp Whatman paper (0.2X SSC, 0.05% sodium
pyrophosphate, 0.5% SDS), and wrapped with plastic film to prevent them from
drying out during exposure. The filters were exposed to a storage phosphor
screen, and analyzed on a Molecular Dynamics Storm phosphorimager at a
resolution of 100µm. After exposure, the filters were stripped using Ambion’s
Strip-EZ DNA kit at 68°C. After stripping, the filters were re-exposed to a
phosphor screen to ensure that the signal was effectively removed.
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CHAPTER III
RESULTS

stp1∆
∆ and stp2∆
∆ cells have decreased ability to uptake toxic amino acid and
dipeptide.
To determine whether cells lacking STP1 or STP2 had a functional di/tri-peptide
system, cells carrying a deletion of STP1 or STP2 (RG-stp1∆ or RG-stp2∆ cells,
respectively) were tested by measuring their responses to toxic dipeptide. The
wild-type cells (Fig. 1A) formed approximately a 3.5 cm diameter zone of
inhibition to the toxic amino acid Eth and a 2.1 cm diameter zone to the toxic
dipeptide Ala-Eth, indicating that the wild-type cells were able to uptake amino
acid and dipeptide. In the presence of Arg-Glu as an inducer of peptide
transport, similar responses to toxic dipeptide were observed (data not shown).
The ptr2∆ cells, which are ptr2 null mutant strains, formed a zone in the presence
of Eth showing that these cells transported amino acids in the absence of Ptr2p,
but did not form a zone of inhibition in the presence of Ala-Eth, showing that
these cells did not have a functional di/tri-peptide transport system (Fig. 1B).
The zone of inhibition by the toxic amino acid Eth in either RG-stp1∆ or RG-stp2∆
cells was decreased compared to that of the wild-type or ptr2∆ cells, suggesting
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Fig. 1. Toxic peptide and amino acid sensitivity. Each strain was tested for its
sensitivity or resistance to the toxic amino acid ethionine (E) and the toxic
dipeptide alanyl-ethionine (A-E). In each petri plate, the disk on the left
contained E, whereas the disk on the right contained A-E. (A) wild-type cells, (B)
ptr2∆ cells, (C) RG-stp1∆ cells, and (D) RG-stp2∆ cells.
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that RG- stp1∆ or RG-stp2∆ cells have reduced ability to uptake amino acid (Fig.
1C and 1D). The assays also showed that STP1 and STP2 are involved in di/tripeptide uptake. The zone of inhibition by dipeptide Ala-Eth (A-E) in either RGstp1∆ (Fig. 1C) or RG-stp2∆ (Fig. 1D) cells was not visible.
The level of radiolabeled Leu-Leu uptake was decreased in stp1∆
∆ or stp2∆
∆
cells.
The reduced toxicity to amino acid and dipeptide observed in the previous assay
was difficult to measure quantitatively. Therefore, a direct assay of radiolabeled
Leu-Leu uptake was performed. The radiolabeled Leu-Leu uptake showed that
wild-type cells were able to transport Leu-Leu dipeptide (Fig. 2). In the presence
of Arg-Glu as inducer of peptide transport instead of tryptophan and leucine,
similar uptakes were observed (data not shown). The peptide uptake in ptr2∆
cells (Fig. 2) was not above background levels as measured by adsorption of
peptide to cells at 00C (data not shown). The ability to uptake radiolabeled LeuLeu dipeptide in RG-stp1∆ or RG-stp2∆ cells was greatly decreased compared to
wild-type cells (Fig. 2). In contrast to abolished uptake in ptr2∆ cells, RG-stp1∆ or
RG-stp2∆ cells still had about 7% and 15%, respectively, functional dipeptide
transport in comparison to that of the wild-type. The results corroborate the lack
of visible halos observed in the previous assays (Fig. 1C and 1D) and indicate
that RG-stp1∆ or RG-stp2∆ cells have a limited ability to transport di/tri-peptide.
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Fig. 2. Peptide transport assay. Accumulation of L-leucyl-L-[3H]leucine was
measured after 10 minutes as described in Materials and Methods. Each S.
cerevisiae strain was grown overnight in minimal medium lacking ammonium
sulfate (0.67% Difco yeast nitrogen base without amino acids and ammonium
sulfate, 2% glucose, with auxotrophic amino acids) supplemented with 0.1%
proline as a nitrogen source, and leucine (228 µM) and tryptophan (98 µM) to
induce di/tri-peptide transport.
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Amino acid and dipeptide induction of PTR2 expression require STP1 and
STP2.
STP1 and STP2 were identified as transcription factors for BAP2, a branchedchain amino acid permease whose expression is induced by extracellular amino
acids (Nielsen et al., 2001). PTR2 expression is induced by amino acids (Klasson et
al., 1999) and dipeptides (Turner et al., 2000; Hauser et al., 2001). To test whether
STP1 and STP2 are involved in di/tri-peptide transport, PTR2 expression,
induced by either amino acids or dipeptide in the presence or absence of STP1 or
STP2, was measured using a colorimetric assay that detected activation of the
native PTR2 promoter. In wild-type cells, the addition of amino acids L and W or
dipeptide R-E caused a 4- or 6-fold induction of PTR2 expression, respectively
(Fig. 3, solid bars). Without any inducer, RG-stp1∆ or RG-stp2∆ cells expressed
PTR2 at about 50% of the level of the wild-type. In the presence of amino acid
inducers, PTR2 expression in RG-stp2∆ was about 60% of the wild-type
expression, while RG-stp1∆ only expressed 20% of the wild-type level of PTR2. In
the presence of R-E dipeptide inducer, RG-stp1∆ and RG-stp2∆ cells had PTR2
expression levels about 30% of that of the wild-type. The results suggest that
both Stp1p and Stp2p are necessary for optimal amino acid- or dipeptidemediated induction of PTR2 expression.
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Fig. 3. PTR2 expression patterns determined by liquid β-galactosidase assay on
the lac-Z reporter gene under the native PTR2 promoter. For each analysis, each
strain was grown in minimal medium without and with inducer of the peptide
transport system (indicated by +L/W [plus leucine and tryptophan] or +R-E
[plus Arginyl-Glutamate]).
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stp2∆
∆ and ptr3∆
∆stp2∆
∆ cells have similar ability to uptake toxic amino acid and
dipeptide.
Amino acid and peptide induction of PTR2 expression are also regulated by
PTR3. The product of this gene is a component of the amino acid complex sensor
Ssy1p-Ptr3p-Ssy5p (Klasson et al., 2000). PTR3 acts upstream of SSY5 and CUP9,
which are genes involved in the regulation of PTR2 expression (Andre et al.,
2001; Barnes et al., 1998). To test the epistatic relationship between STP2 and
PTR3, stp2∆ and ptr3∆stp2∆ strains were constructed in a FY2 wild-type
background (see Materials and Methods), and their di/tri-peptide transport
functions and PTR2 expression levels were compared to those of ptr3∆ cells. To
analyze the di/tri-peptide transport function of ptr3∆, stp2∆, and ptr3∆stp2∆ cells,
each strain was tested for its response to toxic dipeptide. The wild-type cells
formed approximately a 3.5 cm diameter zone of inhibition to the toxic amino
acid Eth and a 2.1 cm diameter zone to the toxic dipeptide Ala-Eth (Fig. 4, panel
A and Fig. 1). The ptr3∆ cells formed a 1 cm diameter fuzzy zone of inhibition in
the presence of Eth and a nearly invisible zone of inhibition in the presence of
Ala-Eth (Fig. 4, panel B). The fuzzy zone was previously observed in identical
assay, and was an indication of a leaky phenotype of ptr3∆ strain (Island et al.,
1991). The zones of inhibition by the toxic amino acid Eth or toxic dipeptide AlaEth in either stp2∆ or ptr3∆stp2∆ cells were similar (Fig. 4, panels C and D).
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Fig. 4. STP2 and PTR3 epistatic relationship as determined by toxic peptide
sensitivity. Each strain was tested for the ability to uptake amino acid or
dipeptide by measuring the zone of inhibition due to transport of the toxic amino
acid ethionine (E) and the toxic dipeptide alanyl-ethionine (A-E). In each petri
plate, the disk on the left contained E, whereas the disk on the right contained AE. (A) Wild-type FY2 cells, (B) ptr3∆ cells, (C) stp2∆ cells, and (D) ptr3∆stp2∆ cells.
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These cells formed a 2 cm diameter fuzzy zone of inhibition in the presence of
Eth. The zone of inhibition by dipeptide Ala-Eth (A-E) in either stp2∆ or
ptr3∆stp2∆ cells was not visible.
The level of radiolabeled Leu-Leu uptake was equivalent in stp2∆
∆ and
ptr3∆
∆stp2∆
∆ cells.
A direct radiolabeled Leu-Leu uptake experiment was performed to complement
the peptide toxicity assay. Fig. 5 shows that the wild-type cells were able to
transport Leu-Leu dipeptide. In the presence of Leu and Trp or Arg-Glu as
inducers of peptide transport, similar uptakes were observed (data not shown for
Arg-Glu induced cells). The peptide uptake in ptr3∆ cells was reduced to about
20% of that of the wild-type. The level of radiolabeled Leu-Leu dipeptide uptake
in stp2∆and ptr3∆stp2∆ cells was similarly decreased to approximately 60% of
that of the wild-type cells.
Amino acid and dipeptide mediated PTR2 expression levels were comparable
in stp2∆
∆ and ptr3∆
∆stp2∆
∆ cells.
We tested the level of PTR2 expression induced by either amino acids or
dipeptide in ptr3∆, stp2∆, and ptr3∆stp2∆ cells by utilizing a lac-Z reporter gene
under the native PTR2 promoter. In wild-type cells, the addition of amino acids L
and W or dipeptide R-E caused a 4 or 6 fold induction of PTR2 expression,
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Fig. 5. Peptide transport assay. Accumulation of L-leucyl-L-[3H]leucine in wildtype FY2, ptr3∆, stp2∆, or ptr3∆stp2∆ strains was measured after 10 minutes as
described in materials and methods. Each S. cerevisiae strain was grown
overnight in minimal medium lacking ammonium sulfate (0.67% Difco yeast
nitrogen base without amino acids and ammonium sulfate, 2% glucose, with
auxotrophic amino acids) supplemented with 0.1% proline as a nitrogen source,
and leucine (228 µM) and tryptophan (98 µM) to induce the di/tri-peptide
transport .
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Fig. 6. PTR2 expression patterns determined by liquid β-galactosidase assay of
the lac-Z reporter gene. For each analysis, each strain was grown in minimal
medium without and with inducer of the peptide transport system (indicated by
+L/W [plus leucine and tryptophan] or +R-E [plus Arginyl-glutamate]).
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respectively (Fig. 6, solid bars). These results were similar to those found in a
separate experiment using the same cells and conditions (Fig. 3). Without any
inducer, the absence of PTR3 decreased the expression of PTR2 to 10% of that of
the wild-type, and stp2∆ and ptr3∆stp2∆ cells had approximately 25% of the PTR2
expression level compared to that of the wild-type. In the presence of L and W
amino acid inducers, PTR2 expression in ptr3∆ cells was decreased to 17% of that
of the wild-type. Under the same conditions, both stp2∆ and ptr3∆stp2∆ cells had
about 50% PTR2 expression compared to that of the wild-type. In the presence of
R-E dipeptide inducer, ptr3∆ cells had PTR2 expression levels about 20% of that
of the wild-type, and similar PTR2 expression levels were observed in stp2∆ and
ptr3∆stp2∆ cells.
PTR3 does not regulate STP1 or STP2 expression.
Since the results of the above epistatic analysis suggested that STP2 acts
downstream of PTR3 and both amino acid and dipeptide induction of PTR2
expression involved PTR3 and STP2, we carried out an experiment to determine
whether PTR3 was involved in regulation of expression of STP2 or its homolog
STP1. As shown by a northern analysis (Fig. 7), PTR3 regulated PTR2 expression,
because in the absence of PTR3 the amino acid-induced expression of PTR2 was
greatly reduced. The expression of STP1 or STP2 was not induced or repressed
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Fig. 7. STP2, STP1, and PTR2 expression patterns in the presence or absence of
PTR3 as determined by northern analysis. For each analysis, the wild-type (FY2)
strain was grown in minimal medium and compared to ptr3∆ (BWS-201 strain).
Northern blots and quantitative representation of the signal strengths relative to
actin (ACT1) expression are shown.
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by the addition of amino acid, and STP1 and STP2 expression levels were not
noticeably affected by amino acids L and W in the absence or presence of PTR3.
STP1 and STP2 are highly expressed in medium containing a rich nitrogen
source.
Because nitrogen source is known to affect PTR2 expression, the effect of
nitrogen source on expression of STP1 and STP2 was tested. Wild-type cells were
grown in medium containing ammonium sulfate (0.1%) as a rich nitrogen source
or medium containing proline (0.1%) as a poor nitrogen source. Appropriate
amino acid prototrophic markers (K, H, L, or W) were added. A northern
analysis showed that when the cells were grown in a poor nitrogen source, PTR2
expression was increased by 35% compared to that of cells grown in a rich
nitrogen source (Fig 8). Among the cells grown in the two conditions, PTR3,
STP1 or STP2 were expressed highest when the cells were grown in a rich
nitrogen source. When the cells were grown in a poor nitrogen source, PTR3,
STP1 or STP2 expression was decreased to 64%, 47%, or 44%, respectively,
compared to that of cells grown in a rich nitrogen source.
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Fig. 8. PTR3, STP1, STP2, and PTR2 expression patterns in rich or poor nitrogen
source determined by northern analysis. For each analysis, wild-type cells (ptr2∆
cells containing pMSI, a plasmid encoding wild-type Ptr2p under PTR2
promoter) were grown in minimal medium with rich (indicated by MR) or poor
(indicated

by

MP)

nitrogen

source.

Northern

blots

and

quantitative

representation of the signal strengths relative to actin (ACT1) expression are
shown.
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CHAPTER IV
DISCUSSION

The present work reports on the involvement of STP1 and STP2 in the di/tripeptide transport system of S. cerevisiae. We began the study by examining
transport function and PTR2 expression in the absence of STP1 or STP2. By
measuring response to toxic amino acid and dipeptide and direct dipeptide
uptake, we showed that STP1 and STP2 were involved in di/tri-peptide
transport. A liquid β-galactosidase reporter gene assay showed that these genes
were required for optimal amino acid and dipeptide induced PTR2 expression.
Because the absence of Stp1p had a greater impact on amino acid induced PTR2
expression than that in the absence of Stp2p, STP1 may play a greater role in
amino acid induction of di/tri-peptide transport than STP2 (Fig. 3). We also
noticed that the absence of Stp2p or Stp1p did not completely abolish the
induction of PTR2 expression.

Thus, STP1 and STP2 are not essential, but

required for optimal induction of expression of PTR2.
Because mutations in SSY5 manifest phenotypes that are indistinguishable from
those resulting from either single ssy1 and ssy5 mutations or ssy5 ssy1 and ssy5 ptr3
double mutations, Ssy5p and Ptr3p are hypothesized to be a component of the
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Ssy1p-Ptr3p-Ssy5p amino acid sensory machinery (Hanna and Forsberg, 2001).
We explored the relationship between PTR3 and STP1 or STP2 and showed that
although PTR3 regulated amino acid-mediated PTR2 expression, PTR3 did not
affect STP1 or STP2 expression (Fig. 5). Furthermore, through an epistasis
analysis, we showed that stp2∆ and ptr3∆stp2∆ strains had similar phenotypes
indicating that STP2 functions in the same pathway as PTR3, likely by acting
downstream of PTR3 (Fig. 4, 5, and 6). Thus, it is likely that PTR3 acts upstream
of STP1 and STP2 through a mechanism other than expression regulation. For
example, PTR3 may regulate the turnover of Stp1p and Stp2p or interact with
Stp1p or Stp2 leading to the activation or inactivation of an Stp1p or Stp2p
function. It is interesting to note that, in cells grown in the presence of amino
acids, biochemical analysis found that Ptr3p appeared to acquire distinct as yet
undetermined modifications

(Forsberg and Ljungdahl, 2001). A detailed

biochemical and genetic analysis of the amino acid sensory pathway will be
required to identify all the members of the pathway and their physiological roles.
However, potential members of this pathway have been identified. They include
the global transcription factor coded by ABF1, which is required for amino acid
induction of BAP2 and BAP3 (Della Seta et al., 1990), and the product of UGA35,
which is a common factor that is required for transcription induced by several
compounds such as GABA and allophonate (Iraquie et al., 1999).
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The pleiotrophic phenotype of ptr3∆ cells opens up the possibility that
Ptr3p interacts with a wide range of regulatory proteins involved in the amino
acid induction mechanism. These proteins may include: SCFGRR1 ubiquitin-ligase
complex which is essential for transcription of genes under Ssy1p control (Iraqui
et al., 1999; Bernard and Andre, 2001a), a novel membrane-bound ubiquitin ligase
system (Asi1p, Asi2p, Asi3p) that affects the transcription of amino acid
permease genes, and a ubiquitin ligase system (Rsp5p, Bul1p, Bro1p) that affects
amino acid permease traffic in the late endosomal vacuolar protein sorting
pathways (Nielsen et al., 2001). Whether Stp1p or Stp2p interacts with Ptr3p or
any of these proteins above is unknown. A comprehensive study on yeast
protein-protein interaction by the Yeast PathCallingTM screen (Uetz et al., 2000;
GeneScape Portal Web Site, http://portal.curagen.com) showed that Stp1p
interacts with Cns1p, a component of the Hsp90 chaperone complex (Dolinski et
al., 1998) and Ydl100cp, a protein with similarity to E. coli ArsA ATPase, a
component of the arsenite-antimonite efflux pump (Boskovic et al., 1996).
Northern analysis further showed that cells grown in ammonium sulfate
as a rich nitrogen source have higher expression of STP1 and STP2 than those
grown in proline as a poor nitrogen source. The induced expression levels in a
rich nitrogen source were the opposite to the reduced expression of PTR2 and
several amino acid permease genes in cells grown in a rich nitrogen source, a
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phenomenon called nitrogen catabolite repression (Coornaert et al., 1992;
Magasanik, 1992; Barnes et al, 1998). Complementary studies analyzing the
effects of extracellular amino acids, peptides, and nitrogen sources on the
activation of the transcriptional machinery of di/tri-peptide transport system
will be necessary to elucidate the regulation of di/tri-peptide transport in
response to extracellular stimuli.
The involvement of STP1 and STP2, which were previously hypothesized
to encode pre-tRNA splicing proteins and function as transcription factors of a
branched amino acid permease Bap2p, places an additional layer of regulation of
the di/tri-peptide transport system. Does Stp1p or Stp2p function as pre-tRNA
splicing proteins or transcription factors or in other roles in di/tri-peptide
transport? Several clues to answer these questions can be obtained from similar
regulation of di/tri-peptide and amino acid transport systems. For example, both
PTR2 and BAP2 expression were induced by a micromolar amount of amino acid
inducers, and these amino acid induction mechanisms were regulated by the
same amino acid sensory complex consisting of Ssy1p, Ptr3p, and Ssy5p. It is
possible that Stp1p and Stp2p, which were previously shown to bind directly to
the UASaa (amino acid-dependent upstream activator sequence) found in the
promoter of the BAP2 promoter, also bind to the promoter of PTR2. The
hypothesis was supported by the fact that the hypothetical Stp2p binding
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sequence 5'-CGGCTC-3' in the UASaa of BAP2 promoter (de Boer et al., 2000) is
present in the promoter of PTR2 (Narita and Becker, unpublished observation).
Further analysis supporting interaction of Stp1p and Stp2p at the PTR2 promoter
will be needed to test whether Stp1p and Stp2p are PTR2 transcription factors.
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CHAPTER I
INTRODUCTION

The ability of the yeast Saccharomyces cerevisiae to respond to changing
environmental conditions is essential for the viability of the cell. Sensing
extracellular conditions, receptors on the cytoplasmic membrane transduce
signals to intracellular molecules activating chemical changes of specific
metabolic pathways culminating in a cellular response. One particular group of
environmental sensors monitors nutrients, such as sugars, amino acids, and
peptides, to allow the cell to respond to conditions of starvation or growth in a
rich environment.
Amino acid and peptide transport in yeast occurs through a number of
transport proteins. The amino acid permeases Gap1p and Agp1p, for example,
transport a wide variety of amino acids for catabolic purposes, whereas a
number of amino acid permeases transport only a specific amino acid such as
branched chain amino acids, histidine, or arginine taken up by Bap2p, Hip1p, or
Can1p, respectively (Regenberg et al., 1999). Ptr2p is the only yeast di/tri-peptide
transporter (Island et al., 1991; Perry et al., 1994). Genes encoding these amino
acid and peptide transporters are differentially regulated by the nitrogen source
and the presence of specific amino acids in the growth medium.
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Several studies have been performed on an S. cerevisiae amino acid sensor,
Ssy1p, a unique member of the amino acid permease family characterized by its
long cytoplasmic N-terminal tail (Iraqui et al., 1999; Jorgensen et al., 1998).
Binding of extracellular amino acids to Ssy1p does not result in amino acid
transport; rather binding initiates a signal transduction pathway whose outcome
is the induction of a number of amino acid permeases genes as well as the di/tripeptide transporter gene (Iraqui et al., 1999; Klasson et al., 1999). Together with
regulatory proteins Ssy5p and Ptr3p, Ssy1p is hypothesized to form an amino
acid sensor machinery complex (Forsberg and Ljungdahl, 2001). All three
components of the amino acid sensing complex (named SPS for Ssy1p-Ptr3pSsy5p) are required for amino acid induction of amino acid and peptide
transport. (Forsberg and Ljungdahl, 2001).
Ssy5p was identified as a component of SPS since ssy5∆ mutants are in the
same epistasis group as ssy1∆ and ptr3∆ mutants. All three mutants exhibited
similar phenotypes such as increased resistance to toxic amino acids and
increases in vacuolar pools of histidine and arginine (Forsberg and Ljungdahl,
2001). Ptr3p was originally identified as a regulatory protein for expression of the
di/tri-peptide transporter gene, PTR2, as well as a number of amino acid
permease genes (Barnes et al., 1998; Forsberg and Ljungdahl, 2001). Ptr3p
interacts with the N-terminal domain of amino acid sensor Ssy1p as shown by
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two-hybrid analysis and co-immunoprecipitation (Narita and Becker,
unpublished observation). Growing yeast cells engage distinct developmental
pathways leading to vegetative growth or filamentous-like growth in response to
nutrient availability. Involvement of Ptr3p in these pathways was indicated by
the enhancement of haploid filamentous-like growth in the absence of Ptr3p
(Klasson et al., 1999). Furthermore, PTR3 is involved in induction of PTR2 by not
only amino acids, but also dipeptides (Hauser et al., 2001).
Some limitations to further study of the function of Ptr3p include the fact
that functional motifs have not been identified in Ptr3p, and Ptr3p has no overall
sequence similarity to other proteins in the database. Limited homology exists to
a short sequence (54 amino acids) within Gcn4p and extracellular loops (about 51
amino acids) of some amino acid permeases (Klasson et al., 1999). Previous
results showed that the regulatory events controlled by SPS may require that
Ptr3p disengage from the membrane. After amino acid-induced activation, Ptr3p
was proposed to localize to other regions of the cell to exert control on gene
transcription (Klasson et al., 1999). Ssy5p is apparently proteolytically modified
in a Ptr3p-dependent manner because in extracts derived from ptr3 null mutants,
Ssy5p migrated as a 76-kDa protein, while in those from the wild-type Ssy5p
migrated as a 67-kDa protein (Forsberg and Ljungdahl, 2001). The Ptr3p-
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dependent processing event is likely to occur within the C-terminal portion of
Ssy5p, but the nature of this putative enzymatic role is not clear.
To better understand the function of Ptr3p, we performed several
experiments. We report on the identification of proteins that may functionally
interact with Ptr3p on the basis of a two-hybrid analysis. We expressed truncated
forms of Ptr3p to identify functional domains. A 3-dimensional protein structure
prediction algorithm, called PROSPECT (Xu and Xu, 2000), found a potential
ring finger and a beta propeller motif within Ptr3p. Furthermore, two other
different computational algorithms predicted that two putative nuclear
localization signals (NLS) were present in Ptr3p. Alanine site-directed
mutagenesis of the predicted conserved residues in each of these motifs and NLS
were performed. Each Ptr3p mutant was tested for its ability to complement the
ptr3∆ phenotype using peptide toxicity assays as a measure of a functional Ptr3p.
On the basis of these experiments, we speculate on the role of Ptr3p in the amino
acid-induced signal transduction pathway.
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CHAPTER II
MATERIALS AND METHOD

Strains and media.
Yeast strains used are listed in Table 1. Cells were grown routinely on YEPD
medium (1% yeast extract, 2% peptone, 2% glucose, 2% agar).

Strains

transformed with a plasmid were cultured on minimal medium lacking uracil or
leucine (0.67% Difco yeast nitrogen base with ammonium sulfate, without amino
acids, 2% glucose, 0.2% casamino acids).
For two-hybrid analysis, cells were grown in minimal dropout medium
containing 2% glucose (Glu) or 2% galactose plus 1% raffinose (Gal) and are
designated by the component that was omitted (e.g. SC (Glu)–ura –leu –his –ade
medium has 2% glucose and lacks uracil, leucine, histidine, and adenine). 5bromo-4-chloro-3-indolyl-β-D-galactoside

(X-Gal)

minimal

dropout

plates

contained 40 mg/ml X-Gal and phosphate buffer at pH 7.0. DNA was introduced
into yeast by LiAc-mediated transformation as described elsewhere (Gietz et al.,
1995). For peptide toxicity assays, cells were inoculated into medium lacking
uracil and ammonium sulfate (0.67% Difco yeast nitrogen base without amino
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Table 1. S. cerevisiae strains used.
Strain
FY2

Genotype

Reference

BLS-201

Winston
et
al.
(1995)
MATa ura3-52 ptr3::Loxp
Barnes et al. (1998)
MATa ura3-52 leu2-3 lys1-1 his4-32 ptr2::LEU2 Perry et al. (1994)
MATa ura3-52 leu2-3,112 lys2-801 trp1-1 his3- Bartel et al. (1990)
∆200 gal ubr1-∆1::LEU2
MATa ura3-52 cup9::Loxp
Barnes et al. (1998)

BLS-206

MATa ura3-52 ptr3::Loxp cup9::Loxp

Barnes et al. (1998)

PJ69-4A

MATa trp1-901 leu2-3,112 ura3-52 his3-200
gal4∆ gal80∆ GAL2-ADE2 LYS2::GAL1-HIS3
met2::GAL7-lacZ

James et al. (1996)

BWS-201
PB1X-2A∆
BBY-47

MATa ura3-52
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acids and ammonium sulfate, 2% glucose) supplemented with 0.1% proline as a
nitrogen source, and leucine (228 µM) as inducer (proline medium).
Plasmids.
All plasmids were created by in vivo ligation between the insert gene and the
empty vector. All plasmids and nucleotide used are listed in Table 2. The
plasmids pGBDU-C1, pGAD-C1, and genomic DNA libraries used for twohybrid analysis were obtained from James et al. (1995). pGBD-PTR3, pGBDSSY5, or pGBD-NSSY1 were created by PCR amplification of the ORF YFR209W,
YJL156C, or YDR160w encoding only the first 282 amino acids of Ssy1p,
respectively, and cloning the resultant products into the URA3/2µ-based vector
pGBDU-C1 such that the gene was fused with the Gal Binding Domain (GBD)
gene and under the control of an ADH promoter. The plasmids pGAD-PTR2,
pGAD-PTR1, and pGAD-CUP9 were created by PCR amplification of the
appropriate ORFs (YKR093w, YGR184c, and YPL177c, respectively) and cloning
the resultant products into the LEU2/2µ-based vector pGAD-C1 such that the
gene was fused with the Gal Activation Domain (GAD) gene and under the
control of an ADH promoter. Plasmids pGBD-3(1-250), pGBD-3(1-500), or pGBD3(250-678) encoding fusion protein GBD and Ptr3p residues 1-250, 1-500, or 250678 respectively were created by PCR amplification of the ORF (YFR209W) using
primer pairs GBD(1-250)-F/GBD(1-250)–R, GBD(1-250)-F/GBD(1-500)-R or
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GBD(250-678)-F/GBD(250-678)-R, and the resultant products were ligated into
pGBDU-C1. A similar strategy was used to create the pGAD-PTR3 plasmids. All
Ptr3p mutants were expressed from pUTR3(1-678) based plasmid that expressed
PTR3 under its 5’and 3’ UTR. pUTR3(1-250) which contains PTR3 fragment
residues 1-250 was created by introducing a stop codon at residue 250 on
pUTR3(1-678) through a site directed mutagenesis using SDM3-(1-250)
oligonucleotide. Plasmids pUTR3(1-500) and pUTR3(250-678) containing PTR3
fragment residues 1-500 and 250-678 were created by PCR amplification of the
ORF (YFR209W) using primer pairs 1-UTR-F/250-UTR-R and 250UTR-F/678UTR-R respectively, and the resultant products were ligated into pUTR3(1-678).
Plasmids were transformed into yeast by the LiAc-mediated transformation as
described (Agatep et al., 1998), and transformants were selected by growth on
minimal medium lacking uracil or leucine.
Yeast two-hybrid analysis.
The yeast two-hybrid screens were conducted by utilizing His, Ade, and lac-Z
assays as described (James et al., 1995). For library screening, strains containing
pGBD-PTR3 were transformed with Y2HL-C1, Y2HL-C2, and Y2HL-C3 genomic
libraries (James et al., 1995). These libraries had been amplified to obtain at least
twenty million transformants for each library in DH10B electrocompetent E. coli
to make sure that the libraries remained representative. Plasmids were
171

transformed into yeast by the LiAc-mediated transformation adjusted for 2
Hybrid System TRAFO Protocol (Agatep et al., 1998). For each library about
295,800 transformants were screened representing approximately 5–fold
coverage or 98% of the S. cerevisiae genome. The selection for interacting clones
was performed in media containing glucose and lacking histidine (plus 2 mM 3aminotriazole) or lacking adenine. Then, the colonies were further tested for lac-Z
expression

by

plating

them

on

minimal

dropout

media

containing

galactose/raffinose and X-Gal. Strong (89T and 89L plasmids) and zero
(pGBT9.C and pGAD424.C plasmids) interaction controls (Bartel et al., 1996)
were a kind gift from the Stanley Fields laboratory (Daniel Lockshon, University
of Washington, Seattle, WA). Library plasmids from yeast colonies, expressing
the putative GAD-interacting proteins, were rescued by growing the colonies on
5-Fluoroorotic acid (5-FOA) minimal dropout media lacking leucine to cure the
bait plasmid, then followed by transformation of yeast plasmid into DH5-α E.
coli. The confirmed interacting fusion genes were sequenced and evaluated by
the Basic Local Alignment Search Tool (Altschul et al., 1990) through the
Saccharomyces

Genome

Database

(http://genome-www2.stanford.edu/cgi-

bind/SGD). To test interaction of Ptr3p fragments, strain PJ69-4A containing
pGAD-PTR3(1-250), (1-500), and (250-678) was transformed either with pGBDNSSY1 or pGBDSSY5.
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Table 2. Plasmids, libraries, and nucleotides used.
Plasmid, library,
or oligonucleotide
Plasmids
pGBDU-C1
pGBD-PTR3
pGBD-NSSY1
pGBD-SSY5
pGAD-C1
pGAD-PTR2
pGAD-PTR1
pGAD-CUP9
pGAD-NSSY1

pGBD-PTR3(1250)
pGBD-PTR3(1500)
pGBD-PTR3(250678)
pRS316
pUTR3(1-678)
pPtr3p(C52A)
pPtr3p(C57A)
pPtr3p(C59A)
pPtr3p(C60A)
pPtr3p(C52A;C60
A)
pPtr3p(C52A;C57
A;C60A)
pPtr3p(F544A)
pPtr3p(N545A)
pPtr3p(S546A)
pPtr3p(S547A)
pPtr3p(P548A)
pPtr3p(RKK)
pPtr3p(KKKKK)
pUTR3(1-678)

Description or sequence

Reference

two-hybrid expression vector containing GBD
GBD-PTR3 in pGBDU-C1 (functional)
GBD-NSSY1 in pGBDU-C1
GBD-SSY5 in pGBDU-C1
two-hybrid expression vector containing GAD
GAD-PTR2 in pGAD-C1
GAD-PTR1 in pGAD-C1
GAD-CUP9 in pGAD-C1
GAD-NSSY1 in pGAD-C1

James et al. (1995)
This work
This work
This work
James et al. (1995)
This work
This work
This work
Narita and Becker
(manuscript
in
preparation)
GAD-PTR3 in pGAD-C1 encoding fusion This work
GAD and Ptr3p residues 1-250.
GAD-PTR3 in pGAD-C1 encoding fusion This work
GAD and Ptr3p residues 1-500.
GAD-PTR3 in pGAD-C1 encoding fusion This work
GAD and Ptr3p residues 250-678.
PTR3 expressing residue 1-678 in pRS316
under PTR3 5’ and 3’ UTR
C52A mutation in pUTR3(1-678)
C57A mutation in pUTR3(1-678)
C59A mutation in pUTR3(1-678)
C60A mutation in pUTR3(1-678)
C52A;C60A mutation in pUTR3(1-678)

This work
This work
This work
This work
This work
This work

C52A;C57A;C60A mutation in pUTR3(1-678) This work
F544A mutation in pUTR3(1-678)
N545A mutation in pUTR3(1-678)
S546A mutation in pUTR3(1-678)
S547A mutation in pUTR3(1-678)
P548A mutation in pUTR3(1-678)
RKK(278-280)AAA mutation in pUTR3(1678)
K5(345-358)A5 mutation in pUTR3(1-678)
PTR3 expressing residue 1-678 in pRS316
under PTR3 5’ and 3’ UTR
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This work
This work
This work
This work
This work
This work
This work
This work

Table 2. Continued.
pUTR3(1-250)
pUTR3(1-500)
pUTR3(250-678)
pADH-3(1-250)
pGBD-3(1-250)
pGBD-3(1-500)
pGBD-3(250-678)
Libraries
YL2H-C1,
YL2H-C2,
YL2H-C3
Oligonucleotides
PTR2-F
PTR2-R
CUP9-F
CUP9-R
BAP2-F
BAP2-R
ACT-F
ACT-R
pGBD-PTR3-F
pGBD-PTR3-R
pGAD-PTR2-F
pGAD-PTR2-R
pGAD-PTR1-F
pGAD-PTR1-R

PTR3 expressing residue 1-250 in pRS316
under PTR3 5’ and 3’ UTR
PTR3 expressing residue 1-500 in pRS316
under PTR3 5’ and 3’ UTR
PTR3 expressing residue 250-678 in pRS316
under PTR3 5’ and 3’ UTR
PTR3 in pDB20 expressing residue 1-250
under an ADH promoter
GBD-PTR3 expressing fusion GBD-Ptr3p
residue 1-250 in pGBDU-C1
GBD-PTR3 expressing fusion GBD-Ptr3p
residue 1-250 in pGBDU-C1
GBD-PTR3 expressing fusion GBD-Ptr3p
residue 1-250 in pGBDU-C1

This work

Genomic DNA two hybrid libraries

James et al. (1995)

This work
This work
This work
This work
This work
This work

5’-TTCCGCACCATTCCAAAACTACAT-3’
5’-GCAGCACAGAAAACTCCCGTCAAC-3’
5’-GCTAACAACCTTCGAGAATAGTTACATTCG-3’
5’-CAATTCATATCAGGGTTGGATAGC-3’
5’-TCAACCGGCTCTAATGGGAAGTGT-3’
5’-GTGGTGGGGGCCGGAAATGAC-3’
5’-GCCGGTTTTGCCGGTGACGAC-3’
5’-GGAAGATGGAGCCAAAGCGTG-3’
5’-GAGTAGTAACAAAGGTCAAAGACAGTTGACTGTATCGC
CGCACGCACACTCACACATACAT-3’
5’-TGAAGTGAACTTGCGGGGTTTTTCAGTATCTACGATTCA
TACCAGAACCTTAAACATACG-3’
5’-CCAAAAAAAGAGATCGAATTCCCCGGGGGATCCATCGC
TGCTCCACTGCAAACAA-3’
5’-CGGGGTTTTTCAGTATCTACGATTCATAGATCTCTGCTC
TGTGAAACAAATAACAGCA-3’
5’-CCAAAAAAAGAGATCGAATTCCCCGGGGGATCCATCGA
TTCCGTTGCTGATGATGATTTAGG 3’
5’-CGGGGTTTTTCAGTATCTACGATTCATAGATCTCTGCAG
CTACCAAATCTCTCGCTC-3’
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Table 2. Continued.
pGAD-CUP9-F
pGAD-CUP9-R
C52A
C57A
C59A
C60A
C52A; C60A
F544A
N545A
S546A
S547A
P548A
RKK(278280)AAA
K5(345-358)A5
SDM3-(1-250)
1-UTR-F
500-UTR-R
250-UTR-F
678-UTR-R
GBD3(1-250)-F
GBD3(1-250)-R

GBD3(1-500)-R
GBD3(250-678)-F
GBD3(250-678)R

5’-CCAAAAAAAGAGATCGAATTCCCCGGGGGATCCATCGC
TAACAACCTTCGAGAATAGTTACATTCG-3’
5’-GGTTTTTCAGTATCTACGATTCATAGATCTCTGCAGCTGT
ATACCAGAACCTTAAAC-3’
5’-CGGGGTTTTTCAGTATCTACGATTCATAGATCTCTGCAG
CAATTCATATCAGGGTTGGATAGC-3’
5’-GGTATAGTCAAAGACGCCTCTGTGCTTACGTG-3
5’-CTGCTCTGTGCTTACGGCTGGCTGCTGTATATCTG-3’
5’-GTGCTTACGTGTGGCGCCTGTATATCTGAATC-3’
5’-GCTTACGTGTGGCTGCGCTATATCTGAATCGC-3’
5’-CTGCTCTGTGCTTACGGCTGGCTGCGCTATATCTGAATC
GC-3’
5’-GTGTATCACTAGTACAGCAGCCAATTCATCTCCACTG
G-3’
5’-CTGATGTGTATCACTAGTACAGCATTCGCTTCATCTCCA
CTGGTC-3’
5’-CAACAGCATTCAATGCATCTCCACTGGTC-3’
5’-CAGCATTCAATTCAGCTCCACTGGTCATAAAC-3’
5’-CTGATGTGTATCACTAGTACAGCATTCAATTCATCTGCAC
TGGTCATAAACACC-3’
5’-CCAACTGTTTCCCCATGTACGCAGCAGCATTTCAGTTC
AACACACACCC-3’
5’-CTACTTCTCAAGCGTCAGCAGCGGCAGCGGCAAACTGG
AGCCAACG-3’
5’-CCAAACAAATAGTGCATAAGATCTAGACGAAGAAAA
GG-3’
5’-CCAAACAAATAGTGCATAAGATCTAGACGAAGAAAA
GG-3’
5’-AGAACCTTAAACATACGTATAT ATTTAGATGCATTA
5’-CATAGGTACGAAATACAGATCTGATAGGCGTTCATG
5’-CGTATATATTTAGATGCATTATT TGTGGAATATTTG
5’-CCAAAAAAAGAGATCGAATTCCCCGGGGGATCCATCG
CATCAATGCAGAAGCTGATCTCAGAGGAGGACCTGAACTG
ATAGGCGTTCATGCA-3’
5’-GGTTTTTCAGTATCTACGATTCATAGATCTCTGCAGTGT
TTGGTAGTTTGCTGTGGA-3’
5’-GGTTTTTCAGTATCTACGATTCATAGATCTCTGCAGGGT
ATTGATGGGATCTCTGT-3’
5’-AAAAAAGAGATCGAATTCCCCGGGGGATCCATCGCATC
AATGCAGAAGCTGATCTCAGAGGAGGACCTGAGAGATCCC
ATCAATACCAT-3’
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Prospect.
PROSPECT is a computer package for finding an optimal alignment between a
protein sequence and a protein structural fold (Xu and Xu, 2000). PROSPECT
guarantees to find the globally optimal sequence-structure alignment and does
so in an efficient manner, when considering both alignment gap penalty and
pairwise potential between residues that are spatially close. A neural network
assessment for the reliability of the fold recognition is given by PROSPECT (Xu et
al., in press). The atomic structures were generated using MODELLER (Sali and
Blundell, 1993) based on the alignments obtained from threading. PROSPECT
has been applied successfully to many proteins with unknown experimental
structures (Xu et al., 2001).
Computational analysis of Ptr3p subcellular localization.
Prediction of subcellular location of Ptr3p was performed with two different
programs. The first analysis was done at
http://bioinfo.mbb.yale.edu/genome/yeast server, which predicts subcellular
location of yeast proteins using Bayesian formalism (Alexandrov and Gerstein, in
press). A complementary study was performed at http://psort.ims.utokyo.ac.jp/form2.html server, which uses PSORT II, a program to predict the
subcellular localization sites of proteins from their amino acid sequences. The
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reasoning algorithm was based on the k-nearest neighbors classifier (Horton and
Nakai, 1996; Horton and Nakai, 1997).
Site-directed mutagenesis.
Single-stranded phagemid DNA of pUTR3(1-678) or pPtr3p(C52A;C60A) was
prepared by infecting Escherichia coli strain CJ236 (ung,dut) carrying pUTR3(1678) or pPtr3p(C52A;C60A) with the helper phage M13KO7 (Mead et al., 1986).
Oligonucleotide-directed mutagenesis of single-stranded phagemid DNA was
constructed as described by Kunkel et al. (1991). The product of the mutagenesis
reaction mixture was transformed into E. coli strain DH5α (Invitrogen
Corporation, Carlsbad, CA), and transformants were selected on ampicillincontaining plates. Plasmids were then isolated from transformants using the
Wizard Miniprep kit (Promega, Madison, WI). After sequence confirmation,
constructs were transformed into yeast strain BWS-201 (ptr3-deletion strain) or
wild-type FY2 strain, and transformants were selected by their growth in the
medium lacking uracil. All primers were purchased from Sigma/Genosys (The
Woodlands, TX). Sequences of the primers are shown in Table 2. DNA
sequencing was carried out in the DNA sequencing facility located on the
campus of the University of Tennessee.

177

Toxicity assay.
Functionality of any Ptr3p mutants was measured by their ability to complement
the ptr3∆ phenotype using peptide toxicity assays. This assay has been used may
times, and it mirrors the results of peptide uptake experiments and expression of
PTR2 (Island et al., 1997; Barnes et al., 1998). When the toxic peptide Ala-Eth does
not manifest toxicity, uptake of radiolabeled dipeptide is lowered greatly along
with the expression of PTR2. Cells were grown overnight in medium lacking
uracil and ammonium sulfate (0.67% Difco yeast nitrogen base without amino
acids and ammonium sulfate, 2% glucose) supplemented with 0.1% proline as a
nitrogen source, and leucine (228 µM) and tryptophan (98 µM) as inducer and
suspended in sterile water at 5.0 X 106 cells per ml. Fractions (1 ml) were added
to 0.8% Noble agar and plated on minimal media containing Leu and Trp
supplements to induce peptide transport. A total of 0.38 mmol of L-ethionine
(Eth) or L-alanyl-L-ethionine (Ala-Eth) was added to a disk made of Whatman
3MM filter paper. L-ethionine was obtained from SIGMA (St. Louis, MO), and
Ala-Eth was synthesized as previously described (Naider et al., 1974). Disks
containing each compound were placed on the surface of the plates. After 48 h of
incubation, zones of inhibition were measured for all plates. Figures shown are
representation of three independent measurements.
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Uptake Assays.
Transformed cells were grown overnight to mid-exponential phase in proline
medium. The uptake assay was initiated by combining equal volumes of prewarmed (30 °C) cells and 2X uptake assay mixture (2% glucose, 20 mM sodium
citrate/potassium phosphate, pH 5.5, 500 µM Leu-Leu (SIGMA, St. Louis, MO),
320 µM L-leucyl-L-[3H]leucine (16 mM, 10 mCi/mmol). L-Leucyl-L-[3H]leucine
was synthesized by standard solution-phase techniques as described previously.
For assays done in the presence of competitors, the 2X uptake assay mixture was
supplemented with competitor (2X final concentration) prior to combining with
the cells. At the appropriate time, aliquots (90 µl) were removed and washed by
vacuum filtration four-times with 1 ml ice-cold water onto a membrane filter
(HAWP, Millipore, Bedford, MA). The membranes were counted by liquid
scintillation spectrometry, and results were reported as nmol/mg dry weight.
Data points and error bars reflect the mean and standard deviation of a
minimum of two independent experiments with samples taken in quadruplicate.
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CHAPTER III
RESULTS

Identification of Ptr3p interacting proteins by two-hybrid screen.
To identify potential interactors of Ptr3p, we screened the Y2HL-1, Y2HL-2, and
Y2HL-3 genomic libraries for clones that encoded GBD-Ptr3p-interacting
proteins (see Materials and Methods). Control experiments showed that GBDPtr3p did not activate transcription of any of the reporter genes used in the
library screen. Yeast strains expressing the full length Ptr3p fused to GBD were
transformed with the YH2L-1, -2, and -3 libraries. Following histidine and
adenine screening, we identified 37 clones in which the lac-Z reporter genes were
transcribed, indicating the presence of plasmid-encoded proteins showing a
positive two-hybrid complex with Ptr3p. Isolation and subsequent sequencing of
these plasmids revealed they contained inserts representing the presence of 20
different ORFs (Table 3). RPN10 (non-ATPase component of the 26S proteasome
complex) and RRP1 (protein involved in maturation of 25S rRNA) were
considered as false positives because these highly basic proteins are found
abundantly as interactors in many two-hybrid screens. Although expected to be
identified on the basis of their putative formation of the Ssy1p-Ptr3p-Ssy5p
amino acid regulatory complex, GAD-Ssy1p and Ssy5p were not found in this
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Table 3. Ptr3p interactors found in two hybrid screening using Y2HL libraries.
Gene namea

Permease
VAP1 (47-168)
THI7 (457-554)
YGR125w (274-395)

Transport
YGL014w (809-888)

MTR4 (1022-1040)

Protein function

Strength of
interactionb

Amino acid permease that transports valine, Weak
leucine, isoleucine, tyrosine, and tryptophan
Thiamin transport protein
Weak
Member of sulfate permease of membrane Strong
transporters

Protein with pumilio repeats that is involved
Weak
with Mpt5p in relocalization of Sir3p and Sir4p
from telomeres to the nucleolus
Protein required for mRNA export from Very weak
nucleus, member of the DEAD-box RNA
helicase family

Transcription factor etc.
GRF10 (391-512)
Homeodomain protein required for expression
of phosphate pathway and other genes
CKI1 (1-22)
Choline kinase, first step in CDP-choline
biosynthesis pathway
BRR2 (400-435)
RNA helicase-related protein required for premRNA splicing
FAA4 (346-475)
Acyl-CoA synthase (long-chain fatty acid CoA
ligase); contributes to activation of imported
myristate
SAR1 (143-191)
Component of COPII coat of vesicles involved
in endoplasmic reticulum to Golgi transport,
GTP-binding protein of the arf family in the
ras superfamily
TSL1 (192-291)
Component of the trehalose-6-phosphate
synthase/phosphatase complex; alternate
third subunit with Tps3p
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Very weak
Weak
Very weak
Very weak

Very weak

Very weak

Table 3. Continued.
BUD5 (13-133)

YGL001C (107-227)
RPN 10 (117-187)
False positive
RRP1 (181-321)
False positive
CEF1 (1-101)

GTP/GDP exchange factor for Rsr1p/Bud1p
involved in bud site selection, mutants bud at
random sites
C-3 sterol dehydrogenase, C-4 decarboxylase,
required for ergosterol biosynthesis
Non-ATPase
component
of
the
26S
proteasome complex
Protein involved in maturation of 25S rRNA

Very weak

Very weak
Very weak
Weak

Pre-mRNA splicing factor, also required for Very weak
transition into mitosis, member of the Cdc5p
family

Unclassified protein
YGL258w (10-57)
Protein of unknown function

Very weak

YPL158c (61-179)

Protein of unknown function

Strong

YOL019w (296-439)

Protein of unknown function

Weak

YGL164c (338-402)

Protein of unknown function

Very weak

Interacting residues in two-hybrid constructs are indicated in the bracket after
the gene name
a

b

The strength of interaction was determined by X-gal plate assay.
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two-hybrid screening. Ptr3p interacted with peptides from portions of three
permeases encoded by the two-hybrid library GAD-plasmids. These peptides
include an N-terminal region of Vap1p, an amino acid permease that transports
valine, leucine, isoleucine, tyrosine, and tryptophan, a C-terminal region of
Thi7p, a major facilitator superfamily transporter responsible for thiamine
uptake, and a loop of Ygr125wp, a member of the sulfate permease family of
membrane transporters. The interacting residues of these permeases were
predicted to be on the cytoplasmic face of the plasma membrane. In addition to
the three permeases identified, Ptr3p was shown to interact with portions of a
number of proteins located in the nucleus, although many of the interactions
were apparently weak according to the strength of the β-galactosidase signal on
plates. Transporters involved in movement of proteins within the nucleus
(YGL104w) and export from the nucleus (Mtr4p) and a number of transcription
factors (Table 3) were detected. Furthermore, several unclassified proteins were
identified in the two-hybrid screen, including Ypl158c protein, which interacts
strongly with Ptr3p.
Putative nuclear localization signals were present in Ptr3p.
Previous sucrose gradient centrifugation (Klasson et al., 1999) and GFP fused
Ptr3p localization analysis (Narita and Becker, unpublished observation) showed
that Ptr3p localized at the plasma membrane as a peripheral protein, and a
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biochemical analysis showed that Ptr3p may be cleaved during signal
transduction and then localize to different cellular compartments (Klasson et al.,
1999). The finding of some nuclear localized proteins in the two-hybrid screen
supports the idea that Ptr3p may be modified and then move from the plasma
membrane to the nucleus to interact with nuclear localized proteins.
Computational predictions by both PSORT II and Bayesian formalism highly
favor nuclear localization of Ptr3p (94.1% and 94.9% probability respectively;
Table 4). Ptr3p contains two putative nuclear localization signals (NLS): KKKK
(residues 345-358) and PMYRKKF (residues 275-281). That these two NLS act as
a bipartite NLS was not predicted by the algorithm. According to the same
computational analysis, the amino acid sensor Ssy1p and di/tri-peptide
transporter Ptr2p were predicted to be membrane localized (Table 4). Other
proteins (Ptr1p/Ubr1p, Cup9p, Stp1p, and Stp2p) known to be involved
downstream in the amino acid induction pathway (Byrd et al., 1998; Barnes et al.,
1998; Nielsen et al., 2001) were predicted to localize at the nucleus.
3D modeling predicted that Ptr3p contains ring finger and β -propeller motifs.
Since Ptr3p does not have significant sequence similarity to any proteins with
known structures based on searches using algorithms such as BLAST, we used
PROSPECT (Xu and Xu, 2000) to predict its structure based on structural fold
recognition. For the 678 residues of Ptr3p, the result suggested this protein may
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Table 4. Computational predictions of subcellular localization of
proteins involved in di/tri-peptide transport.

Proteins

Bayesian formalism

involved in

PSORT II predictionb

predictiona

peptide

Subcellular

transport

localization

localization

Ptr2p

Transmembrane 89.4%

Plasma

Probability

Subcellular

Probability
73.9%

membrane
Ssy1p

Transmembrane 85.8%

Plasma

78.3%

membrane
Ptr3p

Nucleus

94.9%

Nucleus

78.3%

Ssy5p

Nucleus

43.2%

Nucleus

60.9%

92%

Endoplasmic

44.4 %

Ptr1p/Ubr1p Nucleus

reticulum
Cup9p

Nucleus

91.4%

Nucleus

78.3%

Stp1p

Nucleus

97.6%

Nucleus

82.6%

Stp2p

Nucleus

45.2%

Nucleus

60.9%

Bayesian formalism analysis was done at
http://bioinfo.mbb.yale.edu/genome/yeast server, which predicts subcellular
location of yeast proteins (Alexandrov and Gerstein, in press).
a

PSORT II was performed at http://psort.ims.u-tokyo.ac.jp/form2.html server,
which predicts the subcellular localization sites of proteins from their amino acid
sequences. The reasoning algorithm was based on the k-nearest neighbors
classifier (Horton and Nakai, 1996; Horton and Nakai, 1997).
b
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have two major domains: one within residues 1-250 and the other residues 260678. For the N-terminal domain, PROSPECT predicted a zinc finger motif of
C3HC4 type (RING finger) around residues 52-61 identified by PROSITE
(Hofmann et al., 1999) (see Fig. 1, panel a). This motif often occurs at the DNA
binding site of a transcription factor. The top hits with good confidence for the Cterminal domain were mostly signal transduction proteins such as 1qqg
[pleckstrin homology (PH) and phosphotyrosine binding (PTB) targeting region
of human insulin receptor substrate 1; Shirano et al., 1999] and 1tbg (the
heterotrimeric G-protein transducin; Noel et al., 1993). A structural model based
on 1tbg is shown in Fig. 1b. The model has a seven-bladed β-propeller fold. We
have high confidence on the prediction of the seven-bladed β-propeller fold (the
probability of the correct fold for this domain is >90%). The prediction of the
seven-bladed β-propeller fold is also confirmed when we used an independent
fold recognition program SAM-T98 (Karplus et al., 1998). Based on the prediction,
the C-terminal domain may be involved in protein-protein interaction, since
many of the β-propeller structures that have been identified have known
functions in governing protein-protein interactions, e.g., lectins (Beisel et al.,
1999) and the WD-40 domains in G-protein signaling molecules (Wall et al.,
1998).
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Fig. 1. Structural model for the Ptr3p protein. For the N-terminal domain
(within residues 1-250), PROSPECT confirmed a zinc finger motif of C3HC4
type (RING finger) around residues 52-61 (panel a), and the C-terminal domain
(within residues 250-678) was predicted to have a seven-bladed β-propeller fold
(panel b).
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(a)

(b)
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Alanine substitution of conserved Cys residues in predicted ring finger motif
reduced Ptr3p function.
The predicted ring finger motif in Ptr3p contains 3 conserved Cys residues (C52,
C57, and C60; see Fig. 2). To test whether this motif was involved in the di/tripeptide function of Ptr3p, site-directed mutagenesis of these conserved Cys
residues were performed. Non-conserved Cys residue 59 was also mutated as a
control. Single Ala substitution of C52, C59, and C60 in Ptr3p did not affect the
ability of the Ptr3p mutant to complement a ptr3∆ phenotype (Table 5). Cells
expressing Ptr3p C52A, C59A, and C60A mutants had similar sizes of halo of
inhibition of toxic amino acid and dipeptide compared to that of wild-type Ptr3p
cells. In contrast, a single Ala substitution of residue C57 reduced the ability of
the cells expressing Ptr3p C57A to complement ptr3∆ strain. The zone of
inhibition in ptr3∆ cells expressing Ptr3p C57A was reduced by 26% and 56% for
Eth and Ala-Eth, respectively, compared to that of wild-type Ptr3p cells. The
C52A;C60A double mutant and the triple C52A;C57A;C60A showed similar
phenotypes to that of the C57A mutant. Because Ptr3p was suggested to interact
with itself by two-hybrid analysis (Andre et al., 2001), we tested whether any of
the mutants affected the function of wild-type Ptr3p. None of these mutants
caused a dominant negative phenotype because the halo of inhibition by toxic
Eth and Ala-Eth in cells expressing both wild-type Ptr3p and mutant Ptr3ps was
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Fig. 2. A map of predicted motifs and nuclear localization signals within Ptr3p.
The mutated residues are underlined. The predicted ring finger motif lies within
residues 52-CSVLTCGCCI-61. The position of Ptr3p’s limited homology
sequence to transcription factor Gcn4p and some permeases are shown. Each
residue within 544-FNSSP-548 was substituted with alanine. The two nuclear
localization signals are present in predicted beta propeller structure residues 275PMYRKK-280 and 352-SSSSLSTTSQASKKKKK-368.
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1

250

500

52-CSVLTCGCCI-61
Ring finger
275-PMYRKK-280
NLS
352-SSSSLSTTSQASKKKKK-368
NLS

544-FNSSP-548
Hypothesized amino acid binding
Gcn4p/permease homology
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678

similar to that of the FY2 cells expressing only the wild-type Ptr3p (Table 5).
Ala substitution of FNSSP residues resulted in Ptr3p conferring an increase in
peptide transport.
Within the predicted seven-bladed β-propeller region of Ptr3p a limited
homology sequence (residues 544-548, Fig. 2) with Gcn4p and an extracellular
loop of some amino acid permeases was present (Klasson et al., 1999). We
decided to perform a single alanine substitution within this region. Single Ala
substitution of each residue generated a mutant Ptr3p conferring greater ability
of the cell to response to toxic Eth and Ala-Eth (Table 5). Cells expressing F544A,
N545A, S546A, S547A, and P548 have a 5%, 10%, 8%, 8%, and 2%, respectively,
greater halo of inhibition in response to ethionine as compared to that of the
wild-type cells (Table 5). An increased ability to complement ptr3∆ phenotype of
each of these mutants was more prominent in their response to toxic Ala-Eth
with increase of 76%, 80%, 68%, 72%, and 52% in halo size compared to that of
the wild-type observed for cells expressing F544A, N545A, S546A, S547A, and
P548A, respectively. None of these mutants affected the response to toxic Eth and
Ala-Eth in FY2 wild-type cells because the halo of inhibition was similar as that
of the FY2 cells (Table 5).
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Table 5. Toxicity assays of Ptr3p mutants.
Function in
Plasmid/Mutant

ptr3∆
∆ cells

wild-type FY2 cells

Diameter (mm) of zone of inhibition in response to:
Eth

Ala-Eth

Eth

Ala-Eth

0.0 + 1 *

0.0 + 0 *

40 + 1

23 + 1

39 + 1

25 + 2

41 + 0

24 + 0

C52A

40 + 1

28 + 0

40 + 1

25 + 1

C57A

29 + 1

11 + 3

41 + 0

24 + 0

C59A

36 + 1

25 + 5

42 + 1

29 + 0

C60A

40 + 0

21 + 1

41 + 1

28 + 1

C52A;C60A

28 + 4

12 + 2

40 + 1

23 + 5

C52A;C57A; C60A

30 + 1

17 + 1

41 + 1

26 + 4

F544A

41 + 1

44 + 2

40 + 1

27 + 1

N545A

43 + 1

45 + 1

42 + 1

28 + 1

S546A

42 + 3

42 + 1

41 + 1

25 + 1

S547A

42 + 1

43 + 1

40 + 3

26 + 1

P548A

40 + 2

38 + 4

40 + 1

24 + 2

K5(345-358)A5

39 + 1

25 + 3

40 + 3

24 + 1

RKK(278-280)AAA

30 + 0

10 + 1

40 + 1

28 + 2

pRS316
pUTR3(1-678)
Ring finger

β -propeller

NLS

* 0.0 mm-zone of inhibition in ptr3∆ cells was actually fuzzy, which was
previously observed in identical assay, indicating a leaky phenotype of ptr3∆
strain (Island et al., 1991).
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Ala substitution of predicted RKK nuclear localization signals resulted in a
reduction in the function of Ptr3p.
The computational analysis by PSORT II and Bayesian formalism programs
predicted the nuclear localization signals within Ptr3p (KKKKK (residues 345358) and PMYRKKF (residues 275-281) with 94.1% and 94.9% probability,
respectively; Table 4). To test whether the predicted nuclear localization signals
affected the function of Ptr3p, site-directed mutagenesis of charged KKKKK and
RKK residues were performed. Ala substitution of KKKKK(345-358)AAAAA in
Ptr3p did not affect the ability of Ptr3p mutant to complement the ptr3∆
phenotype (Table 5). Cells expressing KKKKK(345-358)AAAAA mutant had
similar sizes of halo of inhibition by toxic amino acid Eth and dipeptide Ala-Eth
compared to that of wild-type Ptr3p cells. On the other hand, Ala substitution of
RKK residues reduced the ability of the cells expressing this mutant to
complement ptr3∆ phenotype. ptr3∆ cells expressing Ptr3p RKK(278-280)AAA
had 23% and 60% reduced sizes of the zone of inhibition by toxic Eth and AlaEth, respectively, compared to that of wild-type Ptr3p cells. No dominant
negative phenotype of Ptr3p RKK(278-280)AAA mutant was observed because
its halo of inhibition by toxic Eth and Ala-Eth was similar to that of the FY2 cells.
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Functional domains of Ptr3p identified.
To identify Ptr3p functional domains, we analyzed the ability of a series of Ptr3p
fragments under PTR3 native promoter to complement the ptr3∆ phenotype.
Ptr3p fragments constructed were Ptr3p spanning residues 1-250, 1-500, and 500678. Ptr3p (1-250) was predicted to contain a ring finger motif based on a protein
structure prediction program PROSPECT (Xu and Xu, 2000; Dong Xu, personal
communication). Ptr3p (250-678) contains limited homology with transcription
factor Gcn4p and extracellular loops of some amino acid permeases (Klasson et
al., 1999). Whether each Ptr3p fragment could complement a ptr3∆ strain was
tested by response to toxic dipeptide and direct radiolabeled Leu-Leu uptake.
The zone inhibition by the toxic dipeptide Ala-Eth (A-E) in ptr3∆ cells
expressing Ptr3p (250-678) (Fig. 3A sector f) was similar to that of full lawn Ptr3p
(1-678) (Fig. 3A sector c) or wild-type FY2 cells (Fig. 3A sector a). However, ptr3∆
cells expressing Ptr3p (1-250) and Ptr3p (1-500) did not form zones of inhibition
similar to the wild-type (Fig. 3A sector d and e, respectively). Instead they
formed fuzzy halos similar to that of ptr3∆ cells (Fig. 3A sector b), which were
hard to measure quantitatively. The radiolabeled Leu-Leu uptake assay (Fig. 3B)
showed that Ptr3p (1-250) and Ptr3p (1-500) were able to restore uptake about
25% of that of the wild-type FY2 or ptr3∆ expressing Ptr3p (1-678). Ptr3p (250195

Fig. 3. Toxic peptide sensitivity (panel A) and direct dipeptide uptake (panel B)
as measures of function of Ptr3p fragments. Ptr3p fragments in ptr3∆ cells were
tested for the ability to complement the ptr3∆ phenotype by measuring the zone
of inhibition by toxic amino acid ethionine and dipeptide Ala-Eth (A) or the
ability to uptake 3H-Leu-Leu (B).
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0

678) was able to restore uptake of 3H-Leu-Leu to about 70% of that of the wildtype or ptr3∆ expressing Ptr3p (1-678).
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CHAPTER IV
DISCUSSION

To provide information on how the novel Ptr3p functions specifically in
the amino acid and dipeptide induction of PTR2 and some amino acid permeases
genes, we identified Ptr3p-interacting proteins by a two-hybrid screen. We found
that Ptr3p interacted with proteins of various functions, including proteins
involved in transport, transcription activation, and proteins of unknown function
(Table 3). However, most of the positive clones encoded peptides that interacted
weakly with Ptr3p. Weak interaction may indicate that another protein(s) is
needed to form an interacting complex. On the other hand, weak interaction as
determined by two-hybrid analysis may be sufficient for Ptr3p to initiate signal
transduction for various downstream targets.
It was interesting that Ptr3p interacted with domains of a number of
permeases including the following: (1) a small portion of the first transmembrane
domain and cytoplasmic N-terminal domain of Vap1p, an amino acid permease
that transports valine, leucine, isoleucine, tyrosine, and tryptophan, (2) Thi7p, a
major facilitator superfamily transporter responsible for thiamine uptake, at its
cytoplasmic C-terminal domain, and (3) a protein encoded by YGR125W, a
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member of the sulfate permease family of membrane transporters, at its middle
cytoplasmic loop. Interactions of Ptr3p with cytoplasmic portion of Vap1p,
Thi7p, and YGR125Wp raise a possibility that Ptr3p interacts with these
permeases as part of a sensing mechanism.
Our two-hybrid screening did not pick up an Ssy1p-Ptr3p interaction,
although we showed previously that the N-terminal domain of Ssy1p interacted
strongly with Ptr3p by a two-hybrid assay between GBD-Ptr3p and GAD-Nterminus-Ssy1p residues 1-282 (Narita and Becker, unpublished observation).
Ssy5p was also not observed in the library screen despite the genetic evidence for
the formation of an Ssy1p-Ptr3p-Ssy5p complex (Forsberg and Ljungdahl, 2001).
Several reasons have been proposed for not obtaining a two-hybrid positive
result (Philip James, personal communication). First, the fusion protein may not
fold properly such that the interacting region will not maintain its native
structure in the clones of the two-hybrid libraries. Second, the fusion protein may
not be internalized to the nucleus preventing it from interacting with bait. Third,
the genomic DNA library may not be comprehensive enough or amplified
exhaustively to represent every gene in the library.
Identification of unclassified proteins as candidates for Ptr3p-interacting
proteins raise a possibility that Ptr3p-mediated signal transduction may involve
several novel pathways. Strong interaction with residues 61-179 encoded by
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YPL158c is particularly interesting because it may give clues on how Ptr3p
functions and the role of the unknown Ypl158c protein in yeast metabolism.
YPL158C was one of 113 genes expressed at a peak during M/G1 phase of the
cell cycle (Spellman et al., 1998) suggesting that Ptr3p-mediated regulation of
peptide transport could be interconnected with the cell cycle.
The presence of some transcription factors in the two-hybrid screen
indicates that Ptr3p may interact with these proteins in the nucleus. Putative
nuclear localization signals (NLS), KKKK (residues 345-358) and PMYRKKF
(residues 275-281) were predicted to be present in Ptr3p. Interestingly, the
mutant Ptr3p containing the alanine substitution of KKKKK residues still
maintained its function, but when RKK residues were substituted with alanine
residues, the RKK mutant had a reduced Ptr3p function. The reduced activity in
peptide transport of the RKK-Ptr3p mutant suggests that Ptr3p may move from
the plasma membrane to the nucleus to function. Biochemical analysis also
supports that Ptr3p could dissociate from its plasma membrane localization and
may localize to different cellular compartments in the cell (Klasson et al., 1999).
However, the N-terminus fusion of GFP-Ptr3p did not show a nuclear
localization, but instead localized in a punctate pattern associated with the
plasma membrane (Narita and Becker, unpublished observation). A shuttling
mechanism has been observed in sugar sensing, where Std1p, a regulatory
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protein that interacts with the the carboxy-terminal extensions of the glucose
sensor Snf3p, moves to the nucleus and generates a signal for induction of
several hexose transporter genes (Schmidt et al., 1999; Ozcan, et al., 1998). Std1p
localized both in the nucleus and in a punctate pattern associated with the
plasma membrane. It is possible that when Ptr3p moves from cytoplasmic
membrane to the nucleus in the course of amino acid sensing, the protein may be
cleaved or covalently modified before acting as a shuttling protein. This might be
the reason for why the GFP-Ptr3p signal did not show nuclear localization.
The identification of a zinc finger motif of C3HC4 type (RING finger) in
Ptr3p around residues 52-61 further suggests its potential as part of a
transcriptional complex. This RING finger motif occurs frequently at the DNA
binding site of a transcription factor. Surprisingly only the C57A mutant had a
reduced Ptr3p function, while single Ala substitution of the other two conserved
cysteine residues C52 and C60 did not affect the ability of Ptr3p to complement a
ptr3∆ phenotype (Table 5). The C52A;C60A double or C52A;C57A;C60A triple
mutant had a reduced Ptr3p function similar as that of C57A single mutant.
However, there was no decreasing Ptr3p function when single, double, or triple
conserved cysteine residues were substituted by alanine, suggesting that these
cysteine residues may not form a RING finger motif. The reduced function of
cysteine mutants may indicate that they are involved in other structural function
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such as disulfide bond formation. Ptr3p residues 1 to 250, which contain the
predicted RING finger motif and were shown by preliminary two-hybrid
analysis to interact weakly with the N-terminus of Ssy1p and strongly with
Ssy5p (data not shown), partially complemented a ptr3∆ strain suggesting that
residues 1 to 250 of Ptr3p are not enough to exert fully a functional Ptr3p
phenotype.
The identification of a high probability (>90%) seven-bladed β-propeller
fold within the C-terminal portion of Ptr3p suggested that this domain may be
involved in protein-protein interactions. Shown by both response to toxic
peptide and uptake of radiolabeled Leu-Leu (Fig. 3A and B), Ptr3p residues 250
to

678

which

contain

the

predicted

seven-bladded

β-propeller

motif

complemented a ptr3∆ strain suggesting that these residues contain a domain(s)
sufficient for Ptr3p function. Several β-propeller structures govern proteinprotein interactions, e.g., lectins (Beisel et al., 1999) and the WD-40 domains in Gprotein signaling molecules (Wall et al., 1998). Within the predicted β-propeller at
the C-terminal portion of Ptr3p, a limited homology sequence with Gcn4p and
the extracellular loop of some amino acid permeases was present (Klasson et al.,
1999). These sequences are hypothesized to serve as an amino acid binding site
(Klasson et al., 1999). Alanine substitution of each of the conserved FNNSP
residues resulted in a Ptr3p with a phenotype demonstrating up-regulation of
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peptide transport suggesting that these residues may regulate Ptr3p function
negatively as an autoinhibitory domain. It may also indicate that Ptr3p’s ability
to interact with another protein is regulated by amino acid binding to these
residues.
Further experiments will be needed to analyze protein-protein
interactions among Ssy1p, Ptr3p, and Ssy5p and their post-translational
modification or conformational changes in response to amino acid and peptide
sensing. It will also be necessary to study which residues in Ptr3p are responsible
for its putative proteolytic property on Ssy5p, and whether this enzymatic
capability is the key for Ptr3p to propagate amino acid signal transduction.
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CHAPTER I
SUMMARY AND DISCUSSION

PTR3 modulates the amino acid and dipeptide induction of di/tri-peptide
transport.
We have performed molecular, genetic, and structural analyses of Ptr3p, a novel
protein involved in the regulation of the di/tri-peptide transport system in
Saccharomyces cerevisiae. The new findings obtained from this study are used to
develop further known and potential roles of Ptr3p, which are shown in Fig. 1
and summarized below.
Using a reporter gene assay to determine the activation of PTR2 di/tripeptide transporter gene, we found that Ptr3p mediated not only amino acid, but
also dipeptide induction of PTR2 expression. Ptr3p is likely to play a role in an
early step of amino acid induction pathway because two-hybrid analysis and coimmunoprecipitation showed that Ptr3p interacted with the cytoplasmic, Nterminal 282 amino acid domain of the amino acid sensor Ssy1p suggesting that
the Ssy1p/Ptr3p interaction was involved in generating signal after amino acid
sensing (Chapter II). Interestingly, we found thatGFP-Ptr3p fusion protein was
associated with the plasma membrane in a punctate pattern in the wild-type cell
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Fig. 1. Known and potential roles of Ptr3p in amino acid and dipeptide mediated
signal transduction. We found that Ptr3p is involved in amino acid sensing
regulation by physically interacting with the N-terminal domain of amino acid
sensor Ssy1p. Upon amino acid binding to Ssy1p, Ptr3p is hypothesized to
dissociate from the sensor machinery Ssy1p-Ptr3p-Ssy5p and move to another
subcellular compartment(s) (Klasson et al., 1999). The nature of conformational
changes or covalent modifications is currently unknown (two forms of Ptr3p are
indicated by open circle and open triangle). We found that Ptr3p is involved in
dipeptide induction of PTR2 expression. Dipeptide is likely to provide positive
feedback regulation by binding to allosteric sites of Ptr1p (Turner et al., 2000). We
discovered that STP1 and STP2 are involved in di/tripeptide transport, and
Stp1p and Stp2p (in blue box) may act as candidates for subsequent Ptr3pinteracting proteins besides those listed in black boxes (Bernard and Andre,
2001b; Forsberg et al., 2001; Nielsen et al., 2001). Finally, we propose that
intracellular amino acids (from intracellular pools or from amino acids
transported into the cell) might provide another regulatory loop by binding to
putative amino acid binding sites in Ptr3p, implying Ptr3p as part of intracellular
amino acid sensing signaling perhaps through interactions with Ptr2p and amino
acid permeases (AAP).
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and ssy1∆ mutant indicating that Ptr3p may have other functions besides
working together with Ssy1p to generate intracellular amino acid sensing signals.
Alternatively, the punctate localization may suggest a previously unknown
sensory complex.
Insights into the function of Ptr3p should be further gained with
information on the connection between PTR3 and other genes known to
modulate peptide transport. We identified STP1 and STP2, genes previously
hypothesized to encode pre-tRNA splicing proteins (Wang and Hopper, 1998)
and bind to the BAP2 promoter as transcription factors (Nielsen et al., 2001), as
new players in peptide transport regulation (Chapter III). STP2 likely acts
downstream of PTR3 as shown by epistasis studies, but PTR3 does not regulate
the expression of STP1 or STP2. In contrast to the PTR2 expression pattern, in
rich nitrogen source STP1 and STP2 are expressed at higher levels than those in a
poor nitrogen source. The data provide the first evidence about the involvement
of STP1 and STP2 in the di/tri-peptide transport system, suggesting their
function as transcription factors of PTR2 acting downstream of PTR3.
Ptr3p is expected to play roles in numerous pathways, because we
identified by a two-hybrid screen Ptr3p-interacting proteins involved in
transport including some transporters, transcription processes, and unknown
functions (Chapter IV). Two different computational algorithms predicted that
222

Ptr3p contains two putative nuclear localization signals (NLS), and alanine
substitution of one of these NLS decreased the Ptr3p function as a regulator of
PTR2. PROSPECT, a 3-dimensional protein structure algorithm, also calculated
that Ptr3p has a RING finger and a seven-bladed β-propeller motif. Alanine sitedirected mutagenesis of some conserved residues in the ring finger motif
reduced the function of Ptr3p. Mutations within the predicted β-propeller motif
indicate that this motif may be important as an autoinhibitory domain of Ptr3p,
because their substitution resulted in a more functional mutant than the wildtype Ptr3p. Finally, we identified functional domains of Ptr3p. The expression of
Ptr3p residues 1-250 or 1-500 partially complemented ptr3∆ phenotype, and
residues 250-678 were as functional as full length Ptr3p. These results add further
to an understanding of the role of Ptr3p in the amino acid induced signal
transduction pathway. However, the detailed mechanism of how Ptr3p
participates in a signal transduction after extracellular amino acid sensing
remains elusive.

Identification of hypothesized amino acid sensor machinery complex
consisting of Ssy1p, Ptr3p, and Ssy5p.
Recent genetic and biochemical data indicate that Ptr3p together with the
amino acid sensor Ssy1p and a newly discovered regulatory protein Ssy5p are
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components of the SPS (Ssy1p-Ptr3p-Ssy5p) sensor at the plasma membrane. The
presence of each protein is needed to form a functional sensor (Forsberg and
Ljungdahl, 2001). Genetic analysis showed that deletion mutants of single or
combination of SSY1, PTR3, and SSY5 had identical phenotypes including
inability to induce the transcription of amino acid permease genes and PTR2 in
cells grown in amino acid containing media. (Barnes et al., 1998; Jorgensen et al.,
1998; Iraqui et al., 1999; Klasson et al., 1999; Forsberg and Ljungdahl, 2001). The
N-terminal tail of Ssy1p (NSsy1p), which is expected to face the cytoplasm, is
essential for sensor function. Some small, in-frame mutations within the Nterminal tail of Ssy1p abolished Ssy1p function (Klasson et al., 1999).
Overexpression of NSsy1p caused a dominant negative phenotype suggesting
that the overproduced NSsy1p competes with the full-length of Ssy1p for
binding of a necessary regulatory protein to transduce the amino acid sensing
signals (Klasson et al., 1999).
Biochemical analysis suggests that electrophoretic properties of Ssy1p,
Ptr3p, and Ssy5p components depends on the presence of the other two
components or amino acids in the growth media (Forsberg and Ljungdahl, 2001).
Ssy1p migrates faster in the presence of amino acid-containing media, and both
PTR3 and SSY5 are required for this electrophoretic phenotype. A slower
migrating Ptr3p in amino acid containing media depends on SSY1, but not SSY5.
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The nature of modification in these Ssy1p and Ptr3p species is not known.
Interestingly, Ptr3p seems to have an enzymatic property since the proteolytic
cleavage of Ssy5p’s N-terminus is dependent on the presence of Ptrp3p. Twohybrid analysis also showed that Ssy5p interacted with Ptr3p (Bernard and
Andre, 2001a).
A striking similarity is observed between the amino acid and sugar
sensing mechanism. SNF3 and RGT2 encode unique members of the hexose
transporter (HXT) family that function as sugar sensor proteins and possess
unusually long C-terminal domains. The cytoplasmically oriented C-terminal
extensions of Snf3p and Rgt2p have important roles in signaling. Phenotypes
associated with an snf3 deletion can be partly suppressed when the C terminus of
Snf3p is expressed as a soluble protein (Vagnoli et al., 1998), or as a hybrid with
the Hxt2p hexose transporter (Ozcan et al., 1998). Two homologous proteins,
Std1p and Mth1p, which act as repressors of SNF3 and RGT2 target genes in the
absence of signaling, physically interact with the C-terminal extensions of Snf3p
and Rgt2p (Schmidt et al., 2000; Lafuente et al., 2000). Green fluorescent proteinStd1p fusion proteins are localized to the cell periphery and the cell nucleus; thus
the possibility exists that Std1p mediates information directly from the cell
surface to the nucleus (Lafuente et al., 2000). Similarly, Ptr3p may mediate amino
acid sensing information directly from the cell environment through its
225

interaction with the N-terminal tail of Ssy1p to another subcellular compartment
(Klasson et. al., 1999).
In mammalian systems, there is no amino acid sensor protein yet
identified. However, GLUT2, a human homolog of Snf3p, (Celenza et al. 1988), is
the major facilitative glucose transporter isoform expressed in hepatocytes,
pancreatic beta-cells, and absorptive epithelial cells, and has been suggested
recently to transduce signals from the plasma membrane to the nucleus and to
propagate glucose-regulated gene expression in human (Guillemain et al., 2000).
Unlike Snf3p or Rgt2p, GLUT2 protein is unique because besides its implied
function as a glucose-sensor, it also functions as a glucose transporter. Thus,
GLUT2 protein has a dual function. Furthermore, instead of an extension of the
N-terminal tail like Ssy1p or the C-terminal like Snf3p and Rgt2p, the large
cytoplasmic oriented hydrophilic loop between transmembrane VI and VII of
GLUT2 is responsible for the glucose-induced gene expression after glucose
sensing (Guillemain et al., 2000). The loop is unique among mammalian glucose
transporters for GLUT2, and overexpression of the loop resulted in a dominant
negative effects on the glucose-mediated gene expression in wild-type cells. In
addition, the loop rapidly moved from the cytoplasm to the nucleus in response
to extracellular high glucose concentration and moved in the opposite direction
when the cells were grown in low levels of glucose. The results indicate that this
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loop competes to bind to protein(s) involved in regulation of gene expression
after glucose sensing. Thus, the mechanism has some similarity with those
proposed in yeast sugar or amino acid sensing.

The role of Ptr3p in amino acid and dipeptide-mediated signal transduction.
The fact that yeast amino acid sensors have only been recently discovered
shows how little is understood regarding the molecular signals that enable yeast
cells to adapt to changing environments. Another layer of regulation on amino
acid and peptide transport was also added by dipeptide positive feedback
regulation on peptide transport. In vitro binding assay indicated that dipeptides
accelerated the di/tri-peptide uptake by allostericaly binding to Ptr1p/Ubr1p
thereby activating ubiquitin-mediated degradation of the PTR2 repressor Cup9p
(Turner et al., 2000). Ptr3p, previously known to regulate the amino acid
induction of PTR2 expression, was involved in dipeptide induced PTR2
expression. PTR3 deletion reduced induction by dipeptides, suggesting that
Ptr3p is important for optimal dipeptide induction. Therefore, Ptr3p may
function as a shared regulatory protein between the dipeptide and amino acid
induction pathways, and a complex network of regulatory processes under these
two induction systems should exist in a co-ordinated way.
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Ptr3p was previously shown to localize at the plasma membrane by
gradient centrifugation and GFP-fusion localization (Klasson et al., 1999; Chapter
II). Studies are underway to test a possibility that Ptr3p may dissociate from the
SPS sensor and localize in some other compartment(s) after amino acid sensing.
The reduced activity in peptide transport of a Ptr3p mutant at its predicted
nuclear localization signal RKK residues suggests that Ptr3p may move from the
plasma membrane to the nucleus to function. As discussed above, a shuttling
mechanism is possessed by regulatory protein Std1p, which interacts with the Cterminal domain of the glucose sensors, Snf3p and Rgt2p and needs to move
from the plasma membrane to the nucleus to transduce the sugar sensing signals
(Schmidt et al., 1999). Information on this shuttling mechanism can be gained by
testing whether the predicted NLS RKK is actually a true NLS. GFP-fusion with
Ptr3p containing the RKK alanine mutation did not affect its localization (data
not shown), but this observation does not rule out RKK as a signal. The
resolution of the GFP-Ptr3p fusion protein carried out by standard fluorescent
microscopy may not be fine enough to determine subcellular movement in
intracellular localization. Some experiments should include localization of GFP
containing the predicted NLS RKK residues. If these RKK residues really confer a
signal for nuclear localization, GFP containing the RKK amino acids might
localize in the nucleus in contrast to the cytoplasmic localization of GFP alone.
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Previously, in contrast to localization of GFP-Std1p at both plasma
membrane and nucleus, N-terminal fusion of GFP with Ptr3p localized as a
punctate pattern associated with the plasma membrane only. Nevertheless,
experiments showing that Ptr3p may dissociate from the cytoplasmic membrane
(Klasson et al., 1999) and may move to other subcellular compartment(s) as
truncated Ptr3p (Chapter 4; residues 250-678 complemented a ptr3∆ strain) may
indicate that part of Ptr3p may migrate into the nucleus during signal
transduction. Such movement of a portion of Ptr3p would not be detected by the
analysis of the GFP-Ptr3p construct performed in this dissertation. Our data
suggest that Ptr3p residues 250-678, which contain the predicted NLS RKK
residues, retained properties allowing peptide transport activity similar to that of
the wild-type Ptr3p. Therefore, GFP-fluorescence and biochemical gradientcentrifugation localization analysis of Ptr3p residues 250-678 might address the
possibility that during signal transduction, the full length of Ptr3p is necessary to
form the SPS sensor, but after amino acid sensing and perhaps some postposttranslational modifications, a certain domain of Ptr3p may move to another
subcellular compartment such as the nucleus.
The complexity of regulation is magnified by the fact that mutations in
Ptr3p have a pleiotropic phenotype indicating that this novel protein is involved
in several pathways. If Ptr3p moves to the nucleus to function or stays at the
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plasma membrane to transduce the signals, what are the downstream targets of
the SPS sensor? Specifically, what are the candidates of Ptr3p interacting
proteins, which subsequently send signals to further downstream effectors?
From epistatic analysis, genes involved in di/tri-peptide transport such as CUP9
which encodes a repressor of PTR2 and STP2 which encodes previously
hypothesized pre-tRNA splicing proteins (Wang and Hopper, 1988) and is a
transcription factor that binds to the BAP2 promoter (Nielsen et al., 2001) have
been shown to act downstream of PTR3. Thus, Cup9p or Stp2p are candidates for
downstream Ptr3p interacting proteins within the amino acid induction
pathway.
However, recent discoveries have found additional proteins from several
different pathways involved in induced transcription of amino acid and peptide
permeases.

The list of Ptr3p interacting protein should include all of these

proteins (Fig. 1). Proteins involved in ubiquitin pathways such as the SCFGRR1
ubiquitin-ligase complex (Grr1p, an F-box protein, and Uga35p, a transcription
factor of Cys6-Zn2 family) may interact with Ptr3p during amino acid sensing
pathway mediated by the SPS sensor because the SCFGRR1 ubiquitin-ligase
complex is essential for transcription of genes under Ssy1p control (Iraqui et al.,
1999a; Bernard and Andre, 2001b). Ptr3p localized independently from Ssy1p
indicating functions of Ptr3p other than a component of the SPS sensor. Proteins
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involved in the functional expression of amino acid permeases under an indirect
control of Ssy1p (Forsberg et al., 2001) may also interact with Ptr3p. They include
Asi1p, Asi2p, and Asi3p, which together form a novel membrane-bound
ubiquitin ligase system, and Rsp5p, Bul1p, and Bro1p affect amino acid permease
traffic in the late endosomal vacuolar protein sorting pathways. Furthermore,
because PTR3 has also been shown to regulate the expression of amino acid
permease genes, other proteins that regulate the expression of amino acid
permeases genes may serve as Ptr3p interacting proteins. These include
regulatory proteins of BAP2 expression such as Leu3p, Tup1p, Stp1p, and Stp2p
transcription factors (Nielsen et al., 2001).
Obviously, to determine which proteins interact with Ptr3p requires many
experiments in addition to a two-hybrid screen, whose limitation includes a oneto-one protein-protein interaction assay rather than a protein complex
interaction. A pull-down experiment can be performed to discover members of
putative Ptr3p-interacting complexes. Further biochemical and biophysical
analysis to show post-translational modification(s) important for specific
interaction after or before amino acid sensing could be worthwhile to pursue.
The elucidation of the protein-protein interaction and the post-translational
modification within the SPS sensor and the subsequent downstream targets
should provide valuable information on how amino acid-induced signal
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transduction occurs. Sets of experiments need to be designed carefully to capture
the types of modification and interaction because the amino acid sensing appears
to be a dynamic process. Three sensor states were discovered based on the rapid
physical alterations and reduced levels of sensor components in response to
amino acid availability (Forsberg and Ljungdahl, 2001a). The state I sensor is the
complex present in cells grown in the absence of amino acids, where each of the
SPS component is present at high level. State II is a series of transient complexes
that are rapidly formed when cells grown in the absence of amino acids are
induced by amino acids, and state III corresponds to a down-regulated complex,
which is indistinguishable from those found in the complex of cells grown in
media containing amino acids.

Discoveries of functional domains and motifs in Ptr3p.
The involvement of a PTR3-downstream gene encoding Stp2p, a
previously hypothesized pre-tRNA splicing proteins (Wang and Hopper, 1988),
in di/tri-peptide transport may add an unusual regulation on PTR2 expression.
Linking the roles of Stp1p and Stp2p as hypothetical pre-tRNA splicing proteins
with their role as transcription factors should be important for dissecting
regulatory pathways of di/tri-peptide and amino acid transport. In E. coli a
repression on opp and dpp transport system by gcvB encoding a small232

untranslated RNA was recently identified (Urbanowski et al., 2000) providing a
putative similar regulatory protein in a prokaryote.
The ability of Ptr3p to interact with the cytoplasmic portion of other
membrane proteins localized at the plasma membrane such as the C-terminal
domain of Thi7p and the internal domain of YGR125Wp shown in two-hybrid
assay raises a possibility that the ability of Ptr3p to interact with permeases may
be part of its function in the amino acid sensing feedback mechanism. Ptr3p was
also hypothesized to bind amino acids (Klasson et al., 1999), and alanine
mutation of these proposed amino acid binding residues led to an increased
peptide transport activity compared to that of the wild-type cells (Chapter 4).
Therefore, Ptr3p may also function as a component of an intracellular amino acid
sensing mechanism, and this mechanism may be the type of regulation that
connects amino acid and dipeptide induction of peptide transport in yeast cells.
If Ptr3p plays roles in different pathways, how does it function? The
predicted ring finger motif within residues 1-250 and seven-bladed β-propeller
motif within residues 250-678 indicate that different regions of Ptr3p exert
specific functions. Interestingly, the leaky phenotype of ptr3 null mutant or Ptr3p
residues 1-250 suggests that alternative(s) pathways should exist. SSY5 may
provide a different amino acid induction pathway from that mediated by PTR3
because overexpression of SSY5 can complement the ptr3∆ phenotype (Forsberg
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and Ljungdahl, 2001). It is necessary to perform complementary analyses such as
two-hybrid and co-immunoprecipitation is needed to show which regions of
Ptr3p interact with Ssy1p and Ssy5p. Biochemical analysis to show the domain(s)
responsible for the Ptr3p-dependent proteolytic products of Ssy5p should also be
performed. Additionally, as discussed above localization study on each domain
is needed to test the hypothesis of Ptr3p’s movement from the plasma membrane
to another subcellular compartment.
To study thoroughly the structural properties of Ptr3p a solved crystal
structure of Ptr3p is needed. This may require the crystallization of each
predicted domain independently. The circular dichroism analysis of the purified,
predicted seven bladed β-propeller domain of Ptr3p may also give insight
whether β-sheets, the builders of β-propeller fold, are present. Another
demanding task will be providing answers on how signal transductions occur
after the cells sense amino acid or dipeptide. For example, after amino acid
binding to Ssy1p, what are the subsequent conformational changes or posttranslational modification of Ptr3p that result in the activation of gene
expression? Fig. 2 shows a proposed model of signal transduction pathways after
amino acid sensing. Since Ptr3p may bind to amino acid, and dipeptide actually
binds to Ubr1p/Ptr1p, regulation between extracelullar versus intracellular
amino acid or dipeptide sensing should also exist. This type of regulation might
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Fig. 2. A proposed model of Ptr3p-mediated signal transduction after amino acid
sensing. In the absence of amino acid inducers, the C-terminal portion of Ptr3p
autoinhibits its own function. Amino acid inducer binding to Ssy1p relieves the
Ptr3p autoinhibition, and the C-terminal portion of Ptr3p, which is predicted to
have a β-propeller structure, is exposed. One pathway may involve a subsequent
binding of protein X to Ptr3p (A). Alternatively, Ptr3p may be proteolytically
process and the C-terminal portion moves to another subcellular compartment
such as nucleus (C). Ssy5p may be also enzymatically processed by Ptr3p in this
pathway and generates alternative signals (B).
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also inter-connect with the ubiquitination system. Previously, SCFGRR1 ubiquitinligase complex (Iraqui et al., 1999a; Bernard and Andre, 2001b), a membranebound ubiquitin ligase system Asi1p, Asi2p, Asi3p, and a ubiquitin ligase system
Rsp5p, Bul1p, Bro1p (Nielsen et al., 2001) were shown to be involved in di/tripeptide or amino acid transport. Regulation among these systems and how a
novel protein such as Ptr3p may be involved in a wide variety of metabolic
processes will be essential for understanding how the cells respond to nutrient
availability.
Finally, with the explosion of genome sequencing, it is important to
perform comprehensive searches of the SPS homologs in different organisms.
Ssy1p, Ptr3p, and Ssy5p homologs have been recently identified in other fungal
species (Narita and Becker, unpublished observation), and it is likely that the
other two components of the SPS sensor have homologs in these newly
sequenced fungal organisms. Further regulatory networks could be obtained by
application of techniques utilizing genome-wide scale analysis such as
microarray. Microarray analysis showed that Ssy1p regulated transcription of
many non-amino acid or peptide permease genes (Forsberg et al., 2001b).
Furthermore, our microarray analysis also showed that Ptr3p was involved in
various pathways including other nutrient transport such as sugar and sulfate
uptake systems (Goldstein et al., manuscript in preparation). Comprehensive
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genome-wide two-hybrid analysis that can detect protein complex interaction
will accelerate the completion of amino acid signal transduction pathways maps.
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CHAPTER II
SUGGESTIONS FOR FUTURE EXPERIMENTS

Our recent work has provided a framework of amino acid and dipeptidemediated signal transduction. Ptr3p seems to have several roles that are
worthwhile to test within the pathways proposed. The first hypothesis to be
tested should be that Ptr3p dissociates from SPS and moves to the nucleus after
amino acid sensing. I suggest the following experiments to test this hypothesis:
1. The RKK NLS in Ptr3p, whose mutant was shown to be reduced in transport
activity, needs to be tested. GFP containing a portion of Ptr3p with this RKK
NLS could be designed and tested for localization. If this GFP mutant
localizes to the nucleus, it indicates that the RKK NLS is sufficient to provide
nuclear localization signal.
2. GFP containing both RKK and KKKKK NLS could be tested also for its
localization to test the possibility of a bipartite NLS existence in Ptr3p.
3. Previously, the N-terminal GFP fusion to Ptr3p was shown to localize as a
punctate pattern around the plasma membrane and was not detectable in the
nucleus. Furthermore, fragmentation studies showed that Ptr3p residues 250678 were functional similar to that of the wild-type suggesting that the
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absence of nuclear localization may be due to a cleavage of Ptr3p. Thus,
instead of the full length of Ptr3p, only residues 250-678 may move to the
nucleus. One experiment to test this possibility is creating a GFP fusion to
Ptr3p residues 1-250 and residues 250-678 with the expectation that residues
1-250 should still show a punctate pattern of localization, while residues 25678 should show a nuclear localization. All the GFP fluorescence analysis
should be done in several conditions such as in the presence or absence of
amino acid or dipeptide inducer and using either good or poor nitrogen
sources.
4. Complementation of the GFP analysis should be performed by a biochemical
analysis such as a gradient centrifugation of protein extracts grown in the
presence or absence of amino acid inducers to determine the subcellular
localization of Ptr3p.
Related to the first set of studies above, the second set of experiments
involves protein-protein interactions analyses. All precautions should be taken
carefully to make sure that each experiment is done in the right condition
because amino acid sensing transduction is likely to be a dynamic process. Thus,
the hardest part seems to be determining the correct condition for growing the
cells and extracting the proteins in order to obtain physiological Ptr3p
conformation(s). The following are the suggested experiments:
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1. Two-hybrid analysis on protein-protein interaction among Ssy1p, Ptr3p, and
Ssy5p should be performed. Preliminary two hybrid studies showed that
Ptr3p residues 1-250 interacted weakly with Ssy1p and strongly with Ssy5p,
while residues 250-678 did not seem to interact with either Ssy1p or Ssy5p.
Similar tests therefore need to be done to determine which Ptr3p residues
interact with Ssy1p and Ssy5p.
2. Two-hybrid analysis should also be done for testing the interacting of Ptr3p
with different portions of amino acid permeases and Ptr2p.
3. Co-immunoprecipitation analysis to confirm the two-hybrid results should be
performed.
4. A Ptr3p pull-down assay of cells extracts grown in inducing or non-inducing
condition could be done to complement previous two hybrid screen. The pull
down assay experiment could be done also with different fragments of Ptr3p.
5. Biochemical and physical analysis such as mass spectrophotometry of the
different fragments and full length of Ptr3p in different inducing condition is
necessary to study post-translational modification(s) that are responsible for
protein-protein interaction. Additionally, once the direct downstream Ptr3p
interacting protein identified, experiments above should be performed to test
interacting Ptr3p residues and their covalent modification(s).
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6. Ptr3p interacting proteins may also be discovered by a genetic analysis, which
after obtaining a constitutively active Ptr3p by a random mutagenesis, a
repression of its activity by overexpression or deletion of certain genes
indicate that the products of these genes may interact physically or
genetically with Ptr3p. Pools of yeast cells containing deletion of every gene
in the genome have been constructed and could be purchased from Research
Genetics (Birmingham, AL).
The third set of experiments should address the structural analysis of
Ptr3p. They are:
1. Circular dichroism and crystallization of residues 250-678 should be
performed to test the predicted β-propeller structures.
2. The cross-linking experiment using an amino acid analog along with mass
spectrophometry should be done to analyze amino acid binding to Ptr3p.
3. The proposed autoinhibitory domain within residues 250-678 may be also
analyzed by placing a fluorescent chemical -reagent within these residues,
and then quenching fluorescence experiment could be performed. The results
should tell us whether this domain is buried or exposed during signal
transduction.
Finally, because Ssy1p, Ptr3p, and Ssy5p homologs have been recently
identified in other fungal species such as Candida albicans (Narita and Becker,
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unpublished observation) and because the SPS-system affects filamentous
growth of haploids (Klasson et al., 1999), it will be valuable to test whether these
components have a function during C. albicans invasion in pathogenesis. To
answer this hypothesis, I suggest the following experiments:
1. Deletion of SSY1, PTR3, and SSY5 homologs in the fungal pathogen C.
albicans and then determining the pathogenicity of the mutated strain C.
albicans should be performed.
2. Comparison of microarray analysis of C. albicans gene expressions between
the wild-type and the deletion SPS strain may also give information on
virulent phenotype.
3. Similar techniques could be performed to test the effect of SPS in other
pathogenic fungus.
In summary, results of these experiments could provide valuable
information on Ptr3p subsequent interaction, covalent modification, and
conformation after sensing, and whether Ptr3p regulation should involve sensing
intracellular amino acids by binding to these amino acids. Furthermore, because
Ptr3p may also be involved in various pathways including other nutrient
transport such as sugar and sulfate uptake systems (Goldstein et al., manuscript
in preparation), deletion of PTR3 in this pathogenic fungal could delay the
invasion process by limiting the nutrient availability. Identification of other
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regulatory proteins in S. cerevisiae, C. albicans, and other fungal species should
accelerate the elucidation of amino acid and dipeptide mediated signal
transduction in either model system.
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